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Compartment-Specific Regulation Of Autophagy In Neurons
Abstract
Macroautophagy (hereafter autophagy) is a fundamental catabolic process that delivers damaged
cytoplasmic proteins and organelles to the lysosome for turnover. In this capacity, autophagy controls the
composition and integrity of organelles and the cellular proteome. Autophagy is vital for the development,
functionality, and survival of the nervous system. Autophagy is also essential for learning and memory,
suggesting critical roles for autophagy at the neuronal synapse. The mechanisms and cellular processes
that regulate autophagy in neurons and astrocytes, however, are poorly understood. In this thesis we have
elucidated how synaptic activity, which is a fundamental aspect of neuronal physiology, regulates the
dynamics and function of autophagic vacuoles in primary hippocampal neurons using live-cell confocal
microscopy. We found that synaptic activity regulates the motility of autophagic vacuoles (AVs) in
dendrites. Stimulation of synaptic activity dampened AV motility, whereas silencing synaptic activity
induced AV motility. Activity-dependent effects on dendritic AV motility are local and reversible.
Importantly, these effects are compartment-specific, occurring in dendrites and not in axons. Most
strikingly, synaptic activity increases the presence of degradative autolysosomes in dendrites and not in
axons. We have further defined the molecular underpinnings of autophagy in primary cortical neurons and
astrocytes in response to metabolic stress, using a combination of confocal microscopy and
immunoblotting. We found that inducing metabolic stress by nutrient deprivation or pharmacological
inhibition of MTOR (mechanistic target of rapamycin kinase) robustly activates autophagy in astrocytes,
but have less pronounced effects on autophagy in neurons. Combined, our studies indicate how different
cellular processes regulate autophagy in two dominant cell types of the brain. These findings raise
important implications for how neurons and glia manage cellular stress, and how they may collaborate to
maintain homeostasis in the brain.
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ABSTRACT

COMPARTMENT-SPECIFIC REGULATION OF AUTOPHAGY IN NEURONS
Vineet Vinay Kulkarni
Sandra L. Maday
Macroautophagy (hereafter autophagy) is a fundamental catabolic process that delivers
damaged cytoplasmic proteins and organelles to the lysosome for turnover. In this
capacity, autophagy controls the composition and integrity of organelles and the cellular
proteome. Autophagy is vital for the development, functionality, and survival of the
nervous system. Autophagy is also essential for learning and memory, suggesting
critical roles for autophagy at the neuronal synapse. The mechanisms and cellular
processes that regulate autophagy in neurons and astrocytes, however, are poorly
understood. In this thesis we have elucidated how synaptic activity, which is a
fundamental aspect of neuronal physiology, regulates the dynamics and function of
autophagic vacuoles in primary hippocampal neurons using live-cell confocal
microscopy. We found that synaptic activity regulates the motility of autophagic vacuoles
(AVs) in dendrites. Stimulation of synaptic activity dampened AV motility, whereas
silencing synaptic activity induced AV motility. Activity-dependent effects on dendritic AV
motility are local and reversible. Importantly, these effects are compartment-specific,
occurring in dendrites and not in axons. Most strikingly, synaptic activity increases the
presence of degradative autolysosomes in dendrites and not in axons. We have further
defined the molecular underpinnings of autophagy in primary cortical neurons and
astrocytes in response to metabolic stress, using a combination of confocal microscopy
and immunoblotting. We found that inducing metabolic stress by nutrient deprivation or
pharmacological inhibition of MTOR (mechanistic target of rapamycin kinase) robustly
vi

activates autophagy in astrocytes, but have less pronounced effects on autophagy in
neurons. Combined, our studies indicate how different cellular processes regulate
autophagy in two dominant cell types of the brain. These findings raise important
implications for how neurons and glia manage cellular stress, and how they may
collaborate to maintain homeostasis in the brain.
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CHAPTER 1: INTRODUCTION
Parts of this chapter have been previously published as a review article: Kulkarni V.V
and Maday S., Compartment-specific dynamics and functions of autophagy in neurons,
Developmental Neurobiology, 2018 Mar;78(3):298-310.
1.1. Challenges of being a neuron
Autophagy is an evolutionarily conserved catabolic process that maintains
cellular homeostasis by degrading and recycling proteins and organelles [1-4]. In this
process, cellular components targeted for destruction are engulfed and packaged within
an organelle termed an autophagosome (Fig. 1). Autophagosomes transport enveloped
cargo toward proteolytically-active lysosomes, and fusion between these organelles
results in degradation of autophagosome contents (Fig. 1). The amino acids and lipids
generated through the process of degradation can then be recycled to fuel new
biosynthetic reactions. Thus, autophagy provides a mechanism to constitutively regulate
protein and organelle integrity, thereby balancing the synthesis of new cellular
components with the degradation of old. Further, levels of autophagy are dynamically
modulated in response to various modalities of stress including nutrient deprivation,
protein aggregation, and disease [5, 6].
Neurons are particularly dependent on autophagy to maintain cellular
homeostasis [4, 7, 8]. Being post-mitotic, neurons are simply unable to dilute out
dysfunctional proteins and organelles via cell division. Further, neurons need to live for
the lifetime of the individual, which in the case of humans is ~90 years or longer!
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Figure 1: Diagram of the progression of autophagy
Cargoes are sequestered within double-membraned autophagosomes which then fuse
with lysosomes for degradation. Autophagic cargoes, as well as the inner membrane of
the autophagosome, are degraded by resident lysosomal hydrolases. Degradation
products (e.g., amino acids and lipids) can be re-used for new biosynthetic reactions.
Most neurons in the brain are generated during embryogenesis, and unlike other cell
types that are replaced frequently (e.g. intestinal cells are replaced every 2-3 days, red
blood cells every 4 months, and hepatocytes every 5 months), neurons are typically the
2

age of the individual [9]. Consequently, neuronal proteins and organelles are
exceptionally vulnerable to overuse and damage. Thus, neurons require robust quality
control pathways to sustain functionality over this extended lifetime [10, 11].
Neurons also face unique spatial challenges due to their extreme morphology
and polarized architecture. The soma, central headquarters of the neuron, is considered
the main site of protein synthesis and degradation and can be located up to a meter
away from sites of action for many neuronal proteins and organelles. The axon is
another specialized compartment that communicates information across large distances
reaching up to meters in length, posing a logistical challenge of how homeostatic
pathways such as autophagy are adapted to regulate protein and organelle quality
across this extended landscape.
1.2. Autophagy is essential for neuronal survival
Autophagy plays a critical role in regulating neuronal homeostasis and viability
[12-16]. Evidence supporting this role stems from various mouse models deficient for
key genes in the autophagy pathway. Genetic inactivation of Atg5 or Atg7, core proteins
required for autophagosome formation [1-3], in the nervous system is sufficient to cause
axon swelling and neuron death in mice [12, 13]. Neuronal loss is observed in pyramidal
cells in the cerebral cortex and hippocampus, and most prominently in the Purkinje cell
layer of the cerebellum [12, 13]. Loss of autophagy is also associated with a progressive
increase in ubiquitin-positive aggregates specifically within neurons and not within
surrounding glia, indicating the importance of autophagy in the constitutive surveillance
of proteome quality. Interestingly, different regions of the brain exhibit a differential
response to the loss of autophagy, indicating neuron-specific vulnerabilities to autophagy
deficiency. While Purkinje cells appear most vulnerable to autophagy deficiency, they do
3

not present aggregate pathology [12], suggesting that autophagy may play different roles
in different neuronal subtypes. Autophagy-deficient animals display progressive deficits
in motor function [12, 13] and lethality at 28 weeks [13]. Similarly, neural-specific
deletion of FIP200, a protein required for the initiation of autophagosome formation [3,
17], also results in Purkinje cell degeneration and death, cerebellar ataxia, and animal
lethality [16]. Thus, a basal level of autophagy is critical to maintain neuronal
homeostasis and protect against neurodegeneration.
In these mouse models, however, knockout of Atg5 or Atg7 was effective in
neural progenitor cells, including neuron and glial cell precursors. Therefore, non-cell
autonomous contributions from glia cannot be excluded. As a result, neuron-specific
knockout mice were generated to assess cell autonomous effects of autophagy loss.
Genetic inactivation of Atg5 or Atg7 specifically in Purkinje cells results in similar
phenotypes of progressive axon degeneration followed by neuron death in mice [14, 15].
Animals also display a progressive decline in motor coordination. Taken together, these
neuron-specific models demonstrate that autophagy is an essential and constitutively
active process in neurons that plays a critical role in neuroprotection.
More recent work has demonstrated that loss of neuronal function is the primary
cause of neonatal lethality in mice with a global deficiency in autophagy [18]. While Atg5null mice die within one day of birth [19], restoration of autophagy specifically within the
brain is sufficient to rescue neonatal lethality, extending lifetime into adulthood [18].
Thus, loss of autophagy causes a decline in neuronal function leading to neonatal
lethality. Neuronal dysfunction appears to manifest as a suckling defect, rendering
neonates incapable of surviving the initial starvation period after birth [18, 19].
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Alterations in autophagy are associated with neurodegeneration in humans [7, 8,
20, 21]. Recently, a mutation in the core autophagy protein Atg5 was identified to cause
childhood ataxia, a movement disorder associated with degeneration of Purkinje cells in
the cerebellum [22]. This mutation decreases autophagic flux, directly linking defective
autophagy with human disease. Genetic evidence also links mutations in autophagy
receptors and regulatory proteins with human neurodegenerative disease [8, 23],
although whether autophagic defects arise early in autophagosome biogenesis or later in
autophagosome clearance is under investigation.
Autophagosomes accumulate in vulnerable neurons in various
neurodegenerative diseases ranging from Amyotrophic Lateral Sclerosis, Alzheimer’s,
Parkinson’s, and Huntington’s Diseases [7, 8, 20, 24, 25], but the underlying cause for
this apparent increase is unclear. Autophagosomes accumulate if the balance between
autophagosome formation and degradation is disrupted. For example, autophagy may
be upregulated during neurodegeneration in effort to clear away the excess of misfolded
protein that is prevalent in many of these diseases. Alternatively, defects downstream in
autophagic clearance would prevent the turnover of autophagosomes and result in a
build-up of autophagosome organelles. Emerging evidence provides support for the
latter hypothesis. Defects in axonal transport [26, 27], combined with inefficient
lysosome function [28-31] have been observed in models of neurodegeneration, which
may render the autophagic pathway ineffective at clearing away cellular trash,
contributing to neuronal death.
1.3. Autophagy in the development of the nervous system
In addition to protecting the viability of mature neurons, autophagy may also play
an important role in the development of the nervous system [32-35]. Autophagy has
5

been implicated early in neurodevelopment during formation of the neural tube [32]. Mice
deficient for AMBRA1, a regulator of autophagy enriched in the neuroepithelium, have
defects in closure of the neural tube, associated with an imbalance between cell
proliferation and apoptosis of the neuroepithelium [32].
Autophagy may regulate the development of axon tracts in the central nervous
system (CNS) [34]. In mice with a systemic deficiency for Alfy, a CNS-enriched adaptor
for selective autophagy [36], interhemispheric axon tracts such as the corpus callosum,
anterior commissure, and hippocampal commissure do not develop normally and fail to
cross the midline [34]. Some axonal projections in the CNS follow unusual trajectories,
suggesting a defect in axon guidance [34]. In fact, while Alfy-deficient neurons retain the
ability to extend axons in vitro, they fail to grow in response to Netrin-1-based guidance
cues [34]. Since these animals are specifically deficient in the degradation of
ubiquitinated substrates, and not bulk autophagy, selective forms of autophagy may play
a key role in axon guidance and establishing connectivity in the developing brain.
Recently, other autophagy genes have been implicated in axon outgrowth during
brain development [37, 38]. Mice with loss of function of both copies of WDR47, a
modulator of autophagy, or a single copy of Atg16L1, a core autophagy protein, display
abnormalities in the corpus callosum [37]. Neural-specific depletion of Atg9, a core
autophagy protein that directs membrane to the growing autophagosome [1-3], also
results in abnormal development of axon tracts including the corpus callosum and
anterior commissure [38]. Curiously, while Atg9-deficient neurons show defects in
neurite outgrowth in vitro, Atg7-deficient neurons do not exhibit defects in neurite
outgrowth [38], raising the possibility of autophagy-independent roles for autophagy
genes, such as Atg9, during brain development. In some conditions, autophagy may
6

function as a negative regulator of axon outgrowth with reduced autophagy levels
resulting in increased axon length [35, 39]. While the precise mechanisms underlying the
contributions of autophagy in axonal growth and guidance are unknown, autophagy in
the leading edge of the axon may facilitate membrane recycling or turnover of signaling
information in the migrating growth cone.
Autophagy may also play a critical role in the development of synapses [35, 40,
41]. The autophagy pathway is required for assembly of presynaptic compartments in C.
elegans by regulating synaptic vesicle clustering [35]. Autophagy may also promote
formation of the presynaptic axon terminal at the neuromuscular junction [40, 41], and
inhibition of autophagy results in alterations in neurotransmission [41]. Taken together,
these observations indicate that autophagy may impact synaptogenesis via regulation of
synaptic structure and function.
Lastly, autophagy may function later in neurodevelopment and mediate the
elimination of excess dendritic spines [33]. Tang et al. demonstrated that deficits in spine
pruning exhibited in mouse models of autism with hyperactive mTOR, are attributed to
low levels of autophagy. Mice with selective loss of autophagy in pyramidal neurons
exhibit an increase in dendritic spines in the cortex and social deficits akin to autism-like
behaviors. Taken together, autophagy is implicated in various stages of
neurodevelopment to ensure the stereotyped connectivity of the CNS, and alterations in
autophagy may be associated with neurodevelopmental disorders. In total, the loss of
autophagy manifests differently depending on the gene targeted and neuron-type
examined. Loss of core autophagy proteins can result in neurodevelopmental defects
(e.g. Atg9 and Atg16L1), while others (e.g. Atg5, Atg7, FIP200) display a
neurodegenerative phenotype. Since neural-specific loss of Atg5 and Atg7 protein
7

expression is significantly reduced by embryonic day 15.5 [12, 13], developmental
defects may still contribute to the degeneration observed postnatally in these mouse
models. In other words, these neurons may have reduced longevities as a result of not
being established properly in the first place. Roles for autophagy, independent of
neurodevelopment, could be examined directly with a conditional knockout of autophagy
in adult neurons.
The diversity of phenotypes generated by the reduction of core autophagy and
modulatory proteins may be further confounded by the possibility that perturbing
autophagy proteins may have pleiotropic effects. Indeed, autophagy proteins may
“moonlight” as key players in other cellular processes. The fact that mouse models
deficient for Atg9, FIP200, Alfy, and AMBRA1 die at an earlier developmental stage than
neural-specific loss of Atg5 or Atg7 hints at this possibility. Future studies are necessary
to define additional functions for these autophagy-related proteins.
Further, loss of the same gene can yield different phenotypes depending on the
type of neuron examined. In the case of C. elegans, Atg9 loss-of-function mutants
exhibit synaptogenesis defects in a population of interneurons, and axonal growth
defects in a population of sensory neurons [35]. In summary, the role of autophagy may
evolve with time and depend on neuron-specific demands.
1.4. Compartment-specific dynamics of autophagosomes in neurons
Given the extreme spatial challenges facing neurons, how is autophagy
coordinated in each compartment of the neuron, i.e. the axon, dendrites, and the soma?
Further, how are the dynamics of autophagy in neurons uniquely suited to facilitate
compartment-specific demands and functions? For example, the axon is dependent on
supply from the soma, but how is protein and organelle quality managed far away from
8

sites of synthesis and degradation that are concentrated in the soma? Insights into the
features of autophagosome motility in neurons have emerged from live-cell imaging
studies of GFP-LC3, the canonical marker for the autophagosome [42, 43]. Cytoplasmic
LC3 is lipidated and inserted in the growing autophagosomal membrane, and plays
important roles in sequestering cargo as well as defining the curvature of the
autophagosomal membrane (cite a review).
Under basal conditions of growth, autophagosomes in the axon are preferentially
generated in the distal end of the axon (Fig. 2A) [44-46]. GFP-LC3-positive
autophagosomes initially appear as punctate structures that progressively increase in
size, reaching up to 800 nm in diameter [44, 45]. Autophagy core proteins Atg13 and
Atg5 are recruited, in an ordered fashion, to subdomains of the endoplasmic reticulum
(ER), indicating that autophagosomes are generated from ER membranes present within
the distal axon [45]. Following formation, autophagosomes then undergo robust
retrograde transport toward the soma (Fig. 2B) [30, 44-47]. This movement requires the
microtubule-based motor, dynein, and is correlated with a transition in maturation state
[30, 44]. Newly formed autophagosomes in the distal axon are initially LAMP1-negative
but acquire markers of late endosomes/lysosomes as they journey toward the soma [30,
44]. Thus, nascent autophagosomes fuse with late endosomes and/or lysosomes upon
exit from the distal axon, and this initial advance in maturation may trigger retrograde
transport to the soma [48, 49]. Proximal to the cell body, autophagosomes have fully
acidified and fused with degradative lysosomes [30, 44]. Therefore at steady state,
axonal autophagy is a vectorial pathway that requires long-distance transport to deliver
cargo from the distal axon to the soma. This distal autophagy may function to maintain
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axonal homeostasis and regulate the quality of the neuronal proteome at sites far
removed from the soma.

Figure 2: Overview of compartment-speciﬁc autophagy in neurons.
Key characteristics of autophagosome dynamics and function in the presynaptic terminal
(A), mid-axon (B), soma (C), and dendrites (D). Blue arrows denote directionality of
autophagosome movement.
The soma, however, contains multiple populations of autophagosomes at
different maturation states, including input received from the axon combined with locally
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generated autophagosomes [50] (Fig. 2C). Evidence for autophagosome biogenesis in
dendrites has been limited under basal conditions, but dendritic autophagosomes are
elevated under conditions of enhanced synaptic activity [51], either by increased local
biogenesis or the recruitment of pre-existing autophagosomes to sites of synaptic
function. Once in the soma, autophagosomes are confined within the somatodendritic
domain, unable to enter into the axon [50]. Autophagosomes freely travel into dendrites
where they exhibit either stationary or bidirectional motility [45, 50], likely due to the
mixed polarity of the underlying microtubule cytoskeleton [52, 53]. The majority of
autophagosomes that enter into dendrites, however, return to the soma [50]. In effect,
this restriction to the somatodendritic compartment likely facilitates cargo degradation by
promoting fusion with proteolytically-active lysosomes that are enriched in this region of
the neuron (Fig. 2C) [28, 30]. Concentrating degradative activity in the soma may in turn
facilitate efficient recycling of biosynthetic building blocks to primary sites of protein
synthesis. In sum, autophagosomes exhibit compartment-specific dynamics within the
neuron that may facilitate autophagosome function.
1.5. Degradation of autophagic cargo
Lysosomes with high proteolytic activity are concentrated in the cell body, making
the soma enriched for degradative activity (Fig. 2C) [28, 30]. Inhibition of lysosome
function results in an accumulation of autophagosomes specifically within the soma, and
not in the axon or dendrites [50]. Therefore, the final destination for autophagosome
clearance in the neuron is predominantly the cell body, and autophagosomes originating
in the distal axon travel the entire distance of the axon to deliver their cargo to the soma
for degradation.

11

While the contents of autophagosomes are largely unknown, retrograde axonal
autophagosomes contain engulfed cytosolic as well as organelle cargoes [44]. A small
percentage (~10%) of autophagosomes contain fragments of mitochondria [44]. A key
question is whether this retrograde axonal pathway for autophagy represents constitutive
or selective autophagy, or both? Constitutive or basal autophagy recycles the cytoplasm
and its constituents, in a non-selective and continuous manner, to balance synthesis
with degradation. Selective autophagy is induced by stress, such as organelle damage,
and specific substrates are removed through recognition by adaptors linking cargo to the
autophagic machinery [54-56]. Recent work has suggested that selective autophagy
may be compartmentalized within the neuron [34, 57-59].
Selective removal of damaged mitochondria by autophagy (mitophagy), has been
extensively studied in HeLa cells [60, 61], and involves the serine/threonine kinase
PINK1 and E3 ubiquitin ligase Parkin. The contributions of PINK1 and Parkin to
mitophagy in neurons, however, is less clear [62]. Although under basal conditions, few
autophagosomes are generated in the mid-axon, acute and focally induced
mitochondrial damage can activate autophagy locally within the mid-axon of primary
hippocampal neurons [59]. This axonal mitophagy requires recruitment of PINK1 and
Parkin [59]. In contrast, globally induced mitochondrial damage stimulates retrograde
transport of mitochondria for autophagic engulfment within the soma [57]. Lastly, recent
reports have shown that mitophagy is rare in motor neurons in Drosophila, and Parkin
functions exclusively in the soma to regulate mitochondrial quality control by balancing
mitochondrial fission and fusion [58]. Future work will be important to resolve the
compartment selectivity to mitophagy and whether the type of mitochondrial damage or
insult affects these dynamics.
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Ubiquitinated protein aggregates are targeted for autophagic degradation by the
adaptor Alfy [36]. Alfy is enriched in the axon [34], suggesting that the axon may have its
own machinery for executing selective autophagy. This finding also suggests the
existence of compartment-specific populations of autophagosomes that are essential for
proper axonal guidance and development.
In addition to intra-neuronal autophagy, garbage can be shuttled to neighboring
glia for degradation. Mitochondria can be extruded from retinal ganglion cell axons and
internalized and degraded by neighboring astrocytes [63]. Adult neurons in C. elegans
discard cellular garbage through the secretion of vesicles, called exophers, containing
protein aggregates and organelles [64]. Production of exophers increases when
endogenous quality control pathways, including autophagy, are compromised [64].
Taken together, these findings indicate that neurons have alternative mechanisms for
eliminating cellular garbage, involving non-canonical intercellular pathways for
degradation.
1.6. Neuron-specific functions of autophagy at the synapse
Neuronal synapses are sites of high demand for cellular degradation pathways
[10, 11]. Neurons fire action potentials at rates of up to ~50 impulses per second [65-68],
rendering synaptic proteins and organelles susceptible to being overworked and
damaged. Further, synapses are dynamic, being remodeled in response to
developmental and sensory cues to refine connections and circuits in the brain [69, 70].
Therefore, synapses require efficient degradation systems to maintain integrity of the
local proteome and sustain function [8, 10, 11, 71]. In fact, synaptic activity regulates
levels of autophagy in neurons [51, 72, 73]. In turn, autophagy impacts synaptic function
with emerging roles at both pre- and post-synaptic domains [71, 74]. A significant role for
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autophagy at synapses may help explain why Purkinje cells are the most vulnerable to
the loss of autophagy because they have the highest basal firing rates in the brain [65,
68].
Neuronal stimulation induces autophagosome biogenesis in presynaptic regions
[72, 73, 75]. While formation of these autophagosomes utilizes core machinery
conserved from yeast [45], several neural-specific regulatory factors modulate rates of
autophagosome biogenesis at the synapse [72, 75-77]. Endophillin A, an endocytic
adaptor enriched at the presynaptic terminal, promotes autophagy by generating highly
curved membranes, which serve as a platform to recruit core autophagy proteins that
form autophagosomes [72, 76]. Synaptojanin 1, a lipid phosphatase important for
synaptic vesicle trafficking, is also required for autophagosome biogenesis at
presynaptic terminals [75]. Bassoon, a scaffolding protein localized to the presynaptic
nerve terminal, inhibits presynaptic autophagy by sequestering the core autophagy
protein Atg5, making it unavailable for autophagosome biogenesis [77]. How these
opposing regulatory mechanisms are coordinated to control presynaptic autophagy
levels is unknown. In addition, how synaptic activity is sensed by the aforementioned
mechanisms and how calcium influx may be involved remains uncertain.
While the precise function of autophagy in the presynaptic domain is largely
unknown, identification of engulfed cargoes has provided key insights into this process.
Interestingly, presynaptic autophagosomes appear to engulf structures resembling
synaptic vesicles (Fig. 2A) [77, 78]. Pharmacological activation of autophagy reduces the
number of synaptic vesicles at axon terminals and loss of autophagy specifically within
dopaminergic neurons increases evoked dopamine release in mice [78]. Thus,
presynaptic autophagy negatively regulates neurotransmission by controlling the size of
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the synaptic vesicle pool and neurotransmitter release [78]. Autophagy could impact
neurotransmission either by sequestering vesicles containing neurotransmitter, or by
regulating the pool of empty vesicles available for neurotransmitter loading. Synaptic
activity also regulates autophagy in the postsynaptic domain [51]. Synaptic stimulation in
the presence of Bafilomycin A1, to inhibit lysosome-mediated degradation, results in a
moderate but significant increase in GFP-LC3-positive puncta within the dendritic shaft,
above levels observed in cells treated with Bafilomycin A1-alone, suggesting an activitydependent induction of autophagosome formation or recruitment [51]. Postsynaptic
autophagy plays a role in synaptic plasticity, activity-dependent changes in synaptic
strength [51]. Persistent increases in synaptic strength, Long-Term Potentiation (LTP), or
weakening of synaptic strength, Long-Term Depression (LTD), require structural and
functional changes at the synapse [79]. In LTP, persistent activation of NMDA receptors
leads to an increase in AMPA receptor insertion into the postsynaptic membrane [79].
Conversely, in LTD, moderate activation of NMDA receptors results in downregulation of
AMPA receptors in the postsynaptic membrane [79]. Autophagy plays a role in LTD by
mediating the trafficking and elimination of AMPA receptors (Fig. 2D). Low-dose
activation of NMDA receptors with NMDA, to model chemical-LTD, activates autophagydependent degradation of AMPA receptors [51]. Similarly, lysosomes are recruited to
synapses in an activity-dependent manner, aid in the turnover of AMPA receptors, and
thus regulate synaptic activity and density [80]. Thus, autophagy plays a role in the
plasticity, or changes in strength, of a particular synapse, which are foundational
principles underlying learning and memory [81-83]. Further supporting a role for
autophagy in synaptic plasticity, Brain-Derived Neurotrophic Factor (BDNF), a key
molecule regulating synaptic plasticity, suppresses autophagy in hippocampal neurons,
and this BDNF-induced decrease in autophagy facilitates LTP and the persistence of
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memories in mice [84]. Since autophagosomes contained key post-synaptic scaffolding
proteins such as PICK1, PSD-95 and SHANK3, autophagy may regulate synaptic
plasticity in this model by degrading postsynaptic scaffolds [84]. Lastly, CNS-specific
deletion of WDR45, a gene that encodes a protein involved in autophagosome
formation, is linked to deficits in learning and memory in mice [85]. As a product of the
degradation process, autophagy generates biosynthetic building blocks that fuel the
synthesis of new proteins. It is well known that local translation within dendrites is an
essential process for synaptic function and plasticity [86]. Thus, it is possible that
recruitment of autophagosomes to synapses promotes synaptic formation and function
via new protein synthesis. Consistent with this idea, the proteasome is recruited to
synapses in an activity-dependent manner and fuels the formation of new spine
outgrowth [87]. Under certain conditions, autophagy may function in a similar capacity.
Therefore, autophagy may have dual functions at the synapse; destroying ‘unwanted’
synapses while also sustaining and creating ‘wanted’ synapses.
1.7. Neuronal autophagy in learning and memory
The critical role of autophagy at the neuronal synapse posits the importance of
autophagy in higher order processes like learning and memory. Zhao et.al investigated
the role of neurodegenerative disease-associated protein Wdr45 in learning and memory
formation in mice [85] . Wdr45 is one of the mammalian orthologs of Atg18 found in
saccharomyces cerevisiae, and is essential for an early step of autophagosome
formation [88]. Zhao et.al generated a conditional CNS-specific WDR45 knockout mouse
and showed that Wdr45-deficient mice display defects in learning and show memory
impairment, as assessed by the standard Morris water maze test [85, 89]. Wdr45deficient mice also display ubiquitin-positive inclusions in the hippocampus that indicate
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dysfunctional autophagy and may in turn result in defective hippocampal function [85].
This study was one of the first to indicate how genes important for autophagosome
formation are involved in learning and memory.
Several studies using a variety of training paradigms have since implicated
neuronal autophagy as a key player in long-term memory formation. Hylin et.al, using
the standard Morris water maze task as a spatial training method for mice [89-91], report
that pharmacological inhibition of hippocampal autophagy prior to training leads to loss
of retention of long-term spatial memory [90]. Interestingly, though autophagy was
upregulated during the learning phase, blocking autophagy did not interfere with learning
per se [90]. Finally, stimulating autophagy by increasing the levels of Beclin-1 (a key
protein involved in the nucleation and formation of autophagosomes) leads to the
improvement of long-term spatial memory [90]. In sum, the upregulation of autophagy
upon spatial learning is critical for forming and maintaining long-term memories [90].
In an elegant study done using contextual fear conditioning (CFC), Glatigny and
colleagues report the upregulation of autophagy-initiating proteins Vps34 and Atg5 in
response to novel memory-forming stimuli [92]. In CFC, during the learning phase, mice
are given foot-shocks at precise time intervals in a conditioning chamber. Mice are then
returned to the conditioning chamber 24 hours later, and successful formation and
retention of the foot-shock memory is assessed by measuring freezing behavior. Using
this assay, the authors found that autophagy knockdown prior to training does not affect
training itself, but negatively impacts long-term memory [92]. In fact, autophagy
knockdown after training does not negatively impact long-term memory [92]. In total,
these results suggest that the stimulation of autophagy during training is important for
long-term memory. Induction of neuronal activity by chemical long-term potentiation
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(cLTP) in hippocampal neurons usually leads to an increase in the number of dendritic
spines – however, the authors found that disrupting the autophagy pathway using an
shRNA against Beclin-1 abolished activity induced formation of novel dendritic spines
[92]. These results suggest that autophagy is also essential for activity-dependent
synaptic plasticity. Strikingly, induction of autophagy in the hippocampi of older mice
leads to the reversal of age-related memory defects [92]. Thus, using a contextual fear
conditioning as a training paradigm, Glatigny et.al also concur that autophagy is
upregulated during the learning phase and is vital for the retention of long-term
memories. This study highlights the potential of the autophagy pathway as a therapeutic
target to arrest or reverse age-related memory loss in elderly populations.
A more recent study by Pandey et.al elucidates molecular changes in the
autophagy-lysosome pathway, in this case after inhibitory avoidance (IA) training [93].
Briefly, in IA training, the rodent learns to avoid a specific location after receiving a
negative stimulus [94]. Upon IA training, total protein levels of autophagy and lysosomal
proteins were expectedly upregulated, and this group also reported the necessity of
autophagy stimulation for long-term memory [93]. Interestingly, however, mRNA levels of
autophagy and lysosomal proteins were unaffected upon training [93]. In fact, IA training
led to an increased recruitment of autophagy-related mRNA to ribosomes undergoing
active translation [93]. This finding argues that training-induced upregulation of the
autophagy pathway is controlled by the translation of autophagy and lysosomal-related
mRNA transcripts. Studies in most other cellular systems indicate that the regulation of
autophagy by physiological stimuli occurs on either transcriptional or post-translational
levels [95-98]. Thus, the translational control of autophagy in response to training
appears to be a unique feature of neurons.
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Taken together, these studies identify roles of autophagy in learning and longterm memory. It is interesting to note that while autophagy is upregulated during learning
[90, 92, 93], disruption of autophagy in the training phase did not appear to impair shortterm memories [93], pointing toward very specific roles of autophagy in the long-term
maintenance of learning-induced synapses. These findings necessitate the investigation
of the regulation of autophagy in synaptic compartments.
1.8. Regulation of autophagy in glia
Glia are a dominant cell type in the brain, and can represent up to 90% of brain
cells in specific regions of the brain. Neuron-glia interactions are well established to
maintaining proper neuronal function. In fact, glia have been shown to play an important
role in various aspects of neuronal health ranging from neuronal development, metabolic
function, recovery from injury, as well as synaptic function. Glial autophagy has been
largely understudied, but some clues point toward the importance of autophagy in glial
function. In Schwann cells (which are myelinating glia of the peripheral nervous system),
autophagy is essential for the degradation of myelin following injury to peripheral nerves.
Further, microglial autophagy has been shown to be essential for the clearance of
pathogenic Aβ in the central nervous system. Surprisingly little is known about the
regulation of autophagy in glial cells. Canonically, amino-acid deprivation (starvation) is
sufficient to induce autophagy in most cell types. However, in our previous studies we
observed that neurons do not seem to upregulate autophagy response to starvation or
mTOR inhibition. Do glial cells respond similarly to neurons in the face of starvation?
Since a majority of glial cells are proliferative, while most neurons are post-mitotic,
catabolic pathways such as autophagy may be regulated differentially in these cell types
to facilitate the maintenance of homeostasis in the brain.
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1.9. Dissertation overview
Neurons face unique and localized physiological stresses as they fire action
potentials at high frequencies, and constantly remodel synapses for the entire lifespan of
an organism. Autophagy, a lysosomal degradation pathway, plays a central role in
managing neuronal stress and thus assists in proper functionality of the nervous system.
Little is known, however, about the regulation of neuronal autophagy. In the first part of
this thesis, we hypothesized that synaptic activity may regulate neuronal autophagy. My
results indicate compartment-specific control of neuronal autophagy by synaptic activity.
I further report that synaptic activity regulates the dynamics of autophagic vacuoles in
neurons co-cultured with astrocytes, suggesting that this mechanism is conserved in
more complex culturing paradigms. In the second part of this thesis, I uncovered
differences in how metabolic stress impacts autophagy in astrocytes and neurons.
Taken together, these findings provide key advancements in elucidating the molecular
underpinnings of neuronal autophagy, and highlight the distinct and compartmentspecific nature of the regulation of autophagy in neurons.
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CHAPTER 2: SYNAPTIC ACTIVITY CONTROLS AUTOPHAGIC VACUOLE MOTILITY
AND FUNCTION IN DENDRITES

This chapter has been previously published: Vineet Vinay Kulkarni, Anip Anand, Jessica
Brandt Herr, Christina Miranda, Maria Chalokh Vogel, and Sandra Maday. (2021).
Synaptic activity controls autophagic vacuole motility and function in dendrites. Journal
of Cell Biology. 2021 Jun 7;220(6): e202002084. doi: 10.1083/jcb.202002084.
VVK performed and analyzed all experiments in Figs. 3-6, 8, 10-12, 14 and 18.
VVK performed all experiments in Figs. 13, 15-17. VVK and AA analyzed experiments in
Fig 15-17. VVK performed experiments in Fig. 9B-D.
JBH performed experiments in Fig. 7. CM performed experiments in Fig. 9A
AA analyzed experiments in Figs. 7 and 13. MCV analyzed experiments in Fig. 9B-D
2.1. Introduction
Macroautophagy (hereafter “autophagy”) is a lysosomal degradation pathway
that is important for neuronal development and survival [7, 99]. During autophagy,
cellular components (e.g., proteins and organelles) are initially sequestered and
packaged into autophagosome organelles. Autophagosomes then fuse with lysosomes
to generate autolysosomes that degrade autophagic contents via lysosomal hydrolases.
Breakdown products such as amino acids and lipids are exported from lysosomes to fuel
new biosynthesis. In this way, autophagy can control the integrity and composition of the
proteome and organelles.
Loss of autophagy can have a profound impact during neurodevelopment.
Knockout of autophagy genes leads to defects in axon outgrowth and guidance and to
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the failure to form interhemispheric tracts in the brain [34, 35, 37, 38]. Autophagy deficits
can impair synapse formation and development-based spine pruning [33, 35, 40]. Loss
of autophagy can also elicit degeneration of established neuronal networks. Central
nervous system- and Purkinje cell-specific deletion of key autophagy genes leads to a
characteristic swelling of presynaptic terminals, followed by axon retraction and decay
[12-16, 38, 85]. Combined, autophagy serves essential roles in establishing and
maintaining the proper connectivity of the nervous system.
Neuronal synapses are sites of high demand for protein and organelle quality
control pathways. Neurons fire action potentials at rates that can reach up to ∼50-100
impulses per second for nearly a century of time. This activity renders the synaptic
proteome vulnerable to stress and damage. Furthermore, the composition of the
synaptic proteome is dynamic and remodeled to shape neuronal circuits, a foundational
principle underlying learning and memory. In fact, loss of autophagy has been reported
to cause deficits in learning and memory [85, 90, 92, 93]. Moreover, stimulating
autophagy can rescue age-related cognitive decline [92]. These findings point toward
critical roles for autophagy at synapses. Little is known, however, about the molecular
underpinnings of autophagy in synaptic compartments.
We previously demonstrated that autophagosomes exhibit unique transport
dynamics in axons as compared with dendrites [44, 45, 50], suggesting that there may
be compartment-specific regulation of autophagy in neurons. We, along with other
groups, found that in primary neurons, axonal autophagy follows a pathway of longrange unidirectional transport of autophagosomes that originate in the distal axon and
travel to the soma for maturation into degradative compartments [30, 44-47, 49, 50, 73].
This pathway for axonal autophagy is conserved in intact nervous systems in vivo [58,
72, 100-102]. By contrast, dendritic autophagosomes exhibit bidirectional and stationary
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movement [45, 50]. How the dynamics of autophagic vacuoles (AVs; i.e.,
autophagosomes and autolysosomes) are influenced by the activity state of the neuron
and how alterations in these dynamics impact autophagic function are largely unknown.
Here, we used live-cell confocal microscopy to define how autophagy in dendritic
and axonal compartments is regulated by synaptic activity in primary hippocampal
neurons. We found that synaptic activity regulates the motility of AVs in dendrites.
Stimulating synaptic activity dampens AV motility, whereas silencing synaptic activity
induces AV motility. Activity dependent effects on dendritic AV motility are local and
reversible. Importantly, these effects are observed specifically within dendrites and not
within axons, indicating compartment specific regulation of AV dynamics with synaptic
activity. Most strikingly, synaptic activity increases the presence of degradative
autolysosomes in dendrites and not in axons. Our data suggest that synaptic activity
may induce the maturation of dendritic AVs into proteolytically competent organelles. On
the basis of our findings, we propose a model where synaptic activity locally regulates
AV dynamics and degradative function within dendrites.
2.2. Results
2.2.1 Neuronal depolarization dampens AV motility specifically in dendrites and
not in axons
How autophagy is influenced by the activity state of the neuron is largely
unknown. Here, we define how autophagy in dendritic and axonal compartments is
regulated in response to synaptic activity in primary hippocampal neurons. To stimulate
neuronal activity, we first treated rat hippocampal neurons with 45mM KCl to induce
depolarization [103]. Neurons were loaded with 4μM Fluo-4, a calcium-sensitive dye that
fluoresces upon binding to calcium. We then performed live-cell imaging to measure
23

intracellular calcium levels in real time. On-scope addition of KCl resulted in an
immediate and dramatic increase in intracellular calcium, consistent with depolarization
of the neurons (Fig. 3, A and B). As an osmotic control, we added 45mM NaCl, which
had no effect on calcium levels (Fig. 3, A and B). Thus, treatment with KCl, and not
NaCl, results in depolarization of the neurons.
To examine the effects of stimulating neuronal activity on autophagy, we transfected rat
hippocampal neurons with mCherry-GFP-LC3 (MAP1LC3/LC3; microtubule associated
protein 1 light chain 3). LC3 is a well-characterized marker for autophagic organelles
[42], and the dual color LC3 reporter is a pH-sensitive marker that distinguishes the
maturation state of organelles within the autophagy pathway [104, 105]. Because
mCherry fluorescence is more resistant than GFP to quenching in acidic environments,
mCherry labels both immature autophagosomes and mature, fully acidified
autolysosomes, while GFP labels only immature autophagosomes. However, we
observed significant background in the GFP channel in dendrites that limited our ability
to reliably quantify the GFP signal (Fig. 4). To reduce this background signal, we
photobleached the GFP channel and determined the maturation state for those LC3
puncta that migrated into the bleached zone (Fig. 4, A and B). 15 of 15 LC3 puncta that
moved into the bleached region were positive for mCherry only and lacked GFP
fluorescence (Fig. 4, A and B). This result suggested a higher prevalence of
autolysosomes in dendrites than in axons, where compartments copositive for mCherry
and GFP are more readily detected (Fig. 4 C; [44]). Thus, the higher background with
GFP in dendrites may be due to neurite-specific differences in microtubule density
and/or microtubule binding (LC3 is a microtubule binding protein; [98]). Furthermore, the
longer lifetime and accumulation of mCherry in degradative compartments likely
improves the signal-to-noise ratio for this fluorophore.
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Figure 3. Neuronal depolarization dampens AV motility specifically in dendrites
and not in axons.
(A) Rat hippocampal neurons (13 DIV) were loaded with the calcium indicator Fluo-4
and treated with KCl to depolarize the neurons or with NaCl as an osmotic control. Scale
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bar, 50 µm. (B) Quantitation of mean Fluo-4 fluorescence intensity before and after KCl
or NaCl addition. (C) Distribution of mCherry-LC3-positive AVs in dendrites and axons of
primary rat hippocampal neurons (13 DIV). Image with soma; scale bar, 10 µm.
Magnified images of axons and dendrites with arrowheads denoting mCherry-LC3positive puncta; scale bars, 5 µm. (D) Kymographs of LC3 motility along a dendrite or an
axon of a rat hippocampal neuron. Retrograde direction is from left to right. Arrowheads
denote time of KCl or NaCl addition. Horizontal bars, 5 µm. Vertical bars, 1 min. (E-G)
Quantitation of AV mean speed in dendrites before and after KCl or NaCl addition (E,
paired points represent a single AV before and after salt addition; F, mean ± SEM; G,
difference in AV mean speed before and after salt addition; KCl, n = 68 AVs from 20
neurons from three independent experiments, 13-14 DIV; NaCl, n = 55 AVs from 20
neurons from three independent experiments, 13-14 DIV; E and F, paired t test; G,
unpaired t test; ****, P ≤ 0.0001). (H) Quantitation of AV mean speed in axons before
and after KCl or NaCl treatment (mean ± SEM; n =56-125 AVs from 8-10 neurons from
three independent experiments; 13-14 DIV; unpaired t test).
Due to these limitations in GFP signal resolution in dendrites, we relied exclusively on
the mCherry (LC3) signal to track autophagy. Because mCherry can label both
autophagosomes and autolysosomes, we collectively refer to mCherry-LC3 positive
organelles as AVs.
To assess changes in autophagy in real time, we performed live-cell imaging to
track the dynamics of mCherry (LC3) positive AVs in each compartment of the neuron.
For this experiment, we acquired time-lapse images for 5 min and performed on-scope
addition of 45 mM KCl after 2.5 min of imaging. mCherry (LC3) marks AVs that are
concentrated in the soma and also present within dendritic and axonal compartments
(Fig. 3 C and insets). In dendrites, under basal conditions, mCherry (LC3)-positive AVs
undergo bidirectional movement and oscillate within a confined region along the
dendritic shaft (Fig. 3 D, before addition of treatment). Depolarization of neurons by
addition of KCl resulted in a very striking and rapid decrease in AV motility within
dendrites (Fig. 3 D). By contrast, AV motility in dendrites did not decrease with addition
of NaCl, and AVs continued to undergo bidirectional movement after NaCl treatment
(Fig. 3 D). To quantitate the effects of neuronal depolarization on dendritic AV motility,
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we tracked individual AVs before and after KCl addition and measured the mean speed
(total distance traveled/total time traveled) for individual AVs. For this analysis, we
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Figure 4. Immature autophagic compartments are more readily detected in axons
than in dendrites.
(A and B) En face images (A) and associated kymographs (B) of mCherry-GFP-LC3 in
dendrites of a hippocampal neuron. Dashed white regions denote location of
photobleaching. Arrows in B indicate the time of photobleaching. Throughout the figure,
AVs positive for mCherry and negative for GFP fluorescence are denoted with red
arrowheads in the mCherry channel and open green arrowheads in the GFP channel.
AVs copositive for both mCherry and GFP are denoted with yellow arrowheads in both
channels. Horizontal bars, 5 µm. Vertical bar, 10 s. (C) Kymograph analysis of mCherryGFP-LC3 motility in an axon of a hippocampal neuron. Horizontal bar, 5 µm. Vertical bar,
1 min.
focused on the population of AVs that exhibited motility before treatment addition
by tracking only those AVs that traveled a total distance of ≥5 μm during the 2.5 min. We
found that neuronal depolarization with KCl decreased the average AV mean speed in
dendrites by ∼3.6-fold (Fig. 3, E and F). By contrast, we did not observe alterations in
dendritic AV mean speed upon addition of NaCl (Fig. 3, E and F). To measure the
change in AV speed upon addition of KCl or NaCl, for each individual AV, we subtracted
the mean speed after salt addition from the paired mean speed before salt addition (Fig.
3 G). Treatment with KCl reduced the AV mean speed by an average of ∼0.12 μm/s,
and this value was significantly larger than that measured for NaCl (Fig. 3 G). Indeed,
the difference in mean speeds before and after NaCl treatment was near zero
(∼0.02μm/s; Fig. 3 G). Combined, these results indicate that neuronal activity dampens
AV motility in dendrites. Interestingly, we found that the effects of neuronal
depolarization on AV motility are specific to dendrites. In axons, AV motility is biased
toward long-distance unidirectional transport, in contrast to the short-range oscillatory
movements exhibited by AVs in dendrites (Fig. 3 D). We previously demonstrated with
GFP-LC3 tracking that autophagosomes exhibit a primarily retrograde motility [44, 45,
50]. In addition to these retrograde tracks, mCherry (LC3) compartments also exhibit
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long distance anterograde trajectories, emphasizing an additional population of mature
AVs labeled with mCherry, consistent with our previous reports in dorsal root ganglion
neurons [44]. Addition of KCl (or NaCl), however, did not alter AV mean speeds in axons
(Fig. 3 H). Thus, the activity dependent decrease in AV mean speed is specific to
dendrites and is not observed in axons, indicating compartment-specific regulation of AV
dynamics.
2.2.2 Synaptic activity regulates AV motility specifically in dendrites and not in
axons
We next employed a pharmacological approach to modulate synaptic activity and
assess effects on AV motility. To stimulate synaptic activity, we treated neurons with a
cocktail of 50 μM 4-aminopyridine (4-AP) and 20 μM bicuculline (Bic), antagonists of
voltage-gated potassium channels and inhibitory γ-aminobutyric acid A receptors,
respectively [106]. To silence synaptic activity, we treated neurons with 50 μM 6-cyano7-nitroquinoxaline-2,3-dione (CNQX) and 50 μM D-(−)-2-amino-5-phosphonopentanoic
acid (AP5), antagonists of excitatory α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) and N-methyl-D-aspartate receptors, respectively [106]. Treatment with an
equivalent volume of DMSO solvent served as a control to measure AV dynamics under
the basal activity of the culture.
To validate the effectiveness of our drug treatments, we performed live-cell
imaging to measure intracellular calcium dynamics using Fluo-4; oscillations in calcium
levels serve as a proxy for the firing of action potentials. On-scope addition of 4-AP + Bic
resulted in a dramatic increase in intracellular calcium, as evidenced by increased Fluo-4
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Figure 5. Synaptic activity regulates AV motility in dendrites.
(A) Quantitation of mean Fluo-4 fluorescence intensity in rat hippocampal neurons (15
DIV) before and after on-scope addition of 4-AP + Bic or DMSO. (B) Quantitation of
mean Fluo-4 fluorescence intensity in rat hippocampal neurons (25 DIV) treated with 4AP + Bic before and after on-scope addition of CNQX + AP5. (C) Mean Fluo-4 intensity
in rat hippocampal neurons (14 DIV) either transfected or untransfected with mCherryLC3 and treated with 4-AP + Bic or CNQX + AP5 for 60 min. (D) Kymographs of
mCherry-LC3, tracked AVs (magenta denotes retrograde, cyan denotes anterograde,
and dark blue denotes stationary segments), and GCaMP3 from the same dendrite after
30 min of treatment in 4-AP + Bic, DMSO, or CNQX + AP5. Horizontal bar, 5 µm.
Vertical bar, 1 min. (E-G) Quantitation of AV mean speed in dendrites of rat hippocampal
neurons treated for 30 min in 4-AP + Bic, DMSO, or CNQX + AP5 (E, mean ± SEM; F,
histogram of dendritic AV mean speed; G, cumulative frequency of dendritic AV mean
speed; n =629-731 AVs from 26-32 neurons from three to four independent experiments;
13-14 DIV; one-way ANOVA with Tukey’s post hoc test; ***, P ≤ 0.001; ****, P ≤ 0.0001).
(H) Quantitation of average dendritic AV mean speed per neuron (mean ± SEM; n =2632 neurons from three to four independent ex-periments; 13-14 DIV; one-way ANOVA
with Tukey’s post hoc test; *, P ≤ 0.05; ***, P ≤ 0.001). (I) Quantitation of GCaMP3
fluorescence intensity in the dendrite of a neuron treated with 4-AP + Bic, DMSO, or
CNQX + AP5 for 30 min.
signal relative to DMSO addition (Fig. 5 A). Furthermore, 4-AP + Bic treatment increased
the frequency of calcium oscillations, consistent with increased firing of action potentials
and stimulated synaptic activity (Fig. 5 A). Conversely, on-scope addition of CNQX +
AP5 dampened calcium oscillations induced by 4-AP + Bic, consistent with silencing of
synaptic activity (Fig. 5 B). Next, we transfected neurons with LC3 labeled with only
mCherry (mCherry-LC3). We found that transfection of neurons to express mCherry-LC3
did not affect the response of neurons to the stimulation or silencing treatments (Fig. 5
C). Thus, our treatments establish paradigms of stimulated (4-AP + Bic) versus basal
(DMSO) versus silenced (CNQX + AP5) synaptic activity, and mCherry-LC3 expression
does not affect neuronal functionality.
Next, we incubated neurons in each treatment condition (stimulated versus basal
versus silenced synaptic activity) for 30 min and examined effects on AV dynamics.
Consistent with the effects of KCl-induced neuronal depolarization, stimulating synaptic
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activity with 4-AP + Bic dampened AV motility in dendrites relative to the DMSO control
(Fig. 5 D). With 4-AP + Bic treatment, we observed fewer motile AVs than with the
DMSO control. Conversely, silencing synaptic activity with CNQX + AP5 induced AV
motility in dendrites, as we observed a greater population of motile AVs than with the
DMSO control (Fig. 5 D). These results suggest that synaptic activity and AV dynamics
are inversely linked: Inducing synaptic activity dampens dendritic AV motility, whereas
silencing synaptic activity increases dendritic AV motility.
To quantitate the effect of synaptic activity on AV motility, we measured the
mean speed of individual mCherry-LC3 positive puncta under each paradigm of synaptic
activity. The activity state of each neuron analyzed was confirmed by coexpression of
the calcium sensor GCaMP3 to measure calcium oscillations. Treatment with 4-AP + Bic
increased GCaMP3 oscillations by ∼10-fold relative to DMSO controls (mean rates of
0.28 versus 0.03 events/s), indicating induced synaptic activity (Fig. 5, D and I; and Fig.
6, C and D). Treatment with CNQX + AP5 eliminated GCaMP3 oscillations relative to
DMSO controls (mean rate of 0.00 versus 0.03 events/s), indicating silenced synaptic
activity (Fig. 5, D and I; and Fig. 6, C and D). Similar to KCl-mediated depolarization,
stimulation of synaptic activity with 4-AP + Bic significantly reduced the average AV
mean speed in dendrites by ∼2.7-fold relative to the DMSO control (Fig. 5 E). By
contrast, silencing synaptic activity with CNQX + AP5 increased the mean speed of AVs
in dendrites ∼1.4-fold relative to the DMSO control (Fig. 5 E). Thus, as synaptic activity
decreased, the AV population shifted toward exhibiting higher mean speeds (Fig. 5, F
and G). To evaluate the effects of activity on AV dynamics in individual neurons, we
determined the average AV mean speed for each neuron analyzed (Fig. 5 H). Consistent
with the effects observed by pooling individual AV mean speeds across neurons, 4-AP +
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Bic treatment decreased the average AV mean speed per neuron as compared with the
DMSO control and neurons silenced with CNQX + AP5 (Fig. 5 H). Combined, our results
indicate that the motility of AVs in dendritic compartments is inversely related to the
activity state of the neuron. Increasing neuronal activity leads to a reduction of dendritic
AV motility, whereas silencing neuronal activity leads to an enhancement of dendritic AV
motility when compared with baseline conditions.

Figure 6. Quantitation of calcium oscillations in rat hippocampal neurons.
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(A) Quantitation of mean GCaMP3 fluorescence in an individual neuron (14 DIV) as a
function of time of incubation in E4 solution. (B) Quantitation of mean Fluo-4
fluorescence in a field of neurons (13 DIV) as a function of time of incubation in E4
solution. (C and D) High-speed imaging of GCaMP3 oscillations in dendrites from
hippocampal neurons treated with 4-AP + Bic, DMSO, or CNQX + AP5 for 30 min. (C)
Kymograph analysis of GCaMP3 in dendrites. Horizontal bar, 5 µm. Vertical bar, 5 s. (D)
Corresponding quantitation of GCaMP3 spike frequency (mean ± SEM; n =8-14 neurons
from two independent experiments; 13-14 DIV).
To determine whether these effects are specific to dendrites or whether they also
occur in axons, we measured AV mean speeds in axons. Similar to dendrites, calcium
oscillations increased with 4-AP + Bic treatment and decreased with CNQX + AP5
treatment in axons (Fig. 7 A). However, unlike in dendrites, modulating synaptic activity
did not alter the motility of AVs in axons (Fig. 7, A-D). Axonal AVs exhibited long-range
movements with either 4-AP + Bic or CNQX + AP5 treatment, and no significant
changes in AV mean speed were observed between stimulation or silencing conditions
(Fig. 7, A-D). Thus, the dampening of AV motility with synaptic activity is compartment
specific, occurring primarily in dendrites and not in axons.
To determine whether the effects of synaptic stimulation on dendritic AV
dynamics are reversible, we silenced neurons following a period of stimulation. For this
experiment, neurons were first treated with 4-AP + Bic for 30 min to induce an activitydependent decrease in dendritic AV motility (Fig. 8 A). Neurons were then treated for 30
min in either 4-AP + Bic (control sample) or CNQX + AP5 (rescue sample; Fig. 8 A).
Neurons silenced with CNQX + AP5 exhibited increased AV motility as compared with
neurons in 4-AP + Bic (Fig. 8 B). Silencing led to an increase in the average AV mean
speed ∼3.7-fold relative to the stimulated control (Fig. 8, C-E) and ∼2.2-fold higher than
the average AV mean speed observed after only 30 min of 4-AP + Bic treatment (Fig. 5
E). These results suggest that decreases in AV motility due to synaptic stimulation can
be reversed by silencing neurons. Importantly, these findings also establish that activity34

dependent dampening of AV dynamics is not due to cytotoxicity. Rather, we found that
AV motility in dendrites is coordinated with the activity state of the neuron in a reversible
manner.

Figure 7. Synaptic activity does not alter AV motility in axons.
(A) Kymographs of mCherry-LC3, tracked AVs (magenta denotes retrograde, cyan
denotes anterograde, and dark blue denotes stationary segments), and GCaMP3 from
the same axon after 60 min of treatment in 4-AP + Bic or CNQX + AP5. Horizontal bar, 5
µm. Vertical bar, 1 min. (B-D) Quantitation of AV mean speed in axons of rat
hippocampal neurons treated with 4-AP + Bic or CNQX + AP5 for 60 min (B, mean ±
SEM; C, histogram of axonal AV mean speed; D, cumulative frequency of axonal AV
mean speed; n =495-524 AVs from 21-23 neurons from three independent experiments,
13-14 DIV; unpaired t test).
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Figure 8. Activity-dependent dampening of AV motility in dendrites is reversed by
silencing neurons.
(A) Schematic of experimental paradigm. (B) Kymographs of mCherry-LC3, tracked AVs
(magenta denotes retrograde, cyan denotes anterograde, and dark blue denotes
stationary segments), and GCaMP3 from the same dendrite after the treatments
described in A. Horizontal bar, 5 µm. Vertical bar, 1 min. (C-E) Quantitation of AV mean
speed in rat hippocampal neurons treated with the experimental paradigm in A (C, mean
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± SEM; D, histogram of dendritic AV mean speed; E, cumulative frequency of dendritic
AV mean speed; n =531-641 AVs from 25-26 neurons from three independent
experiments; 13-14 DIV; unpaired t test; ****, P ≤ 0.0001).
To determine whether synaptic activity regulates AV motility in neurons grown in a more
complex environment, we cocultured primary neurons with astrocytes. For this
experiment, we established a robust system for coculturing neurons and astrocytes to
recapitulate intercellular connections present in vivo. Primary neurons (hippocampal or
cortical) were grown for 7-8 d in vitro (DIV) to generate a monolayer of neurites onto
which primary cortical astrocytes were plated. Neurons and astrocytes were then
cocultured for up to 8 DIV. During this period of coculture, astrocytes transition from
polygonal morphologies to elaborate starlike or “astral” morphologies reminiscent of
structures observed in vivo (Fig. 9 A). To examine the effects of synaptic activity on
dendritic AV motility, neurons were transfected with mCherry-LC3 on the day before
astrocyte addition. After 7-8 DIV of coculture, samples were treated for 30 min in 4-AP +
Bic, DMSO, or CNQX + AP5, and live-cell imaging was used to track AV motility in
dendrites. Similar to monocultured neurons, cocultured neurons also exhibited an activity
dependent regulation of AV motility in dendrites (Fig. 9, B-D). Stimulation of synaptic
activity dampened dendritic AV motility, and silencing synaptic activity increased
dendritic AV motility (Fig. 9, B-D). Thus, this synaptic control of AV motility is a
fundamental mechanism observed in neurons grown in monoculture and in coculture
with astrocytes.
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Figure 9. Synaptic activity controls AV dynamics in dendrites of neurons
cocultured with astrocytes.
(A) Maximum projections of Z-stacks of rat hippocampal neurons (immunostained for
neuron-specific β3-tubulin) cocultured with either wild-type mouse cortical astrocytes
[immunostained for astrocyte-specific glial fibrillary acidic protein (GFAP)] or GFP-LC3transgenic mouse cortical astrocytes (immunostained for GFP). Images to the left of the
vertical line were taken with a 40x objective, and images to the right of the vertical line
were taken with a 63x objective. Asterisks denote the location of neuronal cell bodies
within the neurite meshwork. Scale bars, 20 µm. (B) Kymographs of mCherry-LC3 in
dendrites of rat cortical neurons cocultured with mouse cortical astrocytes for 7-8 DIV
(neurons are a total of 14-16 DIV) and treated for 30 min in 4-AP + Bic, DMSO, or CNQX
+ AP5. Retrograde direction is from left to right. Horizontal bar, 5 µm. Vertical bar, 1 min.
(C and D) Quantitation of AV mean speed in dendrites of cortical neurons cocultured
with cortical astrocytes for 7-8 DIV and treated for 30 min in 4-AP + Bic, DMSO, or
CNQX + AP5 (C, mean ± SEM; D, cumulative frequency of dendritic AV mean speed; n
= 323-368 AVs from 9-10 neurons from two independent experiments; neurons are 1416 DIV; one-way ANOVA with Tukey’s post hoc test; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤
0.0001).
Next, we wanted to define whether the regulation of AV motility by synaptic activity is
local. Thus, we locally stimulated synapses by photo-uncaging 4-methoxy-7nitroindolinyl-caged L-glutamate (MNI-glutamate). MNI-glutamate is a caged, or inactive
form of glutamate that, upon exposure to 405-nmlight, releases glutamate to bind to its
cognate receptors and stimulate glutamatergic signaling. When we photo-uncaged
glutamate at 0.33 Hz for 40 pulses, GCaMP3 dendritic fluorescence spiked at every
uncaging event, consistent with increased intracellular calcium in response to successful
uncaging of the MNI glutamate (Fig. 10 A). We did not observe rises in intracellular
calcium levels during the uncaging pulses in the water controls that were exposed to the
same laser conditions as samples with MNI-glutamate (Fig. 10 A). To measure the
effects of glutamate release on AV motility, we tracked AVs before and during uncaging
of MNI-glutamate. We observed a significant reduction in dendritic AV mean speed
during glutamate uncaging (Fig. 10 B). We measured an ∼3.9-fold decrease in mean
speed for AVs with paired tracks before and during treatment (Fig. 10 B) and an∼3.439

fold decrease in mean speed for the total AVs that were tracked (Fig. 10 E). However,
no change in dendritic AV mean speed was observed during the uncaging protocol in the
water control (Fig. 10, C and F). Glutamate release reduced the AV mean speed by an
average of ∼0.12 μm/s, and this value was significantly larger than that measured for the
water control (Fig. 10 D); the difference in mean speeds before and during the water
treatment was near zero (∼0.01 μm/s; Fig. 10 D). Importantly, these effects were not
limited to hippocampal neurons. Glutamate uncaging also decreased AV motility in
cortical neurons (Fig. 11 A). Combined, these results were strikingly similar to our
previous findings of enhanced neuronal activity with KCl or 4-AP + Bic treatments on
decreasing AV speeds (Figs. 3, 5, and 8). Our results with glutamate uncaging further
indicate that the effects of synaptic activity on AV motility are rapid and can be controlled
locally.
Interestingly, we also found that the motility of early endosomes labeled with
mRFP-Rab5 is also reduced in response to glutamate uncaging in dendrites (Fig. 11, BG). Because synaptic activity regulates the motility of other dendritic organelles and
degradative machinery [87, 106-108], these data suggest a core mechanism to regulate
intracellular trafficking in a compartment-specific manner in neurons.
To determine whether AVs stop at synapses in response to activity, we
performed dual-color imaging of mCherry-LC3 with the post-synaptic marker postsynaptic density protein 95 (PSD-95)-GFP under conditions of stimulated versus
silenced synaptic activity (Fig. 12). We then tracked AVs and binned them into one of
three categories based on their proximity and duration at PSD-95-positive puncta: (1)
AVs that are “arrested” at synapses as defined by the localization of AVs within 0.75μm
on either side of a synapse for the entire duration of the AV track, (2) AVs with
“segmented association” that localize within 0.75μm on either side of a synapse for only
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a partial time of the AV track, and (3) AVs that exhibit “no association” with a postsynaptic compartment during its trajectory.

Figure 10. Local stimulation of synaptic activity by uncaging MNI-glutamate (MNIGlu) reduces AV motility in dendrites.
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(A) Kymographs of mCherry-LC3, tracked AVs (magenta denotes retrograde, cyan
denotes anterograde, and dark blue denotes stationary segments), and GCaMP3 from
the same dendrite before and after glutamate (Pre-Glu and Post-Glu, respectively)
uncaging (arrowheads denote time of uncaging; water serves as a control). Horizontal
bar, 5 µm. Vertical bar, 30 s. (B-F) Quantitation of AV mean speed in dendrites before
and after uncaging. (B and C, paired points represent a single AV before and during
uncaging; D, difference in AV mean speed before and after uncaging; MNI-glutamate, n
= 226 AVs from 22 hippocampal neurons; water, n = 268 AVs from 25 hippocampal
neurons; three independent experiments; 13-14 DIV; B and C, paired t test; D, unpaired t
test; ****, P ≤ 0.0001). (E and F) Mean ± SEM of all AVs tracked, including those from
paired analysis, before and after uncaging (E, n = 272 AVs in pre-uncaging and 277 AVs
in post-uncaging from 22 neurons from three independent experiments; 13-14 DIV; F, n
= 321 AVs in pretreatment and 346 AVs in post-treatment from 25 neurons from three
independent experiments; 13-14 DIV; unpaired t test; ****, P ≤ 0.0001).
We found that under conditions of stimulation of synaptic activity, ∼77% of AVs were
arrested at or proximal to synapses (Fig. 12, A-D). This population, however, reduced to
∼34% with silenced synaptic activity, and we observed an increase in AVs that exhibit a
segmented and transient association with synapses (Fig. 12, A-D). Furthermore,
silencing synaptic activity doubled the percentage of AVs with no association with postsynaptic compartments (Fig. 12, A-D). Thus, we found that stimulating synaptic activity
increases the persistent and sustained residence of AVs at or near synaptic
compartments.
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Figure 11. Local activation of synapses by uncaging MNI-glutamate reduces
dendritic AV motility in cortical neurons and early endosome motility in dendrites
of hippocampal neurons.
(A) Kymograph analysis of mCherry-LC3 and GCaMP3 in dendrites of cortical neurons
before and after uncaging (arrowheads denote time of uncaging; water serves as a
control). Horizontal bar, 5 µm. Vertical bar, 30 s. (B) Kymographs of mRFP-Rab5,
tracked early endosomes (magenta denotes retrograde, cyan denotes anterograde, and
dark blue denotes stationary segments), and GCaMP3 from the same dendrite before
and after glutamate uncaging (arrowheads denote time of uncaging; water serves as a
control). Horizontal bar, 5 µm. Vertical bar, 30 s. (C-G) Quantitation of Rab5 mean speed
in dendrites from hippocampal neurons before and during uncaging (C and D, paired
points represent a single early endosome before and after uncaging; E, difference in
early endosome mean speed before and after uncaging; MNI-glutamate, n = 304 early
endosomes from 21 hippocampal neurons; water, n = 313 early endosomes from 20
hippocampal neurons; three independent experiments; 13-14 DIV; C and D, paired t test;
E, unpaired t test; ****, P ≤ 0.0001). (F and G) Mean ± SEM of all early endosomes
tracked, including those from the paired analysis, before and after uncaging (F, n = 319
early endosomes in pre-uncaging and 340 early endosomes in post-uncaging from 21
neurons from three independent experiments; 13-14 DIV; G, n = 330 early endosomes in
pretreatment and 363 early endosomes in post-treatment from 20 neurons from three
independent experiments; 13-14 DIV; unpaired t test; ****, P ≤ 0.0001).
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Figure 12. Synaptic activity arrests AVs at or proximal to post-synaptic
compartments.
(A and B) En face images (A) and kymograph analysis (B) of PSD-95-GFP, mCherryLC3, and tracked AVs (dark blue denotes AVs arrested at synapses, light blue denotes
AVs with segmented association with synapses, and yellow denotes AVs with no
association with synapses) in dendrites of hippocampal neurons. Horizontal bars in A
and B, 5 µm. Vertical bar in B, 1 min.(C) Quantitation of individual AV association with
synapses as a percentage of total AVs tracked (4-AP + Bic, n = 128 AVs from 10
neurons; CNQX + AP5, n =113 AVs from 11 neurons; two independent experiments; 1316 DIV). (D) Quantitation of percentage of AV association with synapses on a per
dendrite basis (mean ± SEM; n =10-11 neurons from two independent experiments; 1316 DIV).

2.2.3 Synaptic activity increases degradative AVs in dendrites
Changes in organelle positioning and motility are often coupled with changes in
their function [109, 110]. Therefore, we proposed that because synaptic activity
regulates AV motility, it may also regulate AV function. Because mCherry-LC3 labels
immature, nondegradative autophagosomes as well as mature, degradative
autolysosomes, we wanted to determine the maturation state of mCherry-LC3-positive
AVs in dendrites and to define whether the nature of these compartments changes
under paradigms of stimulated versus silenced synaptic activity.
To begin to define the maturation state of AVs in dendrites under different
paradigms of synaptic activity, we first measured colocalization of mCherry-LC3-positive
AVs with lysosomal-associated membrane protein 1 (LAMP1)-GFP, a marker for late
endosomes and lysosomes [111, 112]. In the DMSO control, nearly all (∼90%) mCherryLC3 puncta in dendrites were positive for LAMP1-GFP, and this value did not change
with stimulating or silencing activity (Fig. 13, A and A’). Thus, we found that dendritic
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Figure 13. Nearly all AVs in dendrites and axons are positive for LAMP1.
(A) Kymograph analysis of mCherry-LC3 and LAMP1-GFP in dendrites of hippocampal
neurons treated with 4-AP + Bic, DMSO, or CNQX + AP5 for 30 min. Horizontal bar, 5
µm. Vertical bar, 1 min. (A’) Corresponding quantitation of the percentage colocalization
between mCherry-LC3 and LAMP1-GFP in dendrites (mean ± SEM; n =9-10 neurons
from two independent experiments; 13-14 DIV). (B) Kymograph analysis of mCherryLC3 and LAMP1-GFP in axons of hippocampal neurons treated with 4-AP + Bic, DMSO,
or CNQX + AP5 for 30 min. Horizontal bar, 5 µm. Vertical bar, 1 min. (B’) Corresponding
quantitation of the percentage colocalization between mCherry-LC3 and LAMP1-GFP in
axons (mean ± SEM; n =10-13 neurons from two independent experiments; 13-14 DIV).
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mCherry-LC3-positive compartments have largely acquired LAMP1, likely by fusion with
late endosomes, and this step is not modulated with activity. Consistently, LAMP1-GFP
dynamics in dendrites were regulated by activity similar to our observations for mCherryLC3: dampened motility in 4-AP + Bic and increased motility in CNQX + AP5 (Fig. 13 A).
Similar to dendrites, ∼95% of axonal mCherry-LC3-labeled compartments were
copositive for LAMP1-GFP across activity paradigms (Fig. 12, B and B’), consistent with
our previous reports under basal conditions [8, 44]. These data suggest that mCherryLC3 positive AVs in axons and dendrites have largely fused with late endosomes and or
lysosomes and are predominantly amphisomes (fusion intermediates of
autophagosomes and endosomes) or autolysosomes (fusion intermediates of
autophagosomes and lysosomes). These results directed us to examine activitydependent changes in downstream steps in AV maturation in dendrites.
Along those lines, we next sought to define the effects of synaptic activity on the
density of acidic organelles in dendrites. For this experiment, we treated neurons
expressing GCaMP3 with 4-AP + Bic, DMSO, or CNQX + AP5 in the presence of
Lysotracker-Red, a cell-permeant acidotropic dye (Fig. 14). Individual dendrites were
outlined using GCaMP3 fluorescence, and the density of Lysotracker-Red-positive
puncta was measured along the dendrite (Fig. 14, A-C). Interestingly, we observed a
higher density of Lysotracker-Red puncta in dendrites treated with 4-AP + Bic than in
those treated with CNQX + AP5 (Fig. 14, A-C). Thus, we found a greater number of
acidic organelles in dendrites upon stimulating synaptic activity. Because lysosomal
hydrolases are activated in acidic environments, our data suggest that synaptic activity
may increase the presence of degradative organelles in dendrites.
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Figure 14. Synaptic activity increases the density of acidic organelles in dendrites.
(A) Straightened images of GCaMP3 and Lysotracker-Red in dendrites from
hippocampal neurons treated with 4-AP + Bic, DMSO, or CNQX + AP5 for 30 min. The
soma is toward the right. Scale bar, 5 µm. (B and C) Corresponding quantitation of the
number of Lysotracker-Red puncta per 10-µm dendrite (B, mean ± SEM; C, cumulative
frequency; n =21-22 neurons from three inde-pendent experiments; 13-14 DIV; one-way
ANOVA with Tukey’s post hoc test; **, P ≤ 0.01).
Next, we wanted to specifically label compartments that are proteolytically active. For
this experiment, we incubated neurons with DQ-BSA, an endocytosed cargo that
fluoresces only upon proteolytic cleavage. We used two different fluorescent conjugates,
DQ-Green-BSA and DQ-Red-BSA, which exhibited ∼85-90% overlap and thus were
used interchangeably (Fig. 15, B, B’, and B”). We found that DQ-Green-BSA-positive
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puncta were enriched in the soma, present within dendrites, and low in abundance in
axons (Fig. 16, A and B; and Fig. 15 A), in accordance with results reported by Yap et al.
(2018).
We first validated the identity of the compartments labeled with DQ-BSA by
performing dual-color imaging in dendrites with DQ-Red-BSA and various endocytic
markers. To label early endosomes, we transfected neurons with GFP-Rab5 and
measured overlap with DQ-Red-BSA. We observed that only ∼12% of DQ-Red-BSA
positive compartments in dendrites were copositive for GFP-Rab5, and only ∼5% of
GFP-Rab5-positive compartments were copositive for DQ-Red-BSA (Fig. 15, C, C’, and
C”). Thus, degradative compartments labeled with DQ-BSA are largely separate
organelle populations from early endosomes. To label all compartments receiving
endocytic input, we co-incubated neurons with DQ-Red-BSA and the fluid-phase
endocytic cargo BSA-488 for two hours. We found that ∼80% of DQ-Red-BSA-positive
compartments in dendrites were copositive for BSA-488 (Fig. 15, D and D’), indicating
that most proteolytically active compartments receiving endocytic input during the
incubation
window co-label with both DQ-Red-BSA and BSA-488. With the converse analysis, we
found that only ∼52% of BSA-488-positive compartments were copositive for DQ-RedBSA (Fig. 15, D and D’’). The remaining ∼48% of BSA-488-positive compartments likely
represent early and late endosomes of low or no proteolytic activity. Last, we found that
treatment with protease inhibitors E-64d and pepstatin A eliminated fluorescence of DQGreen-BSA but not of BSA-488 (Fig. 15 E), indicating that the loss in DQ-BSA
fluorescence is due to a specific reduction in proteolytic processing rather than a block in
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Figure 15. DQ-BSA labels degradative compartments in the endolysosomal
pathway in hippocampal neurons.
(A) Quantitation of the density of DQ-Green-BSA-positive puncta in dendrites and axons
(mean ± SEM; dendrites, n =34 neurons; axons, n = 49 neurons from three independent
experiments; 13-14 DIV; unpaired t test; ****, P ≤ 0.0001). (B) Kymograph analysis of
DQ-Green-BSA and DQ-Red-BSA in dendrites. Yellow arrowheads denote puncta
positive for both DQ-Green-BSA and DQ-Red-BSA. Horizontal bar, 5 µm. Vertical bar,
10 s. (B’ and B”) Corresponding quantitation of the percentage colocalization (Coloc)
between DQ-Green-BSA and DQ-Red-BSA in dendrites (mean ± SEM; n = 16 neurons
from three independent experiments; 13-15 DIV). (C) Kymograph analysis of DQ-RedBSA and early endosomes labeled with GFP-Rab5 in dendrites. Red arrowheads denote
puncta positive for only DQ-Red-BSA, and green arrowheads denote puncta positive for
only GFP-Rab5. Horizontal bar, 5 µm. Vertical bar, 10 s. (C’ and C”) Corresponding
quantitation of the percentage colocalization between DQ-Red-BSA and GFP-Rab5 in
dendrites (mean ± SEM; n = 11 neurons from two independent experiments; 13-15 DIV).
(D) Kymograph analysis of DQ-Red-BSA and endocytic cargo BSA-488 in dendrites.
Yellow arrowheads denote puncta positive for both DQ-Red-BSA and BSA-488, and
green arrowheads denote puncta positive for only BSA-488. Horizontal bar, 5 µm.
Vertical bar, 10 s. (D’ and D”) Corresponding quantitation of the percentage
colocalization between DQ-Red-BSA and BSA-488 in dendrites (mean ± SEM; n = 8
neurons from two independent experiments; 14 DIV). (E) Maximum projections of Zstacks of rat hippocampal neurons treated with 100 µM E-64d and 30 µM pepstatin A
versus DMSO for 3 h. During the last hour of treatment, neurons were also incubated
with BSA-488 or DQ-Green-BSA. Inhibition of protease activity reduces DQ-Green-BSA
fluorescence but has minimal effect on BSA-488. Scale bar, 20 µm. (F) Kymograph
analysis of BSA-647 and DQ-Green-BSA in the axon. Red arrowheads denote puncta
positive for only BSA-647, and green arrowheads denote puncta positive for only DQGreen-BSA. Horizontal bar, 5 µm. Vertical bar, 10 s.
endocytic flux. In total, we found that DQ-BSA labels degradative organelles within the
endolysosomal pathway.
Do changes in synaptic activity affect the degradative nature of mCherry-LC3positive AVs? To answer this question, we first needed to determine the percentage of
mCherry-LC3-positive AVs that are degradative autolysosomes under basal conditions.
For this experiment, we incubated neurons expressing mCherry-LC3 with DQ-GreenBSA and measured the percentage of AVs that were copositive for DQ-Green-BSA. We
found that ∼51% of mCherry-LC3-positive AVs in dendrites were copositive for DQGreen-BSA, suggesting that approximately half of dendritic AVs are degradative
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autolysosomes (Fig. 16, A, B, and B’). In contrast to dendrites, less than ∼3% of
mCherry-LC3-positive AVs in axons were copositive for DQ-Green-BSA (Fig. 16 A, B,
B’’). Thus, we found a greater percentage of degradative autolysosomes, as labeled with
DQ-BSA, in dendrites than in axons. Because DQ-BSA can label only those degradative
compartments that are receiving endocytic input, we measured the percentage of
mCherry-LC3-positive AVs that were copositive for the endocytic cargo BSA-488. We
found that ∼57% of mCherry-LC3-positive AVs in dendrites were copositive for BSA-488
(Fig. 16, C and C’). By contrast, we find less than ∼2% of AVs in axons are positive for
BSA-488 (Fig. 16, C and C’’). The axon did indeed contain vesicles of endocytic origin,
as labeled with BSA-488 (Fig. 16 C) or BSA-647 (Fig. 15 F). However, these endocytic
compartments in axons were largely negative for mCherry-LC3 (Fig. 16 C) or DQ-BSA
(Fig. 15 F), in contrast to the significant overlap observed in dendrites (Fig. 16, A-C; and
Fig. 15 D, D’, and D’’). Combined, these data highlight important differences in how the
autophagic and endocytic pathways merge in dendritic versus axonal compartments.
Specifically, autophagic organelles in dendritic compartments have fused with newly
endocytosed cargo to a greater extent as compared to autophagic organelles in axons.
Additionally, these compartment-specific differences in the overlap between mCherryLC3 and endocytosed cargo were not due to insufficient labeling time. We performed a
time-course analysis of 2, 4, 6, and 8 h of DQ-BSA uptake (Fig. 16, D and E) and found
that longer incubation times with DQ-BSA did not alter the percentage of AVs copositive
for DQ-BSA in either dendrites or axons (Fig. 16, D and E). Thus, the partial labeling of
mCherry- LC3 compartments with DQ-BSA in dendrites and axons is not due to
inadequate time for proteolytic processing of the DQ-BSA substrate.
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To determine whether the degradative state of dendritic AVs is regulated by synaptic
activity, we measured the number of mCherry-LC3-positive AVs in dendrites that were
copositive for DQ-Green-BSA under paradigms of stimulated versus silenced synaptic
activity. In this experiment, neurons were preloaded for 2 h with DQ-BSA and then
treated with modulators of synaptic activity. Consistent with our previous findings,
mCherry-LC3 motility decreased with 4 -AP + Bic treatment and increased with
CNQX+AP5 treatment relative to the DMSO control (Fig. 17A). Interestingly, we found
that treatment with 4-AP + Bic increased the percentage of mCherry-LC3-positive AVs
that were copositive for DQ-Green-BSA, while treatment with CNQX +AP5 reduced this
degree of colocalization (Fig. 17, A, B, and B’’). Thus, we found a higher percentage of
degradative autolysosomes in dendrites with synaptic stimulation than with silencing.
While the density of total mCherry-LC3 puncta in dendrites remained constant
throughout activity paradigms (Fig. 17 C), the density of total DQ-Green-BSA puncta
increased with synaptic activity (Fig. 17 E). Combined, these results indicate that
synaptic stimulation increases the percentage of dendritic AVs that are degradative
autolysosomes. These results are consistent with our previous observations that
synaptic stimulation also increased the density of acidic organelles in dendrites (Fig. 14).
Using the converse analysis, the percentage of DQ-Green-BSA positive compartments
that were copositive for mCherry-LC3 did not change across activity paradigms,
suggesting that the percentage of degradative lysosomes that receive autophagic input
remains constant (Fig. 17, D and D’’).
Our observations that synaptic activity increases the percentage of AVs marked
with DQ-BSA could be attributed to a stimulation in either degradative activity or the
delivery of endocytosed substrate (BSA) to autolysosomes that were already
proteolytically competent. To distinguish between these possibilities, we measured the
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percentage of AVs receiving the endocytic cargo BSA-488 under the various paradigms
of synaptic activity (Fig. 18). For this experiment, neurons were preloaded for 2 h with
BSA-488 and then treated with modulators of synaptic activity. In contrast to our prior
results with DQ-BSA, the percentage of mCherry-LC3-positive AVs that were copositive
for BSA-488 did not change in response to modulating synaptic activity (Fig. 18, A, B,
and B’). Consistent with our prior results, the density of mCherry-LC3 puncta in dendrites
remained constant across the activity paradigms (Fig. 18 C).
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Figure 16. Degradative AVs labeled with DQ-BSA are detected more frequently in
dendrites than in axons.
(A) mCherry-LC3 and DQ-Green-BSA distribution in the soma, dendrite, and axon of a
hippocampal neuron. Scale bars, 5 µm. In A-C, red arrowheads denote puncta positive
for only mCherry-LC3, green arrowheads denote puncta positive for only BSA (either
DQ-Green-BSA or BSA-488), and yellow arrowheads denote puncta positive for both
LC3 and BSA. (B) Kymographs of mCherry-LC3 and DQ-Green-BSA motility in the
dendrite and axon. Retrograde direction is from left to right. Horizontal bars, 5 µm.
Vertical bars, 10 s. (B’) Quantitation of the percentage of mCherry-LC3-positive puncta
that colocalize (Coloc) or do not colocalize (Non-Coloc) with DQ-Green-BSA in dendrites
(mean ± SEM; n = 34 neurons from three independent experiments; 13-14 DIV). (B”)
Quantitation of the percentage of mCherry-LC3-positive puncta that colocalize or do not
colocalize with DQ-Green-BSA in axons (mean ± SEM; n = 49 neurons from three
independent experiments; 13-14 DIV). (C) Kymographs of mCherry-LC3 and BSA-488
motility in the dendrite and axon. Horizontal bar, 5 µm. Vertical bar, 10 s. (C’)
Quantitation of the percentage of mCherry-LC3 puncta positive for BSA-488 in dendrites
(mean ± SEM; n = 43 hippocampal neurons from four independent experiments; 13
DIV). (C”) Quantitation of the percentage of mCherry-LC3 puncta positive for BSA-488
in axons (mean ± SEM; n = 40 hippocampal neurons from four independent
experiments; 13 DIV). (D) Quantitation of the percentage of mCherry-LC3 AVs that are
copositive for DQ-Green-BSA in dendrites as a function of time of incubation with DQBSA (mean ± SEM; n =25-28 neurons from three independent experiments; 13 DIV). (E)
Quantitation of the percentage of mCherry-LC3 AVs that are copositive for DQ-GreenBSA in axons as a function of time of incubation with DQ-BSA (mean ± SEM; n =24-30
neurons from three independent experiments; 13 DIV).
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Figure 17. Synaptic activity increases degradative AVs in dendrites.
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(A) Kymographs of mCherry-LC3 and DQ-Green-BSA in dendrites of rat hippocampal
neurons treated with 4-AP + Bic, DMSO, or CNQX + AP5 for 30 min. Yellow arrowheads
denote puncta positive for both mCherry-LC3 and DQ-Green-BSA. Red arrowheads
denote puncta positive for only mCherry-LC3. Retrograde direction is from left to right.
Horizontal bar, 5 µm. Vertical bar, 10 s. (B and B’) Quantitation of the percentage of
mCherry-LC3 puncta positive for DQ-Green-BSA in dendrites (B, mean ± SEM; B’,
cumulative frequency; n =29-34 neurons from four independent experiments; 15 DIV;
one-way ANOVA with Tukey’s post hoc test; ***, P ≤ 0.001). (C) Number of mCherryLC3 puncta per 10-µm dendrite (mean ± SEM; n =29-34 neurons from four independent
experiments; 15 DIV; one-way ANOVA with Tukey’s post hoc test). (D and D’)
Quantitation of the percentage of DQ-Green-BSA puncta positive for mCherry-LC3 in
dendrites (D, mean ± SEM; D’, cumulative frequency; n =29-34 neurons from four
independent experiments; 15 DIV; one-way ANOVA with Tukey’s post hoc test). (E)
Number of DQ-Green-BSA puncta per 10-µm dendrite (mean ± SEM; n = 29-34 neurons
from four independent experiments; 15 DIV; one-way ANOVA with Tukey’s post hoc test;
***, P ≤ 0.001). (F and F’) Mean speed of dendritic AVs that either colocalize or do not
colocalize with DQ-Green-BSA (F, mean ± SEM; F’, cumulative frequency; n =159-354
AVs from 29-34 neurons from four independent experiments; 15 DIV; unpaired t test;
****, P ≤ 0.0001). (G) Quantitation of the percentage of mCherry-LC3 puncta that
colocalize or do not colocalize with DQ-Green-BSA puncta in axons treated with 4-AP +
Bic, DMSO, or CNQX + AP5 for 30 min (mean ± SEM; n =48-62 neurons from four
independent experiments; 15 DIV). (H) Quantitation of the density of DQ-Green-BSA
puncta in axons treated with 4-AP + Bic, DMSO, or CNQX + AP5 for 30 min (mean ±
SEM; n =46-62 neurons from four independent experiments; 15 DIV; one-way ANOVA
with Tukey’s post hoc test). (I) Model for activity-dependent regulation of autophagy in
dendrites. Under basal activity, AVs exhibit bidirectional movement in dendrites. Upon
stimulation of synaptic activity, AV motility is dampened, and a population of degradative
autolysosomes is increased.
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Figure 18. Endocytic input to AVs does not change with synaptic activity.
(A) Kymographs of mCherry-LC3 and BSA-488 in dendrites of rat hippocampal neurons
treated with 4-AP + Bic, DMSO, or CNQX + AP5 for 30 min. Yellow arrowheads denote
puncta positive for both mCherry-LC3 and BSA-488. Red arrowheads denote puncta
positive for only mCherry-LC3. Green arrowheads denote puncta positive for only BSA488. Retrograde direction is from leftto right. Horizontal bar, 5 µm. Vertical bar, 10 s. (B
and B’) Quantitation of the percentage of mCherry-LC3 puncta positive for BSA-488 in
dendrites (B, mean ± SEM; B’, cumulative frequency; n =38-40 neurons from four
independent experiments; 13 DIV; one-way ANOVA with Tukey’s post hoc test). (C)
Number of mCherry-LC3 puncta per 10-µm dendrite (mean ± SEM; n =38-40 neurons
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from four independent experiments; 13 DIV; one-way ANOVA with Tukey’s post hoc
test).
Thus, the activity-dependent increase in AVs labeled with DQ-BSA is likely not
due to a stimulation in substrate delivery into autolysosomes; rather, these results
suggest a stimulation in the presence of degradative compartments.
Strikingly, we observed these activity-dependent changes in AV maturation in
only dendrites and not in axons. In axons, <3% of mCherry-LC3-positive AVs were
copositive for DQ-Green-BSA in axons, and this value did not change in response to
modulating synaptic activity (Fig. 17 G). Furthermore, the density of DQ-Green-BSA in
axons also did not change across the activity paradigms (Fig. 17 H). Thus, the density of
degradative organelles as labeled with DQ-BSA appears higher in dendrites than in
axons and is specifically regulated with synaptic activity.
Last, we observed a pattern emerging between AV maturation state and
dynamics. Across activity paradigms, mCherry-LC3 positive AVs that were copositive for
DQ-Green-BSA exhibited lower mean speeds than mCherry-LC3 AVs that were negative
for DQ-Green-BSA (Fig. 17, A, F, and F9). Thus, these data suggest that degradative
AVs are less motile and that nondegradative AVs are more motile. Moreover, these
observations suggest that AV transport and degradative function may be linked and that
activity-dependent dampening of AV motility may be coupled with maturation into
degradative organelles.
2.3. Discussion
How neuronal autophagy is regulated by synaptic activity is largely unexplored.
Here, we defined the dynamics and degradative nature of autophagic organelles in
compartments of the neuron (e.g., dendrites versus axons) in response to synaptic
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activity. We found that KCl-induced neuronal depolarization decreases AV motility in
dendrites (Fig. 3). Furthermore, pharmacological manipulation of synaptic activity
regulates AV motility in dendrites; stimulation of synaptic activity dampens AV motility,
while silencing synaptic activity induces AV motility (Fig. 5). These effects occur in
neurons grown in monoculture, as well as in neurons cocultured with astrocytes to
recapitulate intercellular contacts observed in vivo (Fig. 9). Activity-dependent decreases
in AV motility can be restored by silencing synaptic activity, suggesting that these effects
are reversible and not due to cytotoxicity (Fig. 8). Most strikingly, synaptic activity does
not dampen AV dynamics throughout the neuron. Rather, these effects are specific to
dendrites and are not observed in axons (Figs. 3 and 7), indicating compartment-specific
regulation of AV dynamics with synaptic activity. In fact, we also found that this process
is regulated locally within dendrites because local stimulation of synaptic activity by
uncaging MNI-glutamate is sufficient to reduce AV motility in dendrites (Fig. 10).
Because organelle motility and function can be linked [109, 110], we investigated
the effects of synaptic activity on the degradative activity of autophagic organelles in
dendrites. Thus, we first characterized the maturation state of AVs under basal
conditions. We found that ∼90% of mCherry-LC3-positive AVs in dendrites and axons
are positive for the late endosomal/lysosomal marker LAMP1, suggesting that the vast
majority of autophagic organelles in the neuron are either amphisomes or
autolysosomes (Fig. 13). These results are consistent with prior work in axons showing
that soon after autophagosomes form in the distal axon, they fuse with a LAMP1-positive
compartment [30, 44, 49, 50]. To distinguish a population of AVs that are degradative
autolysosomes, we incubated neurons with DQ-BSA, an endocytic substrate that
fluoresces only upon proteo-lytic cleavage (Fig. 15). Under basal conditions, we found a
higher proportion of degradative autolysosomes, as labeled with DQ-BSA, in dendrites
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than in axons (Fig. 16, A, B, B’, and B’’). These compartment-specific differences are not
due to the duration of incubation with DQ-BSA (Fig. 16, D and E;2-8 h). Because DQBSA can label only those degradative compartments that are receiving endocytic input,
we measured the percentage of mCherry-LC3-positive AVs that were copositive for the
endocytic cargo BSA-488 and found a higher proportion of AVs positive for BSA-488 in
dendrites than in axons (Fig. 16 C, C’, and C’’). Thus, compared with axons, dendrites
have a greater percentage of DQ-BSA labeled degradative autolysosomes due to
compartment-specific differences in how autophagic organelles have fused with newly
formed endosomes. Combined, these results reveal important differences in how the
autophagy pathway intersects with the endolysosomal pathway in dendrites as
compared with axons.
To determine the effects of synaptic activity on the degradative function of AVs,
we pharmacologically stimulated or silenced synaptic activity and assessed changes in
their proteolytic nature. Stimulating synaptic activity increased the percentage of
dendritic AVs copositive for DQ-BSA (Fig. 16, A, B, and B’). This activity-induced
increase in overlap between AVs and DQ-BSA is likely not due to an increase in
endocytic delivery of the BSA substrate (Fig. 18). Interestingly, while the total number of
AVs along the dendrite was unaltered upon changes in synaptic activity (Fig. 17 C), we
did measure an increase in the presence of total DQ-BSA-labeled degradative
compartments (Fig. 17 E). Consistent with this result, we observed that stimulating
synaptic activity increased the density of acidic compartments relative to silencing within
dendrites (Fig. 14). In sum, these observations suggest that dendritic AVs become more
proteolytically active in response to stimulated synaptic activity. In contrast to dendrites,
synaptic activity did not alter the per-centage of AVs copositive for DQ-BSA or the
density of total DQ-BSA-positive compartments, regardless of merging with autophagic
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compartments, in axons (Fig. 17, G and H). Thus, these data suggest that the activitydependent increase in degradative autolysosomes is compartment specific,
preferentially occurring in dendrites as compared with axons.
Combined, we propose a model whereby synaptic activity locally controls AV
transport and degradative function in dendrites (Fig. 17 I). Our evidence suggests that
synaptic activity may induce AV maturation into proteolytically active compartments in
dendrites. Across all paradigms of synaptic activity, nondegradative AVs were more
motile than degradative AVs (Fig. 17, F and F9), suggesting that AV motility and function
may be correlated and that reduction in AV motility may facilitate maturation into
proteolytically active compartments. We found that activity-dependent dampening of AV
motility increases their residence time at or near post-synaptic compartments (Fig. 12).
Thus, this process may facilitate local regulation of the synaptic proteome through
degradation of post-synaptic components and/or through recycling of degradation
products to fuel local protein synthesis. In total, our results suggest a more localized
pathway for autophagy in dendrites, in contrast to the long-range pathway for autophagy
that we previously defined in axons [44, 45, 50]. While the mechanism underlying the
increase in degradative activity of AVs in response to synaptic stimulation is yet to be
unraveled, we note that increases in degradative capacity of lysosomal compartments
have been observed in response to cellular signals in other settings (Trombetta et al.,
2003) [113]. For example, during dendritic cell maturation, lysosomes become
degradative through recruitment and activation of the vacuolar proton pump to promote
processing of internalized antigens (Trombetta et al., 2003). Future studies will delineate
the mechanism by which AVs become more degradative in dendrites in response to
synaptic stimulation.
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Autophagy may control the composition of the synaptic proteome through
degradative, as well as biosynthetic, functions to impact the strength of a synapse.
Autophagy has been shown to degrade post-synaptic components. In chemical models
of long-term depression, autophagy facilitates the degradation of excitatory post-synaptic
AMPA receptors (Shehata et al., 2012). Autophagy can also negatively regulate brainderived neurotrophic factor-mediated long-term potentiation (LTP) by degrading postsynaptic scaffolding proteins (Nikoletopoulou et al., 2017). AVs may receive postsynaptic cargoes for degradation either by local fusion with endosomes or by inward
budding of the autophagic membrane, similar to multivesicular body formation.
While most autophagy studies focus on cargo selection and elimination, another
major function of autophagy is to liberate amino acids and lipids for new biosynthesis.
Because we found that local formation of autophagosomes in dendrites is infrequent
[45], dendritic AVs may be sourced from the soma and preloaded with cargo. In this
capacity, dendritic AVs may provide biosynthetic fuel, on demand in response to activity,
for local translation at post-synaptic compartments, a way of creation by destruction.
Consistent with this possibility, studies show that autophagy is required for LTP and
LTP-induced dendritic spine growth [85, 92]. In total, alterations in these pathways may
provide a mechanistic basis for the learning and memory defects reported in autophagydeficient models [84, 85, 90, 92, 93].
Our observations regarding the impact of synaptic activity on autophagy are
consistent with recent reports linking synaptic activity with lysosome function in postsynaptic compartments. Goo et al. reported that synaptic activity induces the localization
of LAMP1-positive compartments to dendritic spines that may promote the degradation
of AMPA receptors [80]. Inhibition of lysosome function decreases dendritic spine
density [80]. Padamsey et al. demonstrated that synaptic activity induces exocytosis of
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lysosomes from dendrites, leading to remodeling of the extracellular matrix and
enlargement of dendritic spines [114]. We found significant overlap between LAMP1labeled late endosomes/lysosomes and autophagic compartments in dendrites and
axons (Fig. 13). We, along with other groups, previously reported that only newly formed
autophagosomes in distal regions of the axon are negative for LAMP1 and mature into
LAMP1-positive amphisomes during retrograde transport along the mid axon [30, 44, 49,
50]. In dendrites, we previously found very few immature autophagosomes as labeled
with the acid-sensitive GFP-LC3 [45], and our present study indicates a predominance of
autolysosomes in dendrites, as evidenced with the mCherry-GFP-LC3 reporter (Fig. 4).
Additionally, we found that ∼90% of degradative lysosomes labeled with DQ-BSA are
copositive for LC3 (Fig. 17, D and D’’), suggesting that nearly all DQ-BSA-labeled
degradative lysosomes receive autophagic input. Consequently, it is challenging to
untangle specific effects of synaptic activity on autophagic versus lysosomal maturation
into degradative organelles. Future experiments will need to more specifically distinguish
these possibilities.
Synaptic activity has been shown to regulate the distribution and function of other
organelles and degradative machinery in dendrites. For example, neuronal activity
recruits proteasomes to dendritic spines and stimulates their activity [87]; activitydependent proteasomal function results in new spine outgrowth [115]. Synaptic activity
also decreases the motility of post-ER secretory compartments (ER-Golgi intermediate
compartments) in dendrites, resulting in increased appearance of receptors on the postsynaptic membrane [106]. In our study, we found that early endosomes labeled with
Rab5 also arrest in response to synaptic activity (Fig. 11, B-G). Interestingly,
mitochondrial movement is arrested in response to synaptic activity in both dendrites
and axons via a mechanism that involves calcium-sensitive adaptor proteins that
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inactivate kinesin-based motility; synaptic mitochondria provide local ATP and calcium
buffering [107, 108, 116]. Given the rapid effects of synaptic activity on AV dynamics,
calcium may also regulate AV motility in dendrites. However, this mechanism of action is
not applied in the axon, where AV motility is unaffected by increased calcium levels (Fig.
7). In total, activity-dependent effects on autophagy may be part of a broader
mechanism to specifically localize biosynthetic and degradative organelles at postsynaptic compartments to impact synaptic function.
Most studies to date investigating synaptic autophagy have focused on
autophagy in presynaptic compartments. Autophagy is important for the development as
well as maintenance of presynaptic terminals [14, 15, 35, 38, 40, 41]. Studies have also
shown that autophagy regulates presynaptic neurotransmission, potentially by controlling
synaptic vesicle pool size [41, 78]. Axonal autophagosomes preferentially form in the
distal axon and undergo retrograde movement toward the cell soma for degradation [30,
44]. Autophagosome biogenesis in the distal axon is regulated by several presynaptic
proteins and can be induced with synaptic activity [72, 77, 100]. Wang et al.
demonstrated that neuronal depolarization stimulates distal biogenesis and retrograde
flux of autophagosomes from presynaptic terminals to the soma [73]. Our study,
however, provides new insights into the activity-dependent regulation of autophagic
degradation in post-synaptic compartments, emphasizing the significance of degradative
pathways on both sides of the synapse.
Here, we define a pathway for the activity-dependent regulation of autophagy in
dendrites that is distinct from mechanisms previously described in the axon. This
pathway may be particularly important in neurons with large receptive fields, as in the
elaborate dendritic arbors of cerebellar Purkinje cells. Furthermore, alterations in this
pathway may contribute to the preferential susceptibility of Purkinje cells to autophagy
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loss, a phenomenon observed across various mouse models deficient in key autophagy
genes [12, 13, 16, 38]. Thus, compartment-specific roles for autophagy may be critical to
enable the diverse demands and functions of different neuronal populations.
2.4. Materials and Methods
2.4.1. Reagents
Constructs used included mCherry-EGFP-LC3B (gift from Terje Johansen,
University of Tromsø, Tromsø, Norway), mCherry-LC3B (Maday and Holzbaur, 2016),
GCaMP3 (Addgene; 22692), LAMP1-mGFP (Addgene; 34831), PSD-95-GFP
(Addgene), GFP-Rab5 (gift from Marino Zerial, Max Planck Institute of Molecular Cell
Biology and Genetics, Dresden, Germany), and mRFP-Rab5 (Addgene; 14437). BSA
conjugates used included BSA-488 (Thermo Fisher Scientific/Molecular Probes;
A13100), BSA-647 (Thermo Fisher Scientific/Molecular Probes; A34785), DQ-GreenBSA (Thermo Fisher Scientific/Molecular Probes; D12050), and DQ-Red-BSA (Thermo
Fisher Scientific/Molecular Probes; D12051). Fluo-4 acetoxymethyl ester (Fluo-4 AM)
was purchased from Thermo Fisher Scientific/Molecular Probes (F14201). Primary
antibodies used for immunofluorescence microscopy included chicken anti-GFP (Aves
Labs, Inc.; GFP1020), rabbit anti-glial fibrillary acidic protein (EMD Millipore; AB5804),
and mouse anti-TUBB3/β3 tubulin (Novus Biologicals; MAB1195-SP). Secondary
antibodies used for immunofluorescence microscopy included goat anti-chicken Alexa
Fluor 488 (Jackson ImmunoResearch Laboratories; 103-545-155), goat anti-rabbit Alexa
Fluor 488 (Thermo Fisher Scientific/Invitrogen; A11034), and goat anti-mouse Alexa
Fluor 647 (Thermo Fisher Scientific/Invitrogen; A32728). Small molecules used included
4-AP (Thermo Fisher Scientific/Tocris Bioscience; 0940), Bic methiodide (Thermo Fisher
Scientific/Tocris Bioscience; 2503), CNQX (Thermo Fisher Scientific/Tocris Bioscience;
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0190), AP5 (Thermo Fisher Scientific/Tocris Bioscience; 0106), MNI-glutamate (Tocris
Bioscience; 1490), E-64d (Sigma-Aldrich; E8640), and pepstatin A (Sigma-Aldrich;
P5318). Lipofectamine 2000 reagent (Thermo Fisher Scientific/Invitrogen; 11668-027)
was used for transfecting neurons, following the manufacturer’s protocol.
2.4.2. Primary neuron culture
Rat hippocampal and rat cortical neurons were obtained from the Neurons R Us
core facility at the University of Pennsylvania and as a gift from Dr. Kelly Jordan-Sciutto
(University of Pennsylvania, Philadelphia, PA). Neurons were prepared from SpragueDawley rat embryos at gestational days 16-18. Neurons were plated at a density of
3,000,000 cells per 10-cm dish (∼4.7 x 104 cells/cm2) filled with eight 25-mm acidwashed glass coverslips coated with 1 mg/ml poly-L-lysine. Neurons were grown for 1316 DIV in rat neuron maintenance medium (neurobasal medium supplemented with 2%
B-27, 33 mM glucose, 100 U/ml penicillin, and 100 µg/ml streptomycin) at 37°C in a 5%
CO2 incubator. After 3 DIV, 1.7 µM AraC (antimitotic drug, C6645; Sigma-Aldrich) was
added, and every 7-8 DIV, ∼20% of medium volume was added.
2.4.3. Neuron-astrocyte coculture
Primary mouse cortical astrocytes (either GFP-LC3-transgenic or non-transgenic
astrocytes) were isolated from GFP-LC3-transgenic mice [B6.Cg-Tg(CAGEGFP/LC3)53Nmi/NmiRbrc; RIKEN Bio-Resource Center] as we previously described
[117, 118]. Mouse cortical astrocytes were grown in glial media (DMEM supplemented
with 10% FBS, 0.25% Gluta-MAX, 100 U/ml penicillin, and 100 µg/ml streptomycin) on
10-cm tissue culture plates until ∼80-90% confluent. When the neuron culture was 7-8
DIV, mouse cortical astrocytes were dissociated from the 10-cm plate using 0.05%
trypsin-EDTA. Upon dissociation from the 10-cm plate, trypsin was inactivated using glial
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media. Astrocytes were then resuspended in coculture media (neurobasal supplemented
with 2% B-27, 1% G-5, 0.25% GlutaMAX, 100 U/ml penicillin, and 100 µg/ml
streptomycin) and plated on the neuron culture and maintained at 37°C in a 5% CO2
incubator. For immunostain analysis, rat hippocampal neurons were plated at a density
of 960,000 cells per 60-mm dish (∼4.7 x 104 cells/cm2) filled with 12 x 12-mm acidwashed glass coverslips coated with 1 mg/ml poly-L-lysine, onto which astrocytes were
plated at a density of ∼6,600 cells/cm2. For live-cell imaging, rat cortical neurons were
plated at a density of 3,000,000 cells per 10-cm dish (∼4.7 x 104 cells/cm2) filled with 8 x
25-mm acid-washed glass coverslips coated with 1 mg/ml poly-L-lysine, onto which
astrocytes were plated at a density of ∼13,000-20,000 cells/cm2. After 2 d of coculture, 2
µM AraC was added to prevent cell division and promote maturation of the astrocytes.
The coculture was maintained in the coculture medium for up to 8 d, with the day of
astrocyte plating counted as day 0.
2.4.4. Live-cell imaging
Coverslips (25 mm) were sandwiched within a Chamlide CMB magnetic imaging
chamber (BioVision Technologies). Live-cell imaging of organelle dynamics was
performed on a BioVision spinning-disk confocal microscope system consisting of a
Leica DMi8 inverted widefield microscope, a Yokagawa W1 spinning-disk confocal
microscope, and a Photometrics Prime 95B scientific complementary metal-oxidesemiconductor camera. Images were acquired with VisiView software using a 63x/1.4
NA plan apochromat oil-immersion objective (with or without a 2x optical multiplier) or a
40x/1.3 NA plan apochromat oil-immersion objective and solid-state 405-, 488-, 561-,
and 640-nm lasers for excitation. Fluo-4 imaging was performed on a Leica DMi8
inverted widefield microscope with a Hamamatsu Orca Flash 4.0 V2+ scientific
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complementary metal-oxide-semiconductor camera using a 20x/0.80 NA plan
apochromat dry PH2 objective, FITC filter cube, and Leica software. Both microscopes
are equipped with an environmental chamber at 37°C and adaptive focus control to
maintain a constant focal plane during live-cell imaging.
2.4.5. Immunostaining of cocultured neurons and astrocytes
On days 3, 5, and 6 of the coculture, samples were fixed for 10 min in 4%
PFA/4% sucrose in PBS (150 mM NaCl, 50 mM NaPO4, pH 7.4) previously warmed to
37°C. Cells were washed two times in PBS, permeabilized for 5 min in 0.1% Triton X100 (Thermo Fisher Scientific; BP151-100) in PBS, washed two times in PBS, and then
blocked for 1 h in PBS supplemented with 5%goat serum (Sigma-Aldrich; G9023) and
1% BSA (Thermo Fisher Scientific; BP1605-100). Cells were then incubated in primary
antibody diluted in block solution for 1 h at room temperature, washed three times for 5
min each in PBS, and then incubated in secondary antibody diluted in block solution for
1 h at room temperature. Following incubation in secondary antibody, samples were
washed three times for 5 min each in PBS. Samples were mounted in ProLong Gold and
imaged with the Bio-Vision spinning-disk confocal microscope system described above
using the 40x or 63x objectives and using 488- and 640-nm lasers for excitation. Zstacks spanning the entire depth of the field of neurons and astrocytes were obtained at
0.2-µm sections.
2.4.6. Photobleaching experiments
Primary rat hippocampal neurons were transfected with mCherry-GFP-LC3 at 7-8
DIV using Lipofectamine 2000. At 13-15 DIV, neurons were imaged at 1 frame per
second for 1 min in E4 solution (150 mM NaCl, 3 mM KCl, 4 mM CaCl2,15mM glucose,
10 mM Hepes, pH 7.4) with the 63x objective and a 2x optical multiplier (total of 126x
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magnification). After a precount of 3 s, regions along the dendrite (as indicated in Fig. 4,
A and B) were photobleached using the 488-nm laser. The dendrite was then imaged for
an additional 57 s to observe the nature of vesicles moving into the photobleached
region.
2.4.7. KCl and NaCl on scope addition
Primary rat hippocampal neurons were transfected with mCherry-GFP-LC3 at 7-8
DIV using Lipofectamine 2000. At 13-14 DIV, neurons were imaged at 1 frame per
second for 5 min in 500 µl of E4 solution (150 mM NaCl, 3 mM KCl, 4 mM CaCl2, 15 mM
glucose, 10 mM Hepes, pH 7.4) with the 63x objective and a 2x optical multiplier (total of
126x magnification). Approximately halfway through the movie (∼149-150 s), 500 µl of
90 mM KCl or 90 mM NaCl diluted in E4 was added to the imaging chamber to reach a
final concentration of 45 mM KCl or NaCl. Dendrites and axons were distinguished as
we previously published [45, 50], using morphological criteria established by Kaech and
Banker (2006).
2.4.8. Pharmacological treatments to modulate synaptic activity
Primary rat hippocampal neurons were transfected with mCherry-LC3 and
GCaMP3 (Figs. 5, 7,and 8), with mCherry-LC3 and PSD-95-GFP (Fig. 12), or with
mCherry-LC3 and LAMP1-mGFP (Fig. 13)at 7-9 DIV using Lipofectamine 2000. At 13-15
DIV, neurons were treated with 50 µM 4-AP and 20 µM Bic (to stimulate synaptic
activity), 50 µM CNQX and 50 µM AP5 (to silence synaptic activity), or an equal volume
of DMSO solvent, in E4 solution for 30 min at 37°C in a 5% CO2 incubator. For the axon
analysis in Fig. 7, samples were treated for 60 min at 37°C in a 5% CO2 incubator.
Samples were imaged in the same treatment solution using the 63x objective and a 2x
optical multiplier (total of 126x magnification) for a maximum of ∼30 min while on the
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microscope. For AV tracking in Figs. 5, 7, and 8, neurons were imaged at 1.4 frames per
second for 7 min. For synapse association experiments in Fig. 12 and LAMP1
experiments in Fig. 13, neurons were imaged at 1 frame per second for 5 min. For the
coculture experiments in Fig. 9, B-D, rat cortical neurons were transfected with mCherryLC3 on 6-7 DIV 1 d before the addition of astrocytes. After 7-8 d of coculture (neurons
are a total of 14-16 DIV), pharmacological treatments were performed as above, and
neurons were imaged at 1 frame per second for 3 min.
For the rescue experiments in Fig. 8, mCherry-LC3 and GCaMP3 transfected
neurons were first treated with 50 µM 4-AP and 20 µM Bic in E4 solution for 30 min at
37°C in a 5% CO2 incubator. One cohort (i.e., control samples) was treated with fresh 50
µM 4-AP and 20 µM Bic in E4 solution for an additional 30 min, whereas the other cohort
(i.e., rescue samples) was treated with 50 µM CNQX and 50 µM AP5 in E4 solution for
30 min at 37°C in a 5% CO2 incubator. Neurons were imaged in the same treatment
solution at 1.4 frames per second for 7 min with the 63x objective and a 2x optical
multiplier (total of 126x magnification). Data were acquired for a maximum of ∼30 min
while on the microscope.
2.4.9. Glutamate uncaging
Primary rat hippocampal neurons (Fig. 10 and Fig. 11, B-G) or primary rat
cortical neurons (Fig. 11 A) were transfected with mCherry-LC3 and GCaMP3 (Figs. 10
and 11 A) or with mRFP-Rab5 and GCaMP3 (Fig. 11, B-G) at 6-8 DIV using
Lipofectamine 2000. At 13-15 DIV, glutamate uncaging was performed. Neurons were
first incubated for 10 min in E4 salt solution to equilibrate the neuronal field firing
(described below). We then supplemented E4 with 0.5 mM MNI-glutamate or an equal
volume of water as a solvent control. Neurons were imaged on the BioVision confocal
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spinning-disk system described above, with the 63x objective and a 2x optical multiplier
(total of 126x magnification), and data from each coverslip were acquired for a maximum
of ∼30 min while on the microscope. For each movie, neurons were imaged at 1 frame/s
for 30 s before photo-uncaging to establish the baseline organelle motility. During the
uncaging period, a region along the dendrite was exposed to the 405-nm laser at 0.33
Hz (one cycle every 3 s) for a total of 40 cycles over 2 min. Every pixel in the uncaged
region received the 405-nm laser for 3 ms. Images were acquired after each cycle of
photo-uncaging.
2.4.10. Fluo-4 AM and GCaMP3 imaging
In Fig. 3 B and Fig. 5, A-C, primary rat hippocampal neurons were incubated with
4 µM Fluo-4 AM for 20 min in rat neuron maintenance medium at 37°C in a 5% CO2
incubator. Neurons were then washed twice with rat neuron maintenance medium,
transferred to E4 solution [or to Hibernate E (BrainBits) supplemented with 2% B-27 and
2 mM GlutaMAX for Fig. 5 A], and imaged at 1 frame per second for the indicated time.
For imaging calcium dynamics in transfected versus untransfected neurons (Fig. 5 C),
neurons were transferred to E4 solution containing 50 µM 4-AP and 20 µM Bic or 50 µM
CNQX and 50 µM AP5 and incubated for 60 min at 37°C in a 5% CO2 incubator,
followed by imaging in the same solution at 1 frame per second for 6 min.
To qualitatively assess changes in firing patterns in E4 solution (Fig. 6, A and B),
we measured calcium oscillations by GCaMP3 and Fluo-4 fluorescence as a function of
time of incubation in E4. In Fig. 6 A, primary rat hippocampal neurons were transfected
with GCaMP3 at 8 DIV using Lipofectamine 2000. At 14 DIV, GCaMP3-transfected
neurons were transferred to E4 solution and imaged at 2 and 10 min after E4 addition at
1 frame per second for 5 min. As a control, we confirmed the inhibitory effect of Mg2+ on
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neuronal firing in neurons incubated for 2 min in E4 with 2 mM Mg2+ (150 mM NaCl, 3
mM KCl, 2 mM CaCl2, 2 mM MgCl2,15 mM glucose,10 mM Hepes, pH7.4).In Fig. 6 B,
primary rat hippocampal neurons were preloaded with Fluo-4 as described above;
transferred to E4 solution; and imaged at 2, 10, and 30 min after E4 addition at 1 frame/s
for 3 min. The same coverslip was imaged for all three time points and returned to 37°C
in a 5% CO2 incubator between incubation times. Combined, we found that calcium
dynamics change with time of incubation in E4 solution. Initially, we observed sporadic
and individual neuron events that transition to a synchronized and larger field firing of the
entire culture with time in E4 (Fig. 6, A and B).
For high-speed imaging of calcium dynamics (Fig. 6, C and D), primary rat
hippocampal neurons were transfected with GCaMP3 at 7-8 DIV using Lipofectamine
2000. At 13-14 DIV, neurons were treated with 50 µM 4-AP and 20 µM Bic, 50 µM
CNQX and 50 µM AP5, or an equal volume of DMSO solvent, in E4 solution for 30 min
at 37°C in a 5% CO2 incubator. Neurons were imaged in the same treatment solution at
10 frames per second for 1 min with the 63x objective.
2.4.11. BSA and DQ-BSA experiments
Primary rat hippocampal neurons were transfected with mCherry-LC3 at 7-8 DIV
using Lipofectamine 2000. At 13-14 DIV, neurons were treated with 25 µg/ml BSA-488
or DQ-Green-BSA in rat neuron maintenance medium for 2 h (or 4, 6, and 8 h for the
DQ-Green-BSA time-course experiments in Fig. 16, D and E) and rinsed twice with rat
neuron maintenance medium. Neurons were either imaged in E4 solution immediately
(as in Fig. 16) or treated with 50 µM 4-AP and 20 µM Bic, 50 µM CNQX and 50 µM AP5,
or an equal volume of DMSO solvent, in E4 solution for 30 min at 37°C in a 5% CO2
incubator (as in Figs. 17 and 18) and imaged in the same treatment solution. Images
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were acquired at 1.4 frames per second for 42 s with the 63x objective and a 2x optical
multiplier (126x total magnification); data were acquired for a maximum of 30 min on the
microscope. For the dye validation experiments in Fig. 15, primary rat hippocampal
neurons, untransfected or transfected with GFP-Rab5 at 7-8 DIV using Lipofectamine
2000, were treated at 13-15 DIV with 25 µg/ml DQ-Green/Red-BSA, BSA-488, or BSA647 in rat neuron maintenance medium for 2 h and rinsed twice with rat neuron
maintenance medium. Neurons were then imaged in E4 solution at 1-1.4 frames per
second for 30-48 s with the 63x objective with a 2x multiplier (126x total magnification).
2.4.12. Treatment with protease inhibitors
Primary rat hippocampal neurons (23 DIV) were treated with 100 µM of E-64d
and 30 µM pepstatin A, or with an equivalent volume of DMSO as a solvent control, in
rat neuron maintenance medium for 3 h. During the last hour of treatment, neurons were
also treated with 25 µg/ml BSA-488 or DQ-Green-BSA in rat neuron maintenance
medium. After treatment, neurons were washed twice in HibE imaging medium and
imaged in HibE imaging medium. Z-stacks were obtained using the BioVision spinningdisk confocal microscope system described above by taking 0.2-µm sections using the
40x objective.
2.4.13 Lysotracker-Red experiments
Primary rat hippocampal neurons were transfected with GCaMP3 at 7-8 DIV
using Lipofectamine 2000. At 13-14 DIV, neurons were treated with 100 nM LysotrackerRed in rat neuron maintenance medium for 30 min. Following Lysotracker-Red
treatment, neurons were treated with 50 µM 4-AP and 20 µM Bic, 50 µM CNQX and 50
µM AP5, or an equal volume of DMSO solvent, in E4 solution containing 100 nM
Lysotracker-Red for 30 min at 37°C in a 5% CO2 incubator (Fig. 14). After treatment,
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neurons were washed twice with E4 solution containing 50 µM 4-AP and 20 µM Bic, 50
µM CNQX and 50 µM AP5, or an equal volume of DMSO solvent, and imaged in E4
solution containing activity modulators or DMSO control. Images were acquired at 1
frame per second for 3 min with the 63x objective and a 2x optical multiplier (126x total
magnification); data were acquired for a maximum of ∼30 min on the microscope.
2.4.14. Quantitation of calcium oscillations using Fluo-4 AM and GCaMP3 imaging
For Fluo-4 imaging, the mean gray value of the entire field of view was
determined for all images within a time series using Fiji software. Then, the mean gray
value of an area within the field that did not contain any neurons or neurites, and
represented background, was determined for all images within a time series. For each
time point, the background value was subtracted from the corresponding field value.
Each time point was then normalized to the first time point and expressed as a
percentage (designated arbitrary units [AUs]). For GCaMP3 imaging, the mean gray
value of an area within the somatodendritic region of a GCaMP3-expressing neuron was
determined for all images within a time series. Each time point was then normalized to
the first time point and expressed as a percentage (designated AUs). For Fig. 6, C and
D, GCaMP3 spike frequency was calculated by generating kymographs in the
somatodendritic region and counting the number of discrete firing events; data were
plotted as the number of events/s.
2.4.15. Tracking AV dynamics with KCl and NaCl on-scope addition
Using the Kymoanalyzer plugin for Fiji [119], kymographs were generated using
line widths of 9 pixels for dendrites and 3 pixels for axons. In dendrites, kymographs
were drawn >10 µm from the soma; kymographs ranged from ∼30 to ∼100 µm in length,
measuring the late proximal to medial-distal region of the dendrite. For the dendrite
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analysis, only LC3-positive puncta that moved a total distance of 5 µm during the 2.5min pretreatment window, and that could be tracked unambiguously for the entire
duration of the movie, were manually tracked before and after treatment. Using the
segmented line tool, individual tracks were manually traced by clicking on constant
velocity segments. For each vesicle, the mean speed was measured by summing the
individual segment lengths to get total distance traveled and dividing by the total time
traveled. For the axon analysis, neighboring axons in the same field of view as analyzed
dendrites were used for measurements. Because axonal AVs exhibit more processive
movement than those in dendrites, individual AVs in the axon often do not remain within
the field of view for the entire duration of the movie. Thus, we were unable to limit the
tracking to only the same AVs before and after treatment as performed in the dendrite
analysis. Rather, we tracked nearly all LC3 puncta visible in the axon throughout the
movie.
2.4.16. Tracking AV and early endosome dynamics with modulators of synaptic
activity
Using the KymoToolBox plugin for Fiji [120], kymographs were generated using
line widths of 10 pixels for dendrites and 3 pixels for axons. In dendrites, kymographs
were drawn >10 µm from the soma; kymographs ranged from ∼30 to 100 µm in length,
measuring the late proximal to medial-distal region of the dendrite. Only one dendrite
was analyzed per neuron. In the axon, kymographs were drawn in the mid axon, at least
10 µm from the soma; directionality was confirmed by tracing the axon back to the soma.
In both dendrite and axon kymograph analyses, nearly all AVs were tracked. To
measure vesicle speeds, individual tracks were manually traced, using the segmented
line tool, by clicking on constant velocity segments. For each vesicle tracked, the
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KymoToolBox plugin calculated a mean speed (total distance traveled divided by total
time tracked). To generate an AV mean speed per neuron (Fig. 5 H), all the vesicles
tracked from a single neuron were averaged to generate one value for AV mean speed.
For glutamate uncaging experiments, movies were split into pre-uncaging (frames 1-29)
and post-uncaging (frames 30-151), and kymographs were generated as described
above. Nearly all AVs detected in the kymograph were manually tracked as above.
Within the total population of AVs tracked, those AVs that could be traced in both the
pre-uncaging and post-uncaging kymographs were identified, and their speeds were
plotted separately and designated as “paired tracks.”
2.4.17. Colocalization measurements
Using the KymoToolBox plugin for Fiji [120], kymographs were generated using
line widths of 10 pixels for dendrites and 3 pixels for axons. In dendrites, kymographs
were drawn >10 µm from the soma; kymographs ranged from ∼30 to ∼100 µm in length,
measuring the late proximal to medial-distal region of the dendrite. Only one dendrite
was analyzed per neuron. For the co-localization analysis in dendrites, only puncta
present in the first frame of the movie and associated kymograph were included. Given
the short-range movements exhibited by AVs in dendrites, puncta identified in the first
frame account for >95% of dendritic AVs visible throughout the kymograph. Neighboring
axons in the same field of view as analyzed dendrites were used for measurements in
the axon analysis in Fig. 16; Fig. 17, G and H; and Fig. 13, B and B’. For the
colocalization analysis in axons, because AVs in axons exhibit long-range movement
and quickly move out of the field of view, nearly all vesicles detected throughout the
movie and associated kymograph were included. For all colocalization measurements,
both the movie and kymograph were consulted, and two markers were binned as
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colocalized if they overlapped and comigrated within the neurite. The number of AVs
copositive for another marker (DQ-Green-BSA, BSA-488, or LAMP1-GFP) was
expressed as a percentage of total AVs counted for each individual neurite. Similarly, the
number of DQ-BSA puncta that were copositive for LC3 was expressed as a percentage
of total DQ-BSA-positive puncta per neurite. The same calculations were performed for
the markers in Fig. 15, B-D. The analysis in Fig. 17 for dendrites was performed blinded
to the identity of the sample for three of four independent experiments. In Fig. 17, F and
F’, the trajectories of the same AVs included in the colocalization and density analysis
were manually traced by clicking on constant velocity segments. The KymoToolBox
plugin calculated a mean speed (total distance traveled divided by total time tracked) for
each vesicle tracked, and mean speeds were plotted separately on the basis of
colocalization with DQ-BSA.
2.4.18. Quantitation of organelle density
For density measurements in either dendrites or axons, only puncta present in
the first frame of the movie and associated kymograph were included in the analysis.
The entire movie and associated kymograph were used, however, to resolve the number
of individual puncta within clusters present in the first frame. AV and DQ-BSA density
were measured as the number of discrete puncta, normalized for kymograph length (in
µm) and plotted as the number of puncta per 10 µm of neurite. For quantitation of
Lysotracker-Red puncta density (Fig. 14), the KymoToolBox plugin was used to
generate straightened kymostacks with a width of 50 pixels using the criteria mentioned
above for location along the dendrite. Because the GCaMP3 signal serves as a space
filler for dendrites, we used the wand tool in Fiji to generate an outline of the dendrite
based on the first frame of the GCaMP3 kymostack. This outline was overlaid onto the
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first frame of the respective kymostack for the Lysotracker-Red channel. Only discrete
Lysotracker-Red puncta present inside the dendrite outline were counted; however, the
entire movie was considered to determine whether a Lysotracker-Red punctum was
contained within each dendrite of interest as opposed to a crossing axon or dendrite.
The number of Lysotracker-Red puncta was normalized for kymostack total length (per
µm) and plotted as the number of puncta per 10 µm of dendrite.
2.4.19. Quantitation of synapse association
Using the KymoToolBox plugin for Fiji [120], kymographs were generated for the
mCherry-LC3 and PSD-95-GFP channels using a line width of 10 pixels for dendrites, as
described above. AV tracks were then manually traced by clicking on constant velocity
segments in the mCherry-LC3 kymograph, and the AV tracks were then overlaid onto
the PSD-95-GFP kymograph. Referencing both the movie and PSD-95 kymograph (with
overlaid AV tracks), AVs were binned into one of three categories based on their
proximity and duration at PSD-95-positive puncta: (1) “arrested” AVs, defined as AVs
that localize within 0.75 µm on either side of a synapse for the entire duration of the AV
track;(2)AVs with “segmented association,” where at least one segment of the AV track
displays a sustained localization within 0.75 µm on either side of a synapse for ≥3 s; or
(3) AVs that exhibit “no association” with a post-synaptic compartment during its
trajectory, where the AV track did not have a sustained localization within 0.75 µm on
either side of a synapse for ≥3 s. The number of AVs in each of these categories was
plotted as a percentage of total AVs counted from either (1) a pool of all AVs combined
across different neurons and experiments (Fig. 12 C) or (2) individual dendrites (Fig. 12
D).
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2.4.20. Quantitation of dendritic AV maturation state by photobleaching analysis
The identity of the vesicles moving into the photobleached regions was assessed
using kymographs generated in both red (mCherry) and green (GFP) channels using the
KymoToolBox plugin for Fiji and a line width of 10 pixels for dendrites [120]. Vesicles
were then binned either as copositive for GFP and mCherry or as positive for only
mCherry.
2.4.21. Figure preparation and statistical analyses
All image measurements were obtained from the raw data. GraphPad Prism was
used to plot graphs and perform statistical analyses; statistical tests are denoted within
each figure legend. For data that do not appear normally distributed, the large n value
(>20-25 data points) justifies a parametric test. For presentation of images, maximum
and minimum gray values were adjusted linearly in Fiji, and images were assembled in
Adobe Illustrator.
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CHAPTER 3: DIFFERENTIAL REGULATION OF AUTOPHAGY DURING METABOLIC
STRESS IN ASTROCYTES AND NEURONS

This chapter has been previously published: Aditi Kulkarni, Audrey Dong, Vineet Vinay
Kulkarni, Jessica Chen, Olivia Laxton, Anip Anand & Sandra Maday (2020) Differential
regulation of autophagy during metabolic stress in astrocytes and neurons, Autophagy,
16:9, 1651-1667, DOI:10.1080/15548627.2019.1703354.
VVK performed the neuron experiments in Figs. 28 and 29.
3.1. Introduction
Autophagy is an evolutionarily conserved process of self-digestion that is critical
to maintaining cellular homeostasis [121, 122]. Autophagy targets cytoplasmic
components such as proteins and organelles to lysosomes for destruction and recycling.
Cargoes are packaged into autophagosomes that fuse with lysosomes to enable
degradation by resident lysosomal hydrolases. In this way, autophagy can tune the
balance between biosynthesis and degradation, thereby regulating the composition and
quality of the proteome and organelles. Autophagy serves physiological roles in
development, immunity, and adaptive responses to stress (e.g. proteotoxic, metabolic,
and oxidative) [121]. In fact, dysfunctional autophagy is associated with various
pathological states including cancer and neurodegenerative disease [6-8, 123].
Autophagy is particularly critical in cells of the nervous system that must maintain
viability and functionality for up to a century of time [4, 7, 99, 124, 125]. Neurons and glia
must establish and maintain a complex network of trillions of intercellular connections in
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the brain. Further, neurons are extremely active and fire action potentials at rates up to
~50 impulses per second [68]. As a consequence, neuronal proteins and organelles are
exceptionally vulnerable to overuse and damage [10, 71]. Given that neurons are postmitotic, they cannot simply dilute out proteotoxins by cell division, making them reliant on
quality control pathways to maintain homeostasis throughout their extended lifetime [7,
99].
In fact, loss of autophagy in neurons and glia can lead to defects in
neurodevelopment, affecting processes such as axon outgrowth and guidance, astrocyte
differentiation, synaptogenesis, and developmental-based synaptic pruning [33-35, 40,
126, 127]. Therefore, autophagy plays a critical role in establishing proper connectivity of
the nervous system. Autophagy is also important in maintaining the viability and
functionality of established neuronal networks. Central nervous system-specific and
neuron-specific knockout of core autophagy genes causes neuronal dysfunction and
death in mice [12-15]. Furthermore, neuron-specific alterations in autophagy can lead to
synaptic dysfunction [41, 78, 92]. Autophagy in surrounding glia also has a profound
influence on neuronal health. Autophagy in Schwann cells, the myelinating glia of the
peripheral nervous system, degrades myelin in response to axonal injury to promote
neurite regeneration [128, 129]. Additionally, autophagy in microglia, the phagocytic
macro-phages of the central nervous system, facilitates degradation of extracellular Aβ,
linking glial autophagy with the clearance of proteotoxins associated with Alzheimer
disease [130-132] . In total, autophagy serves key roles in neurons and glia during
neurodevelopment and neuroprotection.
The mechanistic basis for how autophagy is regulated in each cell type, however,
is largely unknown. We previously established a vectorial pathway for autophagy in the
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axon that delivers cargo from the distal axon to the soma for degradation in neurons [44,
45]. Unexpectedly, neuronal autophagy was largely unaffected by canonical autophagy
inducers such as nutrient deprivation and pharmacological inhibition of MTOR [50].
These results raise the question of whether these properties are specific to neurons or
whether they are shared by other cell types in the brain, such as glia.
Here, we examine the regulation of autophagy in response to metabolic stress in
primary astrocytes, as compared with primary hippocampal neurons. We find that
autophagy is robustly activated in astrocytes in response to two paradigms of metabolic
stress: (1) nutrient deprivation and (2) pharmacological inhibition of MTOR. While both
paradigms inhibit MTOR, they impact the mechanisms underlying autophagy differently.
Further, activation of autophagy in response to starvation is dependent on the buffering
system of the salt solution. Lastly, we find that autophagy is more robustly activated in
primary astrocytes as compared with primary neurons in response to starvation,
revealing striking differences in how autophagy is managed between different cell types
in the brain.
3.2. Results
3.2.1. MTOR inhibition activates selective autophagy in primary astrocytes
We previously demonstrated that canonical autophagy inducers such as nutrient
deprivation and MTOR inhibition do not robustly activate autophagy in primary neurons
[50]. These unexpected results led us to examine whether these properties are unique to
neurons or are shared by other cell types in the brain such as astrocytes. Here, we
define how autophagy is regulated in response to metabolic stress in primary cortical
astrocytes. To measure autophagy, we isolated cortical glia from transgenic mice
expressing GFP-LC3, a well-characterized marker for autophagosomes [42, 43]. Glial
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cultures were enriched for astrocytes and consisted of ~84%GFAP-positive astrocytes,
~5% IBA1-positive microglia, and ~0.06% GALC-positive oligodendrocytes (Figs. 19 A
and 20). The vast majority of the remaining cells were morphologically indistinguishable
from GFAP-positive astrocytes. Since GFAP expression varies with astrocyte reactivity
[133], this population likely represents non-reactive astrocytes.
In this model, autophagosomes are represented by GFP-LC3-positive puncta
distributed throughout the cytoplasm (Fig. 19 B). At steady state, the number of
autophagosomes measured is a balance between the antagonistic activities of
autophagosome formation and degradation. Therefore, to measure autophagic flux, we
inhibited lysosome-mediated degradation with bafilomycin A1. In this way, we can
measure changes in autophagosome formation without losing autophagosomes due to
degradation. For each treatment condition, levels of autophagy were quantified by
measuring the total area occupied by GFP-LC3-positive puncta per astrocyte,
normalized to the respective astrocyte area.
To determine whether autophagy in astrocytes is regulated by MTOR, we
suppressed MTOR function with torin1, a specific ATP-competitive inhibitor [134]. GFPLC3 trans-genic astrocytes were treated with 250 nM torin1 for 4 h and analyzed by
immunofluorescence microscopy for GFP (LC3). For immunofluorescence microscopy
analysis, only cells that exhibited the characteristic morphology of cultured GFAPpositive astrocytes, defined as polygonal cells often with finger-like projections (Figs. 19
A and 20 A), were analyzed. Thus, the immunofluorescence microscopy analysis
represents a highly pure population of astrocytes. We found that treatment with torin1
dramatically increased the total area of
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Figure 1. Inhibition of MTOR activates SQSTM1-mediated selective autophagy in primary astrocytes. (A) Immunostaining analysis and phase image of primary mouse
cortical glia enriched for astrocytes (GFAP; astrocyte-specific marker). Bar: 20 µm. (B) Maximum projections of z-stacks of GFP-LC3 transgenic astrocytes treated with
the MTOR inhibitor torin1 for 4 h and immunostained for GFP and SQSTM1. Arrowheads denote puncta co-positive for GFP-LC3 and SQSTM1. Outlines define cell
boundaries. Bar: 10 µm. Inset bar: 1 µm. (C) Quantification of total GFP-LC3 puncta area normalized to cell area of astrocytes treated with torin1 for 4 h (mean ± SEM;
one-way ANOVA with Tukey’s post hoc test; n = 54–96 cells from 3 independent experiments, 5–7 DIV). (D) Quantification of total SQSTM1 puncta area normalized to
cell area of astrocytes treated with torin1 for 4 h (mean ± SEM; one-way ANOVA with Tukey’s post hoc test; n = 64–94 cells from 3 independent experiments, 5–7
DIV). (E) Quantification of the percentage of SQSTM1 puncta area that overlaps with GFP-LC3 puncta area in astrocytes treated with torin1 for 4 h (mean ± SEM; oneway ANOVA with Tukey’s post hoc test; n = 53–82 cells from 3 independent experiments, 5–7 DIV cells). (F and G) Immunoblot analysis and corresponding
quantification of lysates generated from glia treated for 4 h with torin1. (F) GAPDH and TUBA1A/α-tubulin serve as loading controls; horizontal lines designate
individual blots. (G) LC3-II levels were normalized to GAPDH (mean ± SEM; one-way
86 ANOVA with Dunnett’s post hoc test; n = 3 independent experiments, each
experiment was performed with technical replicates, 3–6 DIV). (H and I) Immunoblot analysis and quantification of SQSTM1 levels in glia treated with torin1. SQSTM1
levels were normalized to GAPDH (mean ± SEM; one-way ANOVA with Dunnett’s post hoc test; n = 4 independent experiments, 6–8 DIV). Baf A1, bafilomycin A1.

Figure 19. Inhibition of MTOR activates SQSTM1-mediated selective autophagy in
primary astrocytes
(A) Immunostaining analysis and phase image of primary mouse cortical glia enriched
for astrocytes (GFAP; astrocyte-specific marker). Bar: 20 µm. (B) Maximum projections
of z-stacks of GFP-LC3 transgenic astrocytes treated with the MTOR inhibitor torin1 for
4 h and immunostained for GFP and SQSTM1. Arrowheads denote puncta co-positive
for GFP-LC3 and SQSTM1. Outlines define cell boundaries. Bar: 10 µm. Inset bar: 1 µm.
(C) Quantification of total GFP-LC3 puncta area normalized to cell area of astrocytes
treated with torin1 for 4 h (mean ± SEM; one-way ANOVA with Tukey’s post hoc test; n =
54-96 cells from 3 independent experiments, 5-7 DIV). (D) Quantification of total
SQSTM1 puncta area normalized to cell area of astrocytes treated with torin1 for 4 h
(mean ± SEM; one-way ANOVA with Tukey’s post hoc test; n = 64-94 cells from 3
independent experiments, 5-7 DIV). (E) Quantification of the percentage of SQSTM1
puncta area that overlaps with GFP-LC3 puncta area in astrocytes treated with torin1 for
4 h (mean ± SEM; one-way ANOVA with Tukey’s post hoc test; n = 53-82 cells from 3
independent experiments, 5-7 DIV cells). (F and G) Immunoblot analysis and
corresponding quantification of lysates generated from glia treated for 4 h with torin1. (F)
GAPDH and TUBA1A/α-tubulin serve as loading controls; horizontal lines designate
individual blots. (G) LC3-II levels were normalized to GAPDH (mean ± SEM; one-way
ANOVA with Dunnett’s post hoc test; n = 3 independent experiments, each experiment
was performed with technical replicates, 3-6 DIV). (H and I) Immunoblot analysis and
quantification of SQSTM1 levels in glia treated with torin1. SQSTM1 levels were
normalized to GAPDH (mean ± SEM; one-way ANOVA with Dunnett’s post hoc test; n =
4 independent experiments, 6-8 DIV). Baf A1, bafilomycin A1.
GFP-LC3 puncta per astrocyte ~5-fold relative to the DMSO control (Fig. 19 B,
C), suggesting an induction of autophagy with MTOR inhibition. As expected,
bafilomycin A1 increased GFP-LC3 area ~6.5-fold as compared with the DMSO control
(Fig. 19 B, C) due to an accumulation of autophagosomes in the absence of lysosomemediated degradation. Co-treatment of bafilomycin A1 with torin1 further increased GFPLC3 area ~12.4-fold relative to the DMSO control. Most strikingly, torin1 increased GFPLC3 area ~2-fold beyond what is accumulated due to bafilomycin A1 alone (Fig. 19 B,
C), indicating that inhibition of MTOR induces autophagic flux. Combined, these results
demonstrate that MTOR inhibition activates autophagy in primary astrocytes. We also
analyzed these samples for levels of selective autophagy by co-staining for
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Figure 20. Primary cortical glial preparations are enriched for astrocytes.
(A) Representative images of primary mouse non-transgenic cortical glia immunostained
for GFAP to label astrocytes, IBA1 to label microglia, and GALC to label
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oligodendrocytes (images for GALC are maximum projections generated from a Zstack). Hoechst labels total cells in the field. Bar: 50 µm. (B) Corresponding
quantification of the percent cells positive for each glial-specific marker out of total cells
labeled with Hoechst. Mean ± SEM; n=2 independent experiments (3-7 DIV).
SQSTM1/p62. SQSTM1 is a receptor that binds to ubiquitin and LC3 to facilitate
engulfment of specific cargoes into the autophagosome [105]. During the process of
selective autophagy, SQSTM1 will also be engulfed by the autophagosome and
degraded. Treatment of astrocytes with torin1 resulted in a 2.1-fold increase in total area
of SQSTM1-positive puncta, although this effect was not statistically significant (Fig. 19
B, D). Treatment with bafilomycin A1 to block lysosome-mediated degradation increased
the total area of SQSTM1-positive puncta ~11.2-fold relative to the DMSO control (Fig.
19 B, D). Co-treatment with bafilomycin A1 and torin1 resulted in a significant increase in
SQSTM1 puncta area ~1.3-fold relative to bafilomycin A1 alone (Fig. 19 B, D),
suggesting that MTOR inhibition increases the flux of SQSTM1 through lysosomemediated degradative pathways.
We observed a population of SQSTM1-positive puncta in torin1-treated cells that
were co-positive for GFP-LC3 (Fig. 19 B), suggesting that MTOR inhibition may induce
selective autophagy. To examine this possibility, we measured the degree of
colocalization between SQSTM1-positive puncta and GFP-LC3-positive
autophagosomes. First, we measured the percentage of SQSTM1 puncta area that
overlaps with GFP-LC3-positive autophagosomes. Treatment with torin1 increased
overlap of SQSTM1 with LC3 by ~2-fold relative to the DMSO control (Fig. 19 B, E).
Blocking autophagosome clearance with bafilomycin A1 increased overlap of SQSTM1
with LC3 by ~1.8-fold as compared with DMSO (Fig. 19 B, E). Co-treatment of
bafilomycin A1 with torin1 further increased this overlap ~2.3-fold relative to DMSO, and
~1.3-fold relative to bafilomycin A1 alone (Fig. 19 B, E). Thus, a population of
89

autophagosomes that is generated during MTOR inhibition are engulfing SQSTM1,
consistent with an induction of selective autophagy. We also performed the converse
analysis and measured the percentage of GFP-LC3-positive area that is positive for
SQSTM1 puncta. With this analysis, we find that the percentage of GFP-LC3 area that
overlaps with SQSTM1-positive puncta remains largely the same in torin1-treated
samples relative to controls (Fig. 21 A). Combined, these findings suggest that while
more SQSTM1-positive autophagosomes are formed during MTOR inhibition, the
percentage of autophagosomes dedicated to SQSTM1-mediated degradation out of the
total population remains relatively constant. Thus, SQSTM1-mediated selective
autophagy is induced, but not enriched, during MTOR inhibition.

Figure 21. Starvation in ACSF dampens selective autophagy in primary astrocytes.
Quantification of the percentage of GFP-LC3 puncta area that overlaps with SQSTM1
puncta after 4 h in (A) torin1 (mean ± SEM; one-way ANOVA with Tukey’s post hoc test;
n=53-82 cells from 3 independent experiments, 5-7 DIV), (B) ACSF without glucose
(mean ± SEM; one-way ANOVA with Tukey’s post hoc test; n=38-53 cells from 3
independent experiments, 5-6 DIV) and (C) EBSS (mean ± SEM; one-way ANOVA with
Tukey’s post hoc test; n=25-39 cells from 3 independent experiments, 4-5 DIV). Baf A1,
bafilomycin A1.
As a complementary approach, we determined levels of autophagy during MTOR
inhibition by immunoblot analysis of lysates from primary cortical glia. Treatment with
torin1 decreased levels of p-RPS6 (S240/244), a downstream target in the MTOR
signaling pathway [135], relative to total RPS6 levels, indicating that MTOR activity was
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effectively reduced in our treatment conditions (Fig. 19 F). To determine the effects of
MTOR inhibition on autophagy, we immunoblotted for endogenous LC3. During
autophagosome formation, cytosolic LC3 (LC3-I) is converted to LC3-II by addition of a
lipid tag that facilitates association with the autophagosome membrane [42]. Thus, the
density of LC3-II can serve as an indicator for autophagy levels. Treatment with torin1
increased LC3-II levels relative to the DMSO control (Fig. 19 F, G), suggesting an
induction of autophagy with MTOR inhibition. Treatment with bafilomycin A1 to block
autophagosome clearance increased LC3-II levels relative to the DMSO control (Fig. 19
F, G). Co-treatment with bafilomycin A1 and torin1 increased LC3-II levels relative to
bafilomycin A1 alone (Fig. 19 F, G), indicating an increase in autophagic flux with torin1
treatment. Consistent with the immunofluorescence microscopy data, the
immunoblotting results also support that MTOR inhibition activates autophagy in
astrocytes.
To determine whether torin1-induced autophagy results in the degradation of
autophagic cargo, we immunoblotted for total levels of SQSTM1. While
immunofluorescence microscopy measures punctate, autophagosome-associated
SQSTM1, immunoblot analysis measures total levels of SQSTM1 including punctate
forms as well as soluble, cytosolic forms of SQSTM1. Treatment with torin1 consistently
displayed a trend of decreased total SQSTM1 levels across multiple trials, although the
decrease was not statistically significant, raising the possibility that SQSTM1 is
degraded through selective autophagy during MTOR inhibition (Fig. 19 H, I). Combined
with the immunofluorescence microscopy results that show an increased population of
SQSTM1 puncta that colocalize with GFP-LC3 and are targeted for lysosomal
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degradation with torin1 treatment (Fig. 19 B, D, E), these results suggest that inhibition
of MTOR activates selective autophagy in primary astrocytes.
3.2.2. Different starvation treatments elicit varying effects on autophagy in
astrocytes
Next, we examined whether autophagy is upregulated in astrocytes in response
to nutrient deprivation. For this experiment, we incubated astrocytes in artificial
cerebrospinal fluid (ACSF), a buffered salt solution with 10 mM glucose, to starve them
of amino acids. We also incubated astrocytes in ACSF lacking glucose for added energy
deprivation. Surprisingly, starvation in ACSF without glucose for 4 h dampened
autophagic flux in astrocytes (Fig. 22 A, B). While treatment with bafilomycin A1 to block
autophagosome clearance increased GFP-LC3 area ~8.6-fold relative to the DMSO
control, co-treatment of bafilomycin A1 with ACSF lacking glucose decreased the area of
GFP-LC3-positive autophagosomes ~2.6-fold relative to the fed (normal growth media)
bafilomycin A1 condition (Fig. 22 A, B). Co-treatment with bafilomycin A1 with ACSF
lacking glucose also reduced the degradative flux of SQSTM1 ~ 2.1-fold relative to the
fed bafilomycin A1 condition (Fig. 22 A, C). Combined, these results suggest that
starvation in ACSF lacking glucose dam-pens autophagic flux in primary astrocytes.
We also observed a ~ 2-fold reduction in the overlap between SQSTM1-positive
puncta and GFP-LC3-positive autophagosomes with ACSF lacking glucose as
compared with the fed DMSO control (Fig. 22 A, D). Consistent across our experiments,
blocking autophagosome clearance with bafilomycin A1 predictably increased the area
of SQSTM1-positive puncta that overlaps with GFP-LC3-puncta ~2.1-fold (Fig. 22 D).
We also observed a decrease in the percentage of GFP-LC3-positive area that overlaps
with SQSTM1-positive puncta in astrocytes treated with ACSF lacking glucose relative to
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controls (Fig. 21). Together, these data indicate that the decrease in SQSTM1 puncta
that are positive for LC3 is not due to just an overall dampening of autophagy levels, but
is also a selective reduction in the amount of autophagosomes that are involved in
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Figure 2. Starvation in ACSF dampens autophagy in primary astrocytes and induces a switch to SQSTM1-independent autophagy. (A) Maximum projections of
Z-stacks of GFP-LC3 transgenic astrocytes starved in ACSF without glucose for 4 h and immunostained for GFP and SQSTM1. Closed arrowheads denote puncta copositive for GFP-LC3 and SQSTM1. Open arrowheads denote SQSTM1-positive puncta that are not co-positive for GFP-LC3. Outlines define cell boundaries. Bar: 10µm.
(B) Quantification of total GFP-LC3 puncta area normalized to cell area of astrocytes starved in ACSF without glucose for 4 h (mean ± SEM; one-way ANOVA with
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Immunoblot analysis and quantification of SQSTM1 levels in glia starved in ACSF ± glucose for 4 h. SQSTM1 levels were normalized to GAPDH (mean ± SEM; one-way
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Figure 22. Starvation in ACSF dampens autophagy in primary astrocytes and
induces a switch to SQSTM1-independent autophagy.

(A) Maximum projections of Z-stacks of GFP-LC3 transgenic astrocytes starved in ACSF
without glucose for 4 h and immunostained for GFP and SQSTM1. Closed arrowheads
denote puncta co-positive for GFP-LC3 and SQSTM1. Open arrowheads denote
SQSTM1-positive puncta that are not co-positive for GFP-LC3. Outlines define cell
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cell area of astrocytes starved in ACSF without glucose for 4 h (mean ± SEM; one-way
ANOVA with Tukey’s post hoc test; n = 58-68 cells from 4 independent experiments, 3-6
DIV). (C) Quantification of total SQSTM1 puncta area normalized to cell area of
astrocytes starved in ACSF without glucose for 4 h (mean ± SEM; one-way ANOVA with
Tukey’s post hoc test; n = 58-91 from 4 independent experiments, 3-6 DIV). (D)
Quantification of the percentage of SQSTM1 puncta area that overlaps with GFP-LC3
puncta area in astrocytes starved in ACSF without glucose for 4 h (mean ± SEM; oneway ANOVA with Tukey’s post hoc test; n = 38-53 cells from 3 independent experiments,
5-6 DIV cells). (E and F) Immunoblot analysis and quantification of lysates generated
from glia starved in ACSF ± glucose for 4 h. (E) GAPDH and TUBA1A/α-tubulin serve as
loading controls; horizontal lines designate individual blots.(F) LC3-II levels were
normalized to GAPDH (mean ± SEM; one-way ANOVA with Dunnett’s post hoc test; n =
3 independent experiments, 3-6 DIV). (G and H) Immunoblot analysis and quantification
of SQSTM1 levels in glia starved in ACSF ± glucose for 4 h. SQSTM1 levels were
normalized to GAPDH (mean ± SEM; one-way ANOVA with Dunnett’s post hoc test; n =
3 independent experiments, 3-6 DIV). Baf A1, bafilomycin A1; Glc, glucose; GM, glial
media.
SQSTM1-mediated autophagy relative to the total population. Therefore, starvation in
ACSF lacking glucose not only dampens selective autophagy levels, but also deenriches SQSTM1-mediated selective autophagy in primary astrocytes.
We also directly compared autophagy levels in glia incubated for 4 h in ACSF with and
without 10 mM glucose by immunoblotting. In low nutrient conditions, MTOR signaling
has been previously established to be dampened [136]. To determine whether
astrocytes sense starvation in our experimental paradigm, we immunoblotted for p-RPS6
as a measure of MTOR activity. Starvation in ACSF ± glucose decreased p-RPS6 levels
relative to total RPS6, indicating a decrease in MTOR signaling in response to nutrient
deprivation (Fig. 22 E). Thus, the astrocytes are sensing starvation in our experimental
conditions. Treatment in ACSF ± glucose did not alter steady state levels of LC3-II (Fig.
22 E, F). However, ACSF ± glucose decreased the accumulation of LC3-II during
bafilomycin A1 treatment (Fig. 22 E, F). Treatment with ACSF ± glucose also began to
dampen the accumulation of SQSTM1 during bafilomycin A1 treatment although this
effect was not significant until 8 h of treatment (Figs. 22 G, H and 23 B, E, F). Combined,
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the immunoblotting results corroborate the immunofluorescence microscopy findings that
starvation in ACSF with or without glucose dampens autophagic flux in primary
astrocytes.
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Figure 23. Starvation time course in ACSF without glucose dampens autophagy in
primary astrocytes.
(A and B) Time course of glia starved in ACSF without glucose and analyzed by
immunoblotting. GAPDH and TUBA1A/a-tubulin serve as loading controls; horizontal
lines designate individual blots. (C-F) Corresponding quantification of immunoblot
analysis in A and B displayed as either bar graphs (C and E) or line plots (D and F). (C
and D) LC3-II levels were normalized to GAPDH (mean ± SEM; one-way ANOVA with
Dunnett’s post hoc test; statistical tests were performed independently for each time
point; bars not designated are ns; n=3-4 independent experiments, 3-7 DIV). (E and F)
SQSTM1 levels were normalized to GAPDH (mean ± SEM; one-way ANOVA with
Dunnett’s post hoc test; statistical tests were performed independently for each time
point; bars not designated are ns; n=3-4 independent experiments, 3-7 DIV). (G)
Quantification of total GFP-LC3-puncta area normalized to cell area of astrocytes
starved in ACSF without glucose for the indicated times (mean ± SEM; one-way ANOVA
with Tukey’s post hoc test; 30 min, n=73-137 cells from 4 independent experiments; 4 h,
n=58-68 cells from 4 independent experiments; 8 h, n=50-85 cells from 3 independent
experiments, 3-6 DIV). The data for 4 h are the same as the data shown in Figure 2B.
(H) Quantification of total SQSTM1 puncta area normalized to cell area of astrocytes
starved in ACSF without glucose for the indicated times (mean ± SEM; one-way ANOVA
with Tukey’s post hoc test; 30 min, n=87-178 cells from 4 independent experiments; 4 h,
n=58-91 cells from 4 independent experiments, 8 h, n=62-106 cells from 3 independent
experiments, 3-6 DIV). The data for 4 h are the same as the data shown in Figure 2C.
Baf A1, bafilomycin A1; Glc, glucose; GM, glial media.
Next, we assessed whether autophagy might be induced at earlier times in
response to starvation in ACSF, or whether autophagy induction may require longer time
periods of starvation than 4 h. To address these possibilities, we performed a time
course to track the temporal response of autophagy to starvation in ACSF without
glucose from 30 min up to 8 h. Within 30 min, starvation in ACSF lacking glucose
decreased LC3-II levels relative to fed DMSO and fed bafilomycin A1 samples,
suggesting an initial dampening of autophagic flux (Fig. 23 A, C and D). Autophagic flux
increased with time in ACSF no glucose, however, it remained consistently lower as
compared to cognate fed controls (Fig. 23 A, C and D). Curiously, at early time points
when LC3-II and autophagy levels were low, SQSTM1 levels and SQSTM1 degradative
flux were high in ACSF without glucose relative to fed controls (Fig. 23 B, E and F). With
further incubation in ACSF no glucose, SQSTM1 levels and SQSTM1 degradative flux
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decreased (Fig. 23 B, E and F). By 8 h, SQSTM1 was elevated in only the fed
bafilomycin A1-treated sample due to impaired SQSTM1 degradation (Fig. 23 B, E and
F). At this time point, SQSTM1 flux was dampened in ACSF no glucose relative to the
fed bafilomycin A1 condition (Fig. 23 B, E and, F), providing further evidence for
decreased autophagic flux with starvation in ACSF. Collectively, these findings suggest
that starvation in ACSF without glucose unexpectedly dampens autophagy in primary
astrocytes during acute and long-term treatments.
This unanticipated dampening of autophagic flux with starvation in ACSF without
glucose was corroborated with immuno-fluorescence analysis. Bafilomycin A1 added to
normal growth media resulted in a steady increase in GFP-LC3 and SQSTM1 puncta
area over time due to impaired lysosome-mediated degradation (Fig. 23 G and H). By
contrast, co-treatment of bafilomycin A1 with ACSF lacking glucose decreased GFP-LC3
and SQSTM1 puncta area relative to the fed bafilomycin A1 control (Fig. 23 G and H).
This effect is detected as early as 30 min of starvation and persists for up to 8 h (Fig. 23
G and H). In total, based on our immunofluorescence microscopy and immunoblotting
results, we find that starvation in ACSF ± glucose decreases autophagic flux in primary
astrocytes.
Our observations that ACSF dampens autophagic flux in astrocytes was
unexpected, given that nutrient deprivation has been previously established to activate
autophagy in various other cell types [137, 138]. Therefore, we considered whether
some feature of these precise starvation conditions was preventing induction of
autophagy. For this experiment, we starved astrocytes in a different type of buffered salt
solution, Earle’s Balanced Salt Solution (EBSS), that contains 5.6 mM glucose. In
contrast to starvation in ACSF, starvation in EBSS increased the percent area occupied
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by GFP-LC3 puncta per cell by ~4.8-fold relative to the fed DMSO control (Fig. 24 A, B).
Interestingly, we noted that the autophagosomes generated in EBSS were often larger,
ring-like structures, compared to the smaller, punctate structures observed with torin1induced autophagy (Fig. 19 B and 24 A, insets). Consistent across our experiments,
bafilomycin A1 added to the normal growth media increased GFP-LC3 puncta area by
~5.4-fold relative to DMSO alone (Fig. 24 A, B). Co-treatment of bafilomycin A1 with
EBSS resulted in a dramatic increase in GFP-LC3 puncta area per cell, ~14.4-fold above
the fed DMSO control, and ~2.7-fold above the fed bafilomycin A1 control (Fig. 24 A, B).
Thus, starvation in EBSS dramatically induces autophagy in primary astrocytes.
We also found that starvation in EBSS increased selective forms of autophagy. EBSS
increased SQSTM1 puncta area ~3.8-fold relative to fed DMSO (Fig. 24 A, C).
Consistently, bafilomycin A1 added to normal growth media increased SQSTM1 puncta
area ~11-fold relative to the fed DMSO control (Fig. 24 A, C). Treatment with EBSS plus
bafilomycin A1 increased SQSTM1 puncta area ~20-fold relative to the fed DMSO, and
~1.8-fold relative to the fed bafilomycin A1 (Fig. 24 A, C). Thus, starvation in EBSS
increases the appearance of SQSTM1-positive puncta and flux of SQSTM1 through
lysosomal mediated degradative pathways.
Starvation in EBSS also increased the percent area of SQSTM1-positive puncta
that colocalize with GFP-LC3-positive autophagosomes by ~4.2-fold relative to the fed
DMSO control (Fig. 24 A, D). While blocking degradation with bafilomycin A1 increased
colocalization between SQSTM1 and GFP-LC3 by 2.7-fold relative to the fed DMSO
control, EBSS plus bafilomycin A1 increased colocalization by ~4-fold relative to the fed
DMSO control and ~1.5-fold above the bafilomycin A1 alone (Fig. 24 A, D). Using the
converse analysis, the percent area of GFP-LC3-positive autophagosomes that
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colocalized with SQSTM1 puncta in EBSS was similar to that in fed media controls (Fig.
21 C).
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Figure 3. Starvation in EBSS activates autophagy in primary astrocytes. (A) Maximum projections of Z-stacks of GFP-LC3 transgenic astrocytes starved in EBSS for 4 h
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Figure 24. Starvation in EBSS activates autophagy in primary astrocytes.
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starved astrocytes in the presence of cycloheximide to inhibit define the factors in EBSS and ACSF that could account for
protein synthesis. Treatment with cycloheximide dampened, but99such differences. While the salt composition of ACSF and
did not completely abolish, the starvation-induced increase in EBSS is largely similar (Table 1), the glucose concentration
SQSTM1 (Fig. S4A and B). Therefore, elevated SQSTM1 during is 10 mM in ACSF and 5.6 mM in EBSS. To determine
acute starvation is partially attributed to new protein synthesis. whether this difference in glucose concentration could
Interestingly, 30 min in ACSF, but not EBSS, decreased levels of account for the opposing effects of these salt solutions on
ubiquitination (Fig. S4A and C), providing further evidence that autophagic flux, we starved glia for 4 h in ACSF or EBSS
these salt solutions elicit differential effects on degradative with either 5.6 mM or 10 mM glucose. Interestingly, treatment in ACSF with 5.6 mM or 10 mM glucose dampened
pathways.
Our striking observations that the two salt solutions, which autophagic flux to the same degree, and treatment in EBSS

astrocytes starved in EBSS for 4 h (mean ± SEM; one-way ANOVA with Tukey’s post
hoc test; n = 65-91 cells from 3 independent experiments, 4-5 DIV). (C) Quantification of
total SQSTM1 puncta area normalized to cell area of astrocytes starved in EBSS for 4 h
(mean ± SEM; one-way ANOVA with Tukey’s post hoc test; n = 48-61 cells from 3
independent experiments, 4-5 DIV). (D) Quantification of the percentage of SQSTM1
puncta area that overlaps with GFP-LC3 puncta area in astrocytes starved in EBSS for 4
h (mean ± SEM; one-way ANOVA with Tukey’s post hoc test; n = 25-39 cells from 3
independent experiments, 4-5 DIV).
Thus, like MTOR inhibition, starvation in EBSS activates, but does not enrich, SQSTM1mediated selective autophagy in primary astrocytes. These effects are in stark contrast
to those in ACSF where selective autophagy is dampened.
To compare the starvation paradigms directly, we deter-mined levels of
autophagy after 30 min and 4 h in ACSF or EBSS (both containing glucose) by
immunoblotting lysates from primary cortical glia. Starvation in either ACSF or EBSS
progressively decreased p-RPS6 relative to total RPS6, from 30 min to 4 h (Fig. 25 A),
indicating decreased MTOR activity in response to starvation in both salt solutions.
Thus, the cells are sensing nutrient deprivation in either starvation paradigm. At 30 min,
treatment with ACSF (containing glucose) dampened autophagic flux in astrocytes (Fig.
25 A, Ai). By 4 h, levels of LC3-II were equivalent between fed and ACSF conditions,
suggesting that autophagosome levels may be increasing with time of starvation
treatment, however, autophagic flux remained lower in ACSF (with glucose) +
bafilomycin A1 relative to the fed + bafilomycin A1 condition (Fig. 25 A, Ai).
These time-dependent effects are similar to our results with starvation in ACSF
lacking glucose (Fig. 23 A, C and D), indicating that the dampening of autophagic flux in
ACSF is not dependent on glucose. By contrast, we did not observe a dampening of
autophagic flux with EBSS treatment, but rather an activation of autophagic flux in EBSS
(Fig. 25 A, Ai). Thus, while astrocytes sense nutrient deprivation in either ACSF or
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EBSS, they regulate autophagy differently in response to each starvation paradigm;
ACSF dampens autophagic flux and EBSS activates autophagic flux.
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Figure 25. Starvation in EBSS activates autophagy in a buffer-dependent manner.
(A-Aii) Immunoblot analysis and corresponding quantification of glia starved in ACSF
versus EBSS for 30 min or 4 h. LC3-II and SQSTM1 levels were normalized to GAPDH
(mean ± SEM; one-way ANOVA with Dunnett’s post hoc test; statistical tests were
performed independently for each time point; n = 3-5 independent experiments, 5-7
DIV). (B-Bii) Immunoblot analysis and corresponding quantification of glia starved for 4
h in ACSF vs EBSS with either 5.6 mM or 10 mM glucose. LC3-II and SQSTM1 levels
were normalized to GAPDH (mean ± SEM; one-way ANOVA with Dunnett’s post hoc
test; n = 4 independent experiments, 4-5 DIV). (C-Cii) Immunoblot analysis and
corresponding quantification of glia starved for 4 h in ACSF versus EBSS with either
HEPES or bicarbonate/phosphate buffering systems. LC3-II and SQSTM1 levels were
normalized to GAPDH (mean ± SEM; one-way ANOVA with Dunnett’s post hoc test; n =
3 independent experiments, 4-8 DIV). (D and Di) Immunoblot analysis and
corresponding quantification of glia starved for 4 h in the indicated salt solutions. pULK1:TUBA1A was normalized to total ULK1:TUBA1A (mean ± SEM; starvation data
are analyzed by a one-way ANOVA with Dunnett’s post hoc test; torin1 data are
analyzed by a t-test; n = 3 independent experiments, 3-6 DIV). (A-D) GAPDH and
TUBA1A/α-tubulin serve as loading controls; horizontal lines designate individual blots.
Baf A1, bafilomycin A1; GM, glial media.
In addition to opposing effects on autophagy, the two salt solutions also elicited
different effects on SQSTM1 levels. At 30 min, ACSF and EBSS increased SQSTM1
levels and flux of SQSTM1 through lysosome-mediated degradative pathways relative to
fed controls (Fig. 25 A, Aii). These results are similar to our previous results with 30 min
in ACSF without glucose (Fig. 23 B, E and F). Thus, while ACSF dampens autophagic
flux and EBSS activates autophagic flux, SQSTM1 levels increase after 30 min in either
starvation treatment. At 4 h, however, SQSTM1 degradative flux was significantly
increased in only EBSS and not in ACSF with glucose (or ACSF without glucose; Fig. 25
A, Aii and Fig. 23 B, E, F). These results, combined with our colocalization analysis
(Figs. 22 D and 24 D), are consistent with the induction of selective autophagy in EBSS
and not in ACSF.
To determine whether the increase in SQSTM1 after 30 min of treatment in
EBSS and ACSF was due to changes in autophagic flux or contributions from new
protein synthesis, we starved astrocytes in the presence of cycloheximide to inhibit
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protein synthesis. Treatment with cycloheximide dampened, but did not completely
abolish, the starvation-induced increase in SQSTM1 (Fig. 26 A and B). Therefore,
elevated SQSTM1 during acute starvation is partially attributed to new protein synthesis.
Interestingly, 30 min in ACSF, but not EBSS, decreased levels of ubiquitination (Fig. 26
A and C), providing further evidence that these salt solutions elicit differential effects on
degradative pathways.
Our striking observations that the two salt solutions, which both effectively starve
cells, elicit opposing effects on autophagic flux were puzzling. These differential effects
were not due to increased cytotoxicity (Fig. 27). Indeed, there was no toxicity in either
buffer (Fig. 27). Thus, we next sought to define the factors in EBSS and ACSF that could
account for such differences. While the salt composition of ACSF and EBSS is largely
similar (Table 1), the glucose concentration is 10 mM in ACSF and 5.6 mM in EBSS.
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Figure 26. Starvation-induced increase in SQSTM1 is partially due to new protein
synthesis.
(A) Immunoblot analysis of glia starved for 30 min in either ACSF or EBSS ±
cycloheximide (CHX) and analyzed by immunoblotting. GAPDH and TUBA1A/a-tubulin
serve as loading controls; horizontal lines designate individual blots. (B and C)
Corresponding quantification of immunoblot analysis in A. (B) Mean ± SEM; one-way
ANOVA with Dunnett’s post hoc test; n=3 independent experiments; 6-7 DIV. (C) Mean ±
SEM; one-way ANOVA with Dunnett’s post hoc test; n=5 independent experiments; 6-7
DIV.
To determine whether this difference in glucose concentration could account for
the opposing effects of these salt solutions on autophagic flux, we starved glia for 4 h in
ACSF or EBSS with either 5.6 mM or 10 mM glucose. Interestingly, treatment in ACSF
with 5.6 mM or 10 mM glucose dampened autophagic flux to the same degree, and
treatment in EBSS with 5.6 mM or 10 mM glucose induced autophagic flux to the same
degree (Fig. 25 B, Bi). Further, different glucose concentrations had no effect on
SQSTM1 levels within a given salt solution (Fig. 25 B, Bii). Thus, the differential effects
of ACSF and EBSS on autophagic flux are not dependent on glucose concentration.
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Figure 27. Starvation of glia in ACSF or EBSS does not cause cytotoxicity.
Maximum projections of Z-stacks of Hoechst and Draq7 labeling of glia incubated for 4 h
in either normal glial media, ACSF, or EBSS (Bar: 20 µm). Hoechst is a membrane
permeable DNA dye that labels total cells, and Draq7 is a membrane impermeable DNA
dye that will label only dead and membrane-compromised cells. In all treatment
conditions, comparing fed controls (in glial media) to ACSF to EBSS, only ~1% of total
Hoechst-positive cells were co-positive for Draq7, indicating very low levels of
cytotoxicity. As a positive control, following each treatment, cells were permeabilized
with 0.1% Triton X-100 to allow accessibility of the Draq7 dye. Under these conditions,
100% of Hoechst-positive cells were co-positive for Draq7. Thus, the starvation
treatments are not causing cytotoxicity within the 4 h tested.
Another key difference between these salt solutions is in the buffering systems;
EBSS is buffered with bicarbonate and phosphate and ACSF is buffered with HEPES.
Therefore, we examined the contributions of the buffering systems on modulating
autophagy levels during starvation. For this experiment, we swapped the buffering
systems and generated EBSS containing HEPES, and ACSF containing bicarbonate
and phosphate buffers (Table 1). As expected, all generated salt solutions effectively
starved the astrocytes, as indicated by decreased p-RPS6 relative to total RPS6 (Fig. 25
C). Consistent with our previous results, treatment with EBSS buffered with bicarbonate
and phosphate induced autophagy (Fig. 25 C, Ci). Remarkably, starvation in EBSS
buffered with HEPES, and not bicarbonate and phosphate, reduced autophagic flux,
similar to ACSF buffered with HEPES (Fig. 25 C, Ci). Furthermore, when we performed
the converse experiment and substituted bicarbonate and phosphate for HEPES, ACSF
did not dampen autophagy, but activated autophagy to levels induced by EBSS buffered
with bicarbonate and phosphate buffers (Fig. 25 C, Ci). Combined, we find that
starvation in salt solutions buffered with HEPES dampen autophagic flux, and salt
solutions buffered with bicarbonate and phosphate induce autophagic flux. Consistent
with these results, SQSTM1 degradative flux increased in only bicarbonate/phosphatebuffered salt solutions (Fig. 25 C, Cii), further supporting an activation of selective
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autophagy. To our surprise, these findings indicate that the buffering system dramatically
impacts the ability of the cell to activate autophagy in response to nutrient deprivation.
AUTOPHAGY

1659

Table 1. Solutions used for starvation experiments.
Solution:
ACSF
NaCl
125 mM
KCl
5 mM
CaCl2
2 mM
MgCl2
1 mM
MgSO4
–
HEPES
10 mM, pH
7.4
–
NaHCO3
NaH2
–
PO4
Glucose
10 mM

ACSF without
glucose
125 mM
5 mM
2 mM
1 mM
–
10 mM, pH 7.4

ACSF buffered with bicarbonate and
phosphate
125 mM
5 mM
2 mM
1 mM
–
–

ACSF with 5.6 mM
Glucose
125 mM
5 mM
2 mM
1 mM
–
10 mM, pH 7.4

EBSS, Sigma
E3024
116 mM
5.4 mM
1.8 mM
–
0.8 mM
–

EBSS buffered with
HEPES
117 mM
5.3 mM
1.8 mM
–
0.8 mM
10 mM, pH 7.4

EBSS with 10 mM
glucose
116 mM
5.4 mM
1.8 mM
–
0.8 mM
–

–
–

26 mM
1 mM

–
–

26 mM
1 mM

–
–

26 mM
1 mM

–

10 mM

5.6 mM

5.6 mM

5.6 mM

10 mM
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regulation.
Dunnett’s post hoc test;
= 4 independent
experiments, 4–5 DIV). (C-Cii) Immunoblot analysis and corresponding quantification of glia starved for 4 h in ACSF

versus EBSS with either HEPES or bicarbonate/phosphate buffering systems. LC3-II and SQSTM1 levels were normalized to GAPDH (mean ± SEM; one-way ANOVA
with Dunnett’s post hoc test; n = 3 independent experiments, 4–8 DIV). (D and Di) Immunoblot analysis and corresponding quantification of glia starved for 4 h in
the indicated salt solutions. p-ULK1:TUBA1A was normalized to total ULK1:TUBA1A (mean ± SEM; starvation data are analyzed by a one-way ANOVA with Dunnett’s
post hoc test; torin1 data are analyzed by a t-test; n = 3 independent experiments, 3–6 DIV). (A-D) GAPDH and TUBA1A/α-tubulin serve as loading controls; horizontal
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3.2.3. Starvation is a more potent activator of glial autophagy as compared with
neuronal autophagy
We previously reported that starvation in ACSF (buffered with HEPES) did not
robustly activate autophagy in primary hippocampal neurons [50]. In our present study,
we find that activation of autophagy in response to starvation is critically dependent on
the buffering system of the starvation solution, with HEPES buffer leading to an inhibition
of autophagic flux. These results led us to wonder whether the buffer accounted for the
lack of autophagy induction during starvation of neurons in ACSF. To address this
possibility, we evaluated the ability of neurons to activate autophagy in response to
starvation in EBSS buffered with bicarbonate and phosphate. For this experiment, we
isolated hippocampal neurons from GFP-LC3 transgenic mice and measured the
percent area occupied by GFP-LC3-positive autophagosomes in the soma by live-cell
imaging. Our preparations of primary hippocampal neurons are highly pure.
Immunostaining analysis indicated that ~96% of Hoechst-positive cells were positive for
the neuron-specific marker TUBB3/β3 tubulin; GFAP-positive astrocytes were rarely
detected (Fig. 28).

Figure 28. Primary hippocampal neuron preparations are highly pure (~96% of
cells are neurons).
Representative images of primary hippocampal neuron preparations at 8 DIV labeled for
Hoechst (labels total cells), TUBB3/b3 tubulin (neuron-specific marker), and GFAP
(astrocyte-specific marker). Bar: 20 µm.
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Figure 5. Starvation in EBSS does not robustly activate autophagy in primary neurons. (A) Maximum projections of z-stacks in the soma of GFP-LC3 transgenic
hippocampal neurons starved in EBSS for 4 h. Bar: 10 µm. (B) Corresponding quantification of GFP-LC3 puncta area normalized to the soma area of neurons starved in
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and corresponding quantification of wild type hippocampal neurons starved in ACSF versus EBSS for 4 h. GAPDH and TUBA1A/α-tubulin serve as loading controls;
horizontal lines designate individual blots. LC3-II and SQSTM1 levels were normalized to GAPDH (mean ± SEM; one-way ANOVA with Dunnett’s post hoc test;
neurons.
statistical
tests were performed independently for each time point; n = 6 independent experiments, 8–10 DIV). (F) Maximum projections of z-stacks in the soma of
GFP-LC3 transgenic hippocampal neurons starved in EBSS for 6 h and 8 h. Bar: 10 µm. (G) Quantification of GFP-LC3 puncta area normalized to the soma area of
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autophagy.
Notably, buffering systems can affect cellular function in
other contexts. For example, incubating neurons in HEPESbuffered solutions, but not bicarbonate-based solutions, can

Maximum projections of z-stacks in the soma of GFP-LC3 transgenic hippocampal
neurons starved in EBSS for 6 h and 8 h. Bar: 10 µm. (G) Quantification of GFP-LC3
puncta area normalized to the soma area of hippocampal neurons starved in EBSS for 6
h (mean ± SEM; one-way ANOVA with Tukey’s post hoc test; n = 34-64 neurons from 4
independent experiments, 8-9 DIV). (H) Quantification of GFP-LC3 puncta area
normalized to the soma area of hippocampal neurons starved in EBSS for 8 h (mean ±
SEM; student’s t-test; n= 46-68 neurons from 4 independent experiments, 8-9 DIV). Baf
A1, bafilomycin A1; MM, maintenance media.

In contrast to astrocytes, treatment of neurons with EBSS for 4 h had no
significant effect on autophagosome area in the soma relative to the fed control at
steady state (Fig. 29 A, B). As expected, treatment with bafilomycin A1 to block
autophagosome clearance dramatically increased GFP-LC3 puncta area in fed
conditions by ~3.9-fold relative to the fed DMSO control. Co-treatment of bafilomycin A1
with EBSS, however, resulted in only a modest increase in autophagosome area relative
to the fed bafilomycin A1 alone (Fig. 29 A, B). These results demonstrate that while
there is a slight stimulation of autophagy in neurons during starvation, this induction is
not as pronounced in neurons as it is in astrocytes. Therefore, neurons respond
differently than astrocytes when challenged with metabolic stress.
We also measured autophagy levels by immunoblotting lysates from
hippocampal neurons starved for 30 min or 4 h in ACSF (buffered with HEPES) or EBSS
(buffered with bicarbonate and phosphate). Similar to astrocytes, hippocampal neurons
detect nutrient deprivation in both salt solutions and downregulate MTOR signaling, as
indicated by decreased p-RPS6 levels relative to total RPS6 (Fig. 29 C). Unlike in
astrocytes, dampening of autophagic flux in ACSF was not as robust in primary neurons
(Fig. 29 C, D). Treatment with EBSS resulted in only a slight activation of autophagy in
neurons (Fig. 29 C, D). Unlike astrocytes, neurons did not accumulate SQSTM1 during
short-term treatments in either ACSF or EBSS (Fig. 29 C, E). Thus, combined with the
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fluorescence data, these results indicate that autophagy is differentially regulated in
neurons and astrocytes in response to stress, with starvation being a more potent
activator of autophagy in astrocytes as compared with neurons.
Since autophagy is only mildly induced in primary neurons after 4 h of starvation,
we next assessed whether robust activation of autophagy in neurons may require longer
time periods of starvation. To address this possibility, we incubated GFP-LC3 transgenic
hippocampal neurons in EBSS for 6 h and 8 h, and measured the percent area of GFPLC3-positive puncta in the soma, normalized for soma area. Treatment with EBSS
increased autophagosome area in the soma as a function of time, indicating that
autophagy can be induced in neurons with longer periods of starvation (Fig. 29 F-H).
Consistent with this result, autophagic flux was induced after 6 h of starvation in EBSS
(Fig. 29 F, G). We were unable to assess autophagic flux at 8 h due to increasing toxicity
associated with extended bafilomycin A1 treatment. Thus, we find that neurons can
activate autophagy with longer periods of starvation (Fig. 29 F-H), however, the effects
are less pronounced as compared to astrocytes that are starved for less time (4 h; Fig.
24 A, B).
3.3. Discussion
Whether glia and neurons regulate autophagy in a similar manner in response to
stress is poorly understood. Here, we address this issue and investigate the mechanistic
basis for regulating autophagy during metabolic stress in primary astrocytes, and
perform a comparative analysis with primary hippocampal neurons. We find that
autophagy in astrocytes is strongly activated by pharmacological inhibition of MTOR
(Fig. 19). We also find that nutrient deprivation activates autophagy in astrocytes and
this induction is critically dependent on the buffering system of the starvation solution
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(Fig. 24, 25). Starvation in salt solutions buffered with HEPES dampens autophagy while
starvation in salt solutions buffered with bicarbonate and phosphate activates autophagy
(Fig. 22, 24, 25). By contrast, starvation conditions that robustly activate autophagy in
astrocytes have less pronounced effects in neurons, suggesting that nutrient deprivation
is not as potent an activator of autophagy in neurons as compared to astrocytes (Fig.
29).
Our findings help to define the molecular basis for autophagy in response to
various paradigms of metabolic stress and emphasize that different methods of MTOR
inhibition, either by pharmacological inactivation or nutrient deprivation, impact the
autophagy pathway differently. Results from immunofluorescence microscopy and
immunoblotting analyses were corroborative, but immunofluorescence microscopy
analysis allowed more sensitive detection of differences. While both treatments of MTOR
inhibition can induce autophagy, the morphology of the autophagosomes generated in
each treatment are different. Starvation leads to the formation of larger, more ring-like
autophagosomes as compared with the smaller, more punctate autophagosomes formed
during MTOR inhibition with torin1 (Figs. 19 B and 24 A). Additionally, while both
treatments induce SQSTM1-positive, selective forms of autophagy, the effect on total
SQSTM1 levels differs between each paradigm. During a 4 h treatment with torin1,
increased autophagy levels result in a consistent trend of decreased total SQSTM1
levels (Figs. 19 H and I). By contrast, starvation (in either ACSF or EBSS) elicits an early
increase in steady state levels of SQSTM1, which then return to baseline by 4 h of
starvation (Figs. 22 G, H, 25 A, Aii, 23 B, E and F). We find that this initial increase in
SQSTM1 during acute starvation is in part due to new protein synthesis (Fig. 26 A and
B). Interestingly, while MTOR signaling was dampened in all starvation paradigms
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tested, autophagy was not consistently activated (Figs. 22 E, F, 25 A, C, D, 23 A and C).
In fact, starvation in ACSF dampened autophagic flux in astrocytes (Figs. 22, 24 A-C
and 23). Thus, not all conditions of MTOR inhibition are sufficient to stimulate
autophagy. Our findings underscore the mechanistic diversity of different paradigms of
autophagy activation. Further, our results raise important considerations when
interpreting SQSTM1 as a readout for autophagic flux, as total SQSTM1 levels are
differentially impacted depending on the type of metabolic stress.
One of our most striking observations is that not all starvation conditions result in
the activation of autophagy (Figs. 22-25). These differential effects are not due to
differences in glucose concentration (Fig. 25 B, Bi) or an increase in cytotoxicity (Fig.
27). Rather, these differential effects are attributed to the buffering system of the salt
solution. We starved astrocytes in two salt solutions, ACSF versus EBSS, that differed
primarily in the type of buffering system, HEPES versus bicarbonate-phosphate,
respectively. We also performed experiments to swap the buffering system and
generated ACSF buffered by bicarbonate-phosphate and EBSS buffered with HEPES.
All combinations of salt solutions effectively decreased p-RPS6 levels (Figs. 22 E, 25 A,
C and 23 A), indicating a decrease in MTOR signaling, consistent with cells sensing
nutrient deprivation in all paradigms tested. However, most strikingly, autophagy was
activated in only salt solutions buffered with bicarbonate and phosphate, and not HEPES
(Figs. 22-25). Salt solutions buffered with HEPES had an inhibitory effect and dampened
autophagic flux. Differences between these salt solutions was further evident by
measuring levels of SQSTM1-mediated selective autophagy. Indeed, EBSS elicited
SQSTM1-mediated selective autophagy whereas ACSF muted the process. We also
observed a decrease in cellular ubiquitination levels in ACSF (HEPES-buffered) as
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compared with EBSS (bicarbonate/phosphate-buffered) (Fig. 26). Thus, the buffering
system dramatically impacts the ability of the cell to modulate autophagy in response to
metabolic stress. These findings provide an important distinction for the autophagy field
in considering how buffer components impact starvation-induced autophagy.
Notably, buffering systems can affect cellular function in other contexts. For
example, incubating neurons in HEPES-buffered solutions, but not bicarbonate-based
solutions, can alter neuron membrane potential and dampens firing rates [141]. The
mechanisms underlying this effect are unclear. One possibility is that bicarbonate, which
is a more physiological, cell-permeant buffer than HEPES, may enable tighter regulation
of extracellular and hence intracellular pH over extended time periods. One recent report
links acidic intracellular pH with alterations in lysosome distribution and function [110],
which could have profound effects on the autophagy pathway. Likewise, acidic
intracellular environments can decrease autophagic flux [142]. We found that starvation
in either buffering system effectively downregulates p-RPS6:RPS6 and p-ULK1:ULK1
(Fig. 25). Thus, these buffer-dependent effects are not explained by differential activities
of MTOR signaling that regulate new protein synthesis and autophagy, respectively.
Future studies will need to identify the cellular mechanisms underlying these bufferdependent effects.
Our results also highlight differences in the regulation of stress-induced
autophagy between astrocytes and neurons. We find that starvation is a more potent
activator of autophagy in astrocytes as compared with neurons. After 4 h of starvation,
autophagy is activated more robustly in astrocytes as compared with neurons (Figs. 24,
25 and 29). While longer periods of starvation (6 h and 8 h) can activate autophagy in
neurons (Fig. 29), the effects are less pronounced as compared to astrocytes that are
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starved for less time (4 h; Fig. 24). Further, during acute starvation in either ACSF or
EBSS, SQSTM1 levels and SQSTM1 degradative flux are initially elevated in astrocytes,
but are unaltered in neurons (Figs. 25 A, Aii, 29 C, E, and 23 B, E). Since ACSF and
EBSS have opposing effects on autophagy, this increase in SQSTM1 degradative flux in
astrocytes is uncoupled from LC3-II-dependent macroautophagy at early time points of
starvation. We show that a component of this starvation-induced increase in SQSTM1 in
astrocytes is attributed to new synthesis of SQSTM1 (Fig. 26). The remaining increase in
SQSTM1 degradative flux may be attributed to microautophagy, a process where
cargoes are engulfed directly into endolysosomal organelles without an autophagosome
intermediate. A recent study demonstrated that during acute starvation, selective
autophagy receptors, such as SQSTM1, are efficiently degraded through endosomal
microautophagy, independent of macroautophagy [143]. Interestingly, we see this
starvation-induced increase in SQSTM1 degradative flux only in astrocytes and not in
neurons, suggesting that not only macroautophagy, but also microautophagy, may be
differentially regulated in astrocytes versus neurons. Lastly, we show that MTOR
inhibition activates autophagy more robustly in astrocytes as compared to our previous
results in neurons [50] (Fig. 19). Thus, we find that astrocytes exhibit a more pronounced
activation of autophagy during metabolic stress as compared with neurons. These
results may point to a major dichotomy in autophagic regulation between the main cell
types of the brain.
Given that neurons are post-mitotic and must survive for nearly a century, they
are particularly dependent on robust quality control pathways to maintain health and
functionality throughout their extended lifetime. Thus, our findings that metabolic
stressors are more potent activators of autophagy in astrocytes as compared with
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neurons are particularly intriguing. These data may point to a metabolic division of labor
in the brain. The extensive specialization of neurons may render them more dependent
on glia for metabolic support. In fact, Zheng et al. have shown that neural progenitor
cells switch from aerobic glycolysis to oxidative phosphorylation as they differentiate into
neurons, linking different metabolic programs with proliferative versus post-mitotic
differentiation states [144]. Concomitant with this transition to oxidative phosphorylation,
mitochondrial mass increases in neurons [144]. As a consequence, neurons may then
rely on glia to provide fuel, in the form of lactate, for mitochondrial ATP production [145,
146]. This intercellular transfer of lactate represents a point of vulnerability for neurons
as mutations in the oligodendroglial-enriched lactate transporter lead to
neurodegenerative disease in humans [147]. Interestingly, a recent study examined
changes in the neuronal proteome when neurons were grown in isolation or in
combination with glia [148]. Lack of glia greatly enhanced the turnover of neuronal
glycolytic proteins, suggesting that in the absence of metabolic support from glia,
neurons must rely on their own glycolytic machinery [148]. Complexity is further added
when considering region-specific functions for neurons in the brain. A recent study
demonstrates that starvation upregulates autophagy in only hypothalamic neurons and
not cortical, hippocampal, or cerebellar neurons in vivo [84], suggesting neuron-specific
functions for autophagy in the brain. In total, emerging data support a collaboration
between neurons and surrounding glia to regulate metabolic function in the brain. In this
role, we find that glia are more responsive to metabolic stress, in terms of activating
autophagy, as compared with neurons.
Other studies have indicated that autophagy and other branches of the quality
control network might be regulated differently in neurons versus astrocytes in response
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to other modalities of stress. Pamenter et al. show that ischemic stress induces
extensive vacuolization in astrocytes as compared with neurons [149]. Pla et al. suggest
that ethanol stress might elicit autophagy in astrocytes but not in neurons [150]. Postmortem samples from Alzheimer disease patients exhibit elevated levels of TFEB, a
transcription factor that regulates autophagosome and lysosome biogenesis, in
astrocytes as compared with neurons [151]. Mice deficient in PI(3,5)P2 accumulate
SQSTM1 preferentially in astrocytes as compared with neurons [152]. Moruno-Manchon
et al. also demonstrate cell-type specific differences in SPHK1 (sphingosine kinase 1)associated autophagy in neurons versus astrocytes [153]. Tydlaka et al. demonstrate
that glia exhibit higher proteasomal activity with aging as compared with neurons [154].
Thus, accumulating evidence suggests that glia may be more sensitive to different
modalities of stress and respond with different alterations in autophagy as compared
with neurons.
Recent reports also raise an intriguing hypothesis of whether glia may
supplement neuronal degradation systems. Indeed, work has shown intercellular transfer
of organelles from neuronal axons to neighboring astrocytes for degradation by
lysosomes [63]. Further, microglia may have key neuroprotective roles in models of
neurodegenerative disease by degrading aggregated proteins originating from neurons
[155]. An interesting implication for our results is that MTOR inhibitors, such as
rapamycin, may have neuroprotective effects in vivo by stimulating autophagy
preferentially in glia as compared with neurons. These treatments, in combination with
small molecules to further target autophagy in neurons, could be used to strengthen
therapeutic strategies to mitigate neurodegenerative disease [156].
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3.4. Materials and methods
3.4.1. Reagents
GFP-LC3 transgenic mice, strain name B6.Cg-Tg(CAG-EGFP
/LC3)53Nmi/NmiRbrc were obtained from the RIKEN BioResource Center in Japan [43]
and maintained as hetero-zygotes. All animal protocols were approved by the
Institutional Animal Care and Use Committee at the University of Pennsylvania. Primary
antibodies for immuno-fluorescence include chicken anti-GFP (Aves Labs, Inc., GFP1020), mouse anti-SQSTM1/p62 (Abcam, Ab56416), rabbit anti-GFAP (Millipore,
AB5804), rabbit anti-IBA1 (Wako, 019-19741), anti-GALC (galactosylceramidase; H8H9)
mouse hybridoma supernatant (gift from Judith Grinspan, University of Pennsylvania,
Philadelphia, PA), and mouse anti-TUBB3/β3 tubulin (Novus Biologicals, MAB1195-SP).
Secondary antibodies for immunofluorescence microscopy include goat anti-chicken Cy2
(Jackson ImmunoResearch Laboratories, 103-225-155), goat anti-mouse Alexa Fluor
594 (Invitrogen, A11032), goat anti-mouse Alexa Fluor 488 (Thermo Fisher
Scientific/Invitrogen, A11029), goat anti-rabbit Alexa Fluor 488 (Thermo Fisher
Scientific/Invitrogen, A11034), and goat anti-rabbit Alexa Fluor 594 (Thermo Fisher
Scientific/Invitrogen, A11037). Hoechst 33342 was purchased from Thermo Fisher
Scientific/Molecular Probes (H3570). Draq7 was purchased from Abcam (ab109202).
Antibodies for immunoblot analysis include rabbit anti-LC3 (Abcam, ab48394), rabbit
anti-LC3 (Cell Signaling Technology, 2775S), mouse anti-GAPDH (Advanced
Immunochemicals, 2-RGM2 clone 6C5), mouse anti-GAPDH (Abcam, ab9484), mouse
anti-TUBA1A/α-tubulin (Sigma, T9026 clone DM1A), rabbit anti-p-RPS6/S6 (Cell
Signaling Technology, 2215), rab-bit anti-RPS6/S6 (Cell Signaling Technology, 2217S),
mouse anti-SQSTM1/p62 (Abcam, ab56416), mouse anti-ubiquitin (Cell Signaling
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Technology, 3936T, clone P4D1), rabbit anti-p-ULK1 (Ser757; Cell Signaling
Technology, 6888), rabbit anti-ULK1 (Cell Signaling Technology, 8054, clone D8H5),
donkey anti-mouse peroxidase conjugated secondary antibody (Jackson
ImmunoResearch Laboratories, 715-035-151), and donkey anti-rabbit peroxidaseconjugated secondary antibody (Jackson ImmunoResearch Laboratories, 711-035-152).
Small molecules include bafilomycin A1 (Sigma, B1793), torin1 (Calbiochem, 475991),
and cycloheximide (Sigma, C7698).
3.4.2. Primary cortical astrocyte culture
Cerebral cortices were dissected from brains of GFP-LC3 transgenic or nontransgenic neonatal mice of either sex at P0-P1, and carefully stripped of their
meninges. Tissue was digested with 0.25% trypsin (Thermo Fisher Scientific/Gibco,
15090-046) for 10 min at 37°C, then triturated with a 5 ml pipette to break up large
pieces of tissue, and then triturated with a P1000 pipet until a homogeneous cell
suspension is achieved. Cells were passed through a strainer with 40 µm pores (Falcon,
352340) and plated at a density of 2,000,000--3,000,000 astrocytes per 10 cm dish.
Astrocytes were grown in glial media (DMEM [Thermo Fisher Scientific/Gibco, 11965-084] supplemented with 10% heat inactivated fetal bovine serum [Hyclone,
SH30071.03], 2 mM Glutamax [Thermo Fisher Scientific/Gibco, 35050-061], 100 U/ml
penicillin and 100 µg/ml streptomycin [Thermo Fisher Scientific/Gibco, 15-140-122]) at
37°C in a 5% CO2 incubator. The next day after plating, and every 3-5 d following, glia
were fed by replacing glial media. When glia reached 80-90% confluence (~8-10 d after
plating), astrocytes were trypsinized and plated for experiments. 200,000-500,000
astrocytes were plated per 35 mm fluorodish (World Precision Instruments, FD35-100)
coated with 500 µg/ml poly-L-lysine (Sigma, P2636) for immunofluorescence
119

microscopy, or per 6-well for immunoblotting. Astrocytes were grown in glial media for 38 DIV at 37°C in a 5% CO2 incubator. All immunoblot analyses utilized GFP-LC3
transgenic glia except those shown in (Figs. 25 C and 26) which were from nontransgenic glia. We noted no differences in the cellular response to starvation between
GFP-LC3 transgenic and non-transgenic astrocytes.
3.4.3. Primary hippocampal neuron culture
Hippocampi were dissected from brains of GFP-LC3 trans-genic mouse embryos
of either sex at day 15.5; detailed methods are found in Dong et al., 2019 [117]. In brief,
the tissue was digested with 0.25% trypsin for 10 min at 37°C, and then triturated
through a small-bore glass Pasteur pipette to achieve a homogeneous cell suspension.
For live-cell imaging, we plated 750,000-1,500,000 GFP-LC3 transgenic hippocampal
neurons in a 10 cm dish containing eight 25 mm acid-washed glass coverslips coated
with 500 µg/ml poly-L-lysine. For immunofluorescence microscopy in Fig. 28, 1,500,000
non-transgenic hippocampal neurons were plated in a 10 cm dish containing eight 25
mm acid-washed glass coverslips coated with 500 µg/ml poly-L-lysine. For
immunoblotting analysis in (Fig. 29 C-E), we obtained wild-type mouse hippocampal
neurons from the Neurons R Us core facility at the University of Pennsylvania. These
neurons were prepared from C57BL/6 mouse embryos at day 18 and plated at 240,000
cells per 6-well coated with 50 µg/ml poly-L-lysine. Neurons were grown for 8-10 DIV in
maintenance media (Neurobasal medium [Thermo Fisher Scientific/Gibco, 21-103-049]
supplemented with 2% B-27 [Thermo Fisher Scientific/Gibco, 17504-044], 37.5 mM
NaCl, 33 mM glucose [Sigma, G8769], 2 mM glutaMAX, and 100 U/ml penicillin and 100
µg/ml streptomycin) at 37°C in a 5% CO2 incubator. Every 3-4d,20-30% media was
replaced; 1 µM AraC (anti-mitotic drug; Sigma, C6645) was added to the first feed.
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3.4.4. Torin1 and starvation treatments
For the torin1 treatment, glia were incubated in glial media supplemented with
250 nM torin1, 100 nM bafilomycin A1, 250 nM torin1 and 100 nM bafilomycin A1, or an
equivalent volume of DMSO as a solvent control, for 4 h at 37°C in a 5%CO2 incubator.
For starvation experiments, the following solutions were used (Table 1; the pH for all
solutions was confirmed to be within physiological range):
For starvation experiments, cells were washed once in either regular growth
media or the indicated salt solution, and then incubated in each solution supplemented
with 100 nM bafilomycin A1, or DMSO as a solvent control, for the designated time at
37°C in a 5% CO2 incubator. In Fig. 26, glial media or the salt solutions were
supplemented with 20 µg/ml cycloheximide or an equivalent volume of water as a
solvent control and incubated for 30 min at 37°C in a 5%CO2 incubator.
3.4.5. Immunostaining
Neurons or glia were fixed for 10 min in 4% PFA/4% sucrose in PBS (150 mM
NaCl, 50 mM NaPO4, pH 7.4) previously warmed to 37°C. Cells were washed two times
in PBS, permeabilized for 5 min in 0.1% Triton X-100 (Thermo Fisher Scientific, BP151100) in PBS, washed two times in PBS, and then blocked for 1 h in PBS supplemented
with 5% goat serum (Sigma, G9023) and 1% bovine serum albumin (Thermo Fisher
Scientific, BP1605-100). Cells were then incubated in primary antibody diluted in block
solution for 1 h at room temperature, washed 3 times for 5 min each in PBS, and then
incubated in secondary antibody diluted in block solution for 1 h at room temperature.
For experiments requiring nuclear stain, Hoechst dye was included in the incubation with
secondary antibody at a final concentration of 0.5 µg/ml. Following incubation in
secondary antibody, samples were washed 3 times for 5 min each in PBS and kept in
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PBS for imaging. Samples in Fig. 28 were mounted in ProLong Gold (Thermo Fisher
Scientific/Molecular Probes, P36930).
For immunolabeling oligodendrocytes in Fig. 20, live cells were washed once in
PBS and then labeled with anti-GALC antibody for 30 min at room temperature. Cells
were then washed 5 times in PBS and then labeled with secondary anti-body and
Hoechst dye for 30 min at room temperature. Samples were washed 5 times in PBS,
fixed in 4% PFA/4%sucrose for 10 min, and then washed 2 times in PBS and kept in
PBS for imaging.
Images in (Figs. 19 B, 22 A, and 24 A) were acquired on a BioVision spinning
disk confocal microscope system consisting of a Yokagawa W1 spinning disk confocal, a
Leica DMi8 inverted widefield microscope, and Photometrics Prime 95B sCMOS
camera. Images were acquired with VisiView software using a 63X/1.4 NA PlanApochromat oil-immersion objective and solid-state 488 and 561 nm lasers for
excitation. Z-stacks were obtained of the entire astrocyte at 0.2 µm sections. For images
that would be quantitatively compared directly to each other, the same acquisition
parameters were used across treatment conditions. Images in (Figs. 19 A, 20, and 28)
were acquired on a Leica DMi8 inverted widefield microscope with a Hamamatsu Orca
Flash 4.0 V2+ sCMOS camera, with DAPI, GFP, and Texas Red filter cubes, and Leica
software. (Fig. 19 A) used a 40X/ 1.30 NA Plan-Apochromat oil-immersion PH3
objective. Fig. 20 and 28 used a 20X/0.80 NA Plan-Apochromat dry PH2 objective and
Z-stacks were obtained that spanned the entire depth of the field of glia or neurons at
0.4 µm sections.
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3.4.6. Live-cell labeling of glia with Draq7
Following the starvation treatment described above, glia were incubated in 3 µM
Draq7 and 0.5 µg/ml Hoechst dyes in either live-cell imaging media (Hibernate E [Brain
Bits, HE-Lf] supplemented with 2% B-27 and 2 mM GlutaMAX) for the fed samples, or
the indicated salt solution for the starved samples, for 10 min at 37°C in a 5% CO2
incubator. Glia were imaged on the spinning disk confocal microscope using a 40X/1.30
Plan-Apochromat oil-immersion objective and 405 and 640 nm solid state lasers with the
temperature maintained at 37°C with an environmental chamber. Z-stacks were
generated that spanned the entire depth of the field of glia at 0.5 µm sections. As a
positive control for each condition, 0.1%Triton X-100 was added to the samples and the
samples were incubated for 5 min at 37°C in the environmental chamber before
acquiring Z-stacks. Cytotoxicity was measured as the percentage of Hoechst-positive
cells that were co-positive for Draq7.
3.4.7. Live-cell imaging of neurons
For the starvation of neurons, neurons were washed once in either maintenance
media or EBSS, and then incubated in each solution supplemented with 100 nM
bafilomycin A1, or DMSO as a solvent control, for 4, 6, or 8 h at 37°C in a 5% CO2
incubator. For live-cell imaging, fed samples were imaged in Hibernate E supplemented
with 2% B-27 and 2 mM GlutaMAX, and either 100 nM bafilomycin A1 or DMSO.
Starved samples were imaged in fresh EBSS solution with either 100 nM bafilomycin A1
or DMSO. Neurons were imaged using a Chamlide CMB magnetic imaging chamber
(BioVision Technologies) for a maximum of 30 min on the spinning disk confocal microscope in an environmental chamber at 37°C. Z-stacks spanning the entire depth of the
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soma were acquired at 0.2 µm sections using a 40X/1.30 NA objective and 488 nm laser
for excitation.
3.4.8. Immunoblotting
Following torin1 or starvation treatments, cells were washed in PBS (150 mM
NaCl, 50 mM NaPO4,pH7.4)and lysed in RIPA buffer (150 mM NaCl, 1% Triton X-100,
0.5% deoxycholate [Thermo Fisher Scientific, BP349-100], 0.1% SDS [Thermo Fisher
Scientific/Invitrogen, 15-553-027], 1X complete protease inhibitor mixture [Sigma,
11697498001], 50 mM Tris-HCl, pH 7.4) for 30 min on ice. For samples measuring pRPS6/S6 or p-ULK1 levels, Halt Protease and Phosphatase inhibitor mixture (Thermo
Fisher Scientific, 78442) along with 5 mM EDTA were substituted for the Roche
complete protease inhibitor mixture. Following lysis, samples were centrifuged at 17,000
x g for 15 min at 4°C. Supernatants were analyzed by SDS-PAGE and transferred onto
an Immobilon-P PVDF membrane. Membranes were blocked in 5% milk in TBS-Igepal
(2.7 mM KCl, 137 mM NaCl, 0.05% Igepal [Sigma, I3021], 24.8 mM Tris-HCl, pH 7.4) for
30 min at room temperature, followed by incubation in primary antibody diluted in block
solution for overnight at 4°C, rocking. The following day, membranes were washed 3
times for 20 min each in HRP wash buffer (150 mM NaCl, 0.1% BSA, 0.05% Igepal, 50
mM Tris-HCl, pH 8.0) and incubated in peroxidase-conjugated secondary antibody
diluted in HRP wash buffer for 45 min at room temperature, rocking. Following
incubation in secondary antibody, membranes were washed 3 times for 20 min each in
HRP wash buffer and developed using the SuperSignal West Pico Chemiluminescent
Substrate (Thermo Fisher Scientific, PI34580).
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3.4.9. Image analysis
3.4.9.1 GFP-LC3 and SQSTM1 area
Maximum projections of Z-stacks were generated in Fiji, and the entire astrocyte
or neuron soma was outlined and measured for total area. Using Ilastik, GFP-LC3positive and SQSTM1-positive puncta were identified and segmented. Ilastik
segmentations were imported into FIJI and the area of identified objects was measured
using the “analyze particles” function. Total area occupied by GFP-LC3-positive and
SQSTM1-positive puncta per cell or soma was normalized to the corresponding cell or
soma area.
3.4.9.2. Colocalization between SQSTM1 puncta and GFP-LC3 puncta
Using the binary segmentations of GFP-LC3 and SQSTM1 puncta for each cell,
the GFP-LC3 image was subtracted from the SQSTM1 image. The remaining area
which represents SQSTM1-positive puncta that do not overlap with GFP-LC3-positive
puncta was measured in FIJI using “analyzed particles”. This area was subtracted from
the original total area of SQSTM1 puncta to express the percent area of SQSTM1positive puncta that overlaps with GFP-LC3-positive puncta. To determine the percent
area of GFP-LC3-positive puncta that overlaps with SQSTM1-positive puncta, the
SQSTM1 image was subtracted from the GFP-LC3 image and processed as above.
3.4.9.3. Quantification of western blotting
Bands were quantified using the gel analyzer tool in Fiji. To control for sample
loading differences between lanes, values for LC3-II, SQSTM1, p-ULK1, or ULK1 were
divided by values for GAPDH or TUBA1A/α-tubulin loading controls from each
corresponding lane. Values were then normalized relative to the control sample (glial
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media or maintenance media + DMSO) and expressed as a fold difference above the
control.
3.4.9.4. Statistical analysis and figure preparation
All image measurements were obtained from the raw data. GraphPad Prism was
used to plot graphs and perform statis-tical analyses; statistical tests are denoted within
each figure legend (ns, not significant; *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤
0.0001). For presentation of images, maximum and minimum gray values were adjusted
linearly in FIJI and images were assembled in Adobe Illustrator.
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CHAPTER 4: DISCUSSION

The autophagy pathway is vital for neuronal survival and function [12-16].
Neuronal autophagy has important functions at the synapse and is essential for learning
and memory [85, 90, 92, 93]. However, the molecular details of the autophagy pathway
in neurons, especially in synaptic compartments, are only beginning to be uncovered. In
this thesis, we elucidate how autophagy is regulated in neurons in response to synaptic
activity. We also demonstrate that neurons and astrocytes differentially regulate
autophagy in response to metabolic stress. In this chapter, I conclude this thesis by
highlighting the key findings from our work in the context of the field, and how they open
future paths of exploration in the field.
4.1. Conclusions
In chapter 2, we found that synaptic activity regulates the movement and function
of autophagic vacuoles (AVs) in dendrites. The effect of synaptic activity on the
dynamics of dendritic AVs is local, immediate, and reversible. Interestingly, synaptic
control of AV dynamics is specifically found in dendrites and not in axons, pointing to
compartment-specific effects of activity on autophagy. The effect of activity on AV
motility is a fundamental property of neurons grown in monoculture and in coculture with
astrocytes. Thus, synaptic control of dendritic AV motility is maintained in more complex
culturing paradigms that recapitulate intercellular interactions observed in vivo.
We found that AVs preferentially arrest at synapses in response to neuronal
activity, indicating they may be required to regulate the synaptic proteome and to
facilitate synaptic function. Induction of synaptic activity leads an increase in acidic as
well as degradative organelles in dendrites. Strikingly, synaptic activity also leads to an
increase in the percentage of AVs that are degradative, but not in the total number of
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AVs along the dendrites. These results suggest that synaptic activity stimulates the
degradative function of AVs in dendrites. Comprehensive BSA-uptake experiments
confirm that the increase in degradative function of AVs is not a consequence of
increased delivery of the BSA substrate to dendritic AVs, but rather a specific stimulation
in organelle maturation. In sum, synaptic activity controls the dynamics and degradative
function of autophagic vacuoles in neurons in a local and compartment-specific manner.
In Chapter 3, we highlight key differences in how autophagy in neurons and
astrocytes is regulated in response to metabolic stress. In astrocytes, starvation or
mTOR inhibition robustly upregulates autophagy whereas in neurons, these paradigms
have only a modest effect on autophagy [50]. Taken together, these studies
considerably strengthen our knowledge of the regulation of autophagy in the brain, and
lead to the following avenues of research.
4.2. Future directions:
4.2.1. Mechanisms regulating the transport and function of AVs in dendrites
In Chapter 2, we establish the effect of synaptic activity on AV motility in
dendrites. However, the molecular details of this process are only starting to be
discovered. Synaptic activity regulates the motility of several different organelles in
dendrites. In our study, we found that local uncaging of glutamate along dendrites also
reduced the motility of RAB5 labelled early endosomal compartments. Goo et.al found
that synaptic activity leads to lysosomes localizing more into dendritic spines [80]. Hanus
and colleagues have also reported biosynthetic ER-Golgi intermediary compartments
(ERGICs) to arrest reversibly in response to synaptic activity [106]. They note that the
mechanism driving synaptic control of dendritic ERGICs is via the upregulation of the
calcium dependent CamKII pathway. In response to increased intracellular calcium,
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CamKII mediates the phosphorylation of the serine on site 1029 of KIF17 (a motor
protein essential for ERGIC trafficking). Phosphorylation of KIF17 on the 1029 serine site
uncouples KIF17 (and thus, ERGIC compartments) from microtubules, consequently
leading to their arrest [106]. Interestingly, MacAskill et. al found that dendritic
mitochondria also display reduced motility in response to synaptic activity in a calciumdependent manner, albeit employing a slightly different mechanism [107] . They
demonstrate that activity-dependent increases in intracellular calcium uncouple the
mitochondrial adaptor Miro1 from KIF5 motors, thus indirectly disconnecting
mitochondria from microtubules and causing them to arrest [107]. Taken together, these
studies hint toward a core mechanism in dendrites that regulates organelle motility
including AVs in an activity-dependent manner. However, important questions yet
remain to be answered in the context of synaptic control of dendritic AV dynamics. For
instance, we observe that upon induction of synaptic activity, dendritic AVs preferentially
localize to synapses. Would mere uncoupling from microtubules (as observed in
ERGICs or mitochondria) be sufficient for directing AVs at specific synapses that have
degradative or biosynthetic needs? What other factors regulate the activity-dependent
localization of dendritic to synapses?
The rapid timescale on which neuronal activity affects AV motility (Figs. 3, 10)
also hints toward a mechanism driven, at least in part, by changes in intracellular
calcium. To test this, we plan to conduct experiments where we first will deplete
intracellular calcium in neurons and assess whether we observe the same arrest of
dendritic AV motility upon induction of synaptic activity. We plan to use newly developed
voltage sensing constructs (HASAP and HArcLight) [157] to assess neuronal activity and
uncouple it from changes in intracellular calcium. To further dissect the mechanism of
whether the CamKII pathway is involved, we also plan to utilize the CamKII inhibitor
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KN93 in conjunction with increasing neuronal activity and assess changes in the motility
of dendritic AVs. Interestingly, we also observed activity-dependent calcium oscillations
in axons (Fig. 7A) – but we do not observe activity-dependent changes in AV motility!
This raises the possibility of axonal AVs having molecular components that are
insensitive to changes in intracellular calcium (discussed below in further detail).
It will be important to investigate the mechanism behind the activity-dependent
maturation of dendritic AVs. One possibility is that synaptic activity leads to the
recruitment and activation of the vacuolar proton pump to dendritic AV membranes, as
observed previously in lysosomes [113]. Alternatively, as neuronal activity is coupled
with changes in the concentration of intracellular ions such as calcium, sodium,
potassium etc., counterion currents across AV membranes may be responsible for AV
acidification and thus lead to an increase in their degradative capacity. Future
experiments from our lab will test these hypotheses, and will broaden the scope of our
current study. They will lead to a molecular understanding of the activity-dependent
mechanism regulating AV motility and function in dendrites.
4.2.2. Neuronal autophagic vacuoles come in many flavors
Our studies highlight the differences in autophagic vacuoles (AVs) in dendrites
with those found in axons, both in terms of dynamics and function. Recent studies have
indicated that axonal versus dendritic AVs may also have different cargo [71, 84]. Thus,
moving forward, autophagic vacuoles in neurons need to be studied in a compartmentspecific manner and cannot be considered as homogenous organelles spanning the vast
spatial landscape of the neuron.
In axons, we observe that AVs exhibit long range processive movement in line
with previous work from our and other groups [44, 45, 50]. Indeed, immature AVs in the
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axon (Fig. 4 C) (as marked by the unquenched GFP signal from the mcherry-GFP-LC3
protein) predominantly exhibit retrograde motility, whereas mature AVs (as marked by
the lack of GFP signal from the mcherry-GFP-LC3 protein) exhibit both anterograde and
retrograde motility. Previous observations from our group have found that the majority of
immature AVs become positive for the acidotropic dye Lysotracker very quickly upon
formation [44] , indicating that they might be fusing with late endosomes/lysosomes very
early in their lifetimes after forming in the distal axon. In fact, a large majority of
immature AVs found in the axon appear to be fusion products of autophagosomes and
late endosome/lysosomes, since they are copositive for LAMP1 [44]. Cheng et. al have
since reported that fusion with late endosomes is essential for AVs to acquire the motor
protein dynein, to facilitate retrograde AV transport [49]. Along with dynein, axonal AVs
could also acquire new adaptor proteins via fusion with late endosomes or lysosomes.
Neurons may thus exploit differences in motor and adaptor protein composition on AVs
to fine-tune the regulation AV dynamics in response to various physiological stimuli.
In contrast to the long-range motility of axonal AVs, dendritic AVs predominantly
display short-range bi-directional motility. These differences can be partially attributed to
differences in microtubule polarity in axons (uniform polarity) vs dendrites (mixed
polarity). Additionally, dendritic and axonal AVs may also differ in the composition of
their motor and adaptor proteins. What can account for these differences? The answer
may lie in what specific subsets of organelles fuse with dendritic and axonal AVs. In our
study, we found that dendritic AVs fuse more readily with newly endocytosed fluid-phase
cargo - whereas axonal AVs display a very low fusion capacity with endosomes carrying
the same cargo! This indicates that axonal AVs and dendritic AVs fuse with different
subsets of organelles along the endolysosomal pathway. Different subset of organelles
are decorated with a unique set of motor and adaptor proteins. The motor and adaptor
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protein compostion of axonal and dendritic AVs may thus depend on what organelles
they fuse with. This hypothesis can provide one explanation for differences in the motility
of dendritic vs axonal AVs.
Intriguingly, in our studies we found that the motility of axonal AVs is not affected
due to changes in synaptic activity. We know that the axons also display calcium
oscillations in response to pharmacologically upregulating synaptic activity (Fig. 7 A);
however, axonal AVs do not seem to be affected by activity-mediated calcium
oscillations. This observation lends further support to the idea that axonal AVs may have
different motors or adaptor proteins that are less sensitive to changes in calcium, as
compared with dendritic AVs. Further investigation of the membrane composition of
axonal and dendritic AVs will shed more light on these potential molecular differences in
their motor and adaptor protein composition.
While acidity of an organelle is a good indicator of its maturation state, a
degradative AV (or degradative autolysosome) must also contain active lysosomal
enzymes. The presence of active lysosomal enzymes can be detected in live-cell
settings by using conditionally fluorescing substrate dyes. Such dyes (for example, DQBSA dyes as elaborated in chapter 2) only exhibit fluorescence upon being cleaved by
specific lysosomal enzymes (in the case of DQ-BSA, Cathepsin B and aspartyl
proteases – Fig. 15 E). In our studies, we found that at least ~50% of dendritic AVs are
co-positive for DQ-BSA, indicating that they are degradative autolysosomes. In contrast,
very few axonal AVs exhibit DQ-BSA fluorescence, raising the possibility that fewer
axonal AVs house active lysosomal enzymes. To further assess the functionality of
axonal AVs, we recently developed a microfluidic isolation system for culturing neurons,
where we can isolate axons from the somatodendritic region with high fidelity. Using this
approach, we first plan to assess the extent to which axonal AVs contain lysosomal
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enzymes using confocal and electron microscopy. Future experiments will be crucial in
determining the dynamics of degradative AVs in both axons and dendrites by co-labeling
these compartments with more specific, cell permeant conditionally fluorescent substrate
dyes that have been reported [158], but are not yet commercially available. It will then be
important to assess changes in degradative function of axonal and dendritic AVs upon
challenging neurons with proteotoxic stress (for example, with pathogenic a-synuclein
fibrils that are known to cause neurodegeneration). These experiments will be
instrumental in elucidating the degradative capacity of AVs in axons and dendrites in
both basal and stressed conditions.
4.2.3. Uncovering the roles of autophagy in post-synaptic compartments
Autophagy may play a critical role in local degradation as well as new
biosynthesis in post-synaptic compartments. Some recent data points towards the role of
autophagy in regulating the abundance of post-synaptic scaffolding proteins.
Components of the post-synaptic machinery such as PICK1, SHANK3 and PSD-95 have
been identified as cargoes that localize to dendritic AVs [84]. Dendritic AVs may also
sequester post-synaptic receptors and thus regulate synaptic transmission. Indeed,
previous reports have noted the presence of AMPA receptors (AMPARs) in dendritic
AVs after the neurons had undergone a paradigm of chemical LTD [51] . Goo et.al
showed that GluA1-AMPARs colocalize with a subset of LAMP1 positive vesicles in
dendrites, suggesting that GluA1-AMPAR degradation might be mediated via the
lysosomal pathway [80]. However, these groups do not assess the dynamics of
autophagy-mediated AMPAR degradation, especially using more physiological stimuli for
inducing synaptic activity, or in more complex cell-culture environments. The techniques
we developed in our study can help address these interesting questions.
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Our work highlights how synaptic activity specifically increases the degradative
capacity of dendritic AVs. We can thus hypothesize that selectively blocking dendritic
autophagy could disrupt the activity-dependent turnover of the scaffolding and receptor
proteins mentioned above. To selectively block dendritic autophagy, we can employ an
optogenetic approach. To develop this methodology, we can first tag proteins involved in
autophagy initiation with a photosensitive domain that can bind to specific membrane
proteins upon activation by light. Tagged proteins can thus be sequestered away from
synapse of interest along the dendritic shaft. This approach may be able to selectively
deplete the pool of dendritic AVs. We can then stimulate synaptic activity and assess the
turnover of candidate scaffolding and receptor proteins. These experiments will uncover
the specific roles of dendritic autophagy in the maintenance of post-synaptic proteins,
especially in different modes of neuronal activity.
Degradation of proteins via autophagy leads to the recycling of amino acids and
lipids to fuel new protein and organelle biosynthesis. We demonstrate that a high
percentage (77%) of dendritic AVs arrest at synapses in response to neuronal activity
(Fig 12), while ~70% of this pool are degradative in nature. We can thus hypothesize
that a subclass of dendritic AVs (that are degradative) may fuel new protein biosynthesis
locally in post-synaptic compartments by providing the local translational machinery with
amino acids and lipids. A second subclass of non-degradative dendritic AVs that localize
to synapses might be responsible for sequestering post synaptic membrane receptors
(as mentioned above) and damaged proteins and organelles in the short-term, to ensure
proper functioning of synapses. These non-degradative AVs may eventually fuse with
degradative compartments at later timepoints, either in the dendrites or the cell soma, to
mediate the turnover of their cargoes. In this way, a balance of sequestration and
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degradative/biosynthetic functions of dendritic AVs may be important to maintain proper
synaptic function in the face of increased neuronal activity.
Autophagy may also be important for modulating the structure of dendritic spines
in response to changes in neuronal activity. Indeed, some recent work from Glatigny and
colleagues has shown that knocking down autophagy in neurons leads to loss of activitydependent spine numbers [92]. Notably, these effects were only observed upon
induction of neuronal activity by chemical LTP, and not under basal conditions. It will be
important to assess whether these effects can be recapitulated by specifically inhibiting
post-synaptic autophagy using the optogenetic approach mentioned above. Further, it
will be critical to explore the exact mechanism by which activity-dependent changes in
dendritic spine morphology occur, in the context of autophagy. In other words, are
dendritic AVs responsible for regulating the availability of cytoskeletal and structural
proteins required for changes in the morphology of dendritic spines?
Finally, it will be important to assess the roles of autophagy at different types of
individual synapses. For instance, excitatory vs inhibitory synapses may differentially
rely on autophagy for their maintenance and plasticity. To test this, we plan to
specifically label excitatory or inhibitory synapses and assess the relative dynamics of
dendritic AVs upon modulating synaptic activity. Taken together, these experiments will
further our understanding of how dendritic autophagy can impact the formation,
maintenance and function of neuronal synapses in response to changes in neuronal
activity.
4.2.4. Synaptic autophagy in learning and memory
Several recent studies have illuminated the importance of autophagy in learning
and memory formation. A common theme across these studies is that autophagic flux in
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mouse hippocampal neurons is upregulated in response to various models of learning
(e.g., inhibitory avoidance, spatial learning, etc. as elaborated in Chapter 1.7). Further,
these studies found that autophagy is required for the formation of long-term memory but
not for short-term memory! [90, 92, 93]. Pandey et. al further noted that learning
promotes the maturation of autophagic vacuoles in hippocampal neurons [93]. As
discussed above, our studies could provide a link to understand how activity-based
induction of autophagy and degradation could impact learning and memory through
remodeling the synaptic proteome.
Many studies have also suggested that defects in the autophagy pathway lead to
neuronal dysfunction and death [12-15, 85]. Glatigny et.al demonstrated that in older
mice, autophagic activity was dampened as evidenced by lower levels of expression of
autophagy-related genes, and lower autophagic flux [92]. In fact, Glatigny et. al also
found that stimulating autophagy in older mice rescued age-related memory decline. It
will therefore be interesting to test whether increasing neuronal activity specifically in
aged or diseased neurons stimulates neuronal autophagy [92]. Increased autophagic
flux can facilitate the clearance of pathology-inducing proteins and organelles and can
also provide the biosynthetic building blocks for formation and maintenance of new
synapses. These experiments can open therapeutic avenues to employ neuronal activity
for “rejuvenating” damaged neurons.

4.2.5. Regulation of dendritic AV dynamics in different neuronal populations
In our study, we found that synaptic activity controls dendritic AV motility in both
cortical and hippocampal neurons. It will be important to assess whether our
observations of the synaptic control of dendritic AV motility extend to other neuronal
populations. As various types of neurons have a wide range of firing patterns, we can
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speculate that the dynamics and degradative capacity of dendritic AVs in each neuronal
subtype may be different, as determined by their activity state.
For instance, Purkinje cells are known to fire spontaneous action potentials at
rates higher than most hippocampal neurons[159, 160]. We can therefore predict that
the overall basal and activity-induced speeds of dendritic AVs may be much lower in
Purkinje cells than what we observe in hippocampal neurons. In our study, we found that
higher neuronal activity led to the increased degradative capacity of dendritic AVs. We
can thus speculate that even under basal conditions, the dendritic AVs of Purkinje cells
may also be more degradative in nature as compared to the dendritic AVs of
hippocampal neurons. Hence, the techniques we have developed in our studies open
avenues to explore the activity-dependent dynamics and function of AVs in various
neuronal subtypes.
In vivo, neurons display bursts of synaptic activity followed by periods of low/no
activity [161]. We may thus speculate that the biosynthetic and degradative machinery
may localize to synapses during periods of increased synaptic activity to maintain the
local proteome - and be free to navigate the dendritic shaft during periods of low/no
activity. This mechanism can enable neurons to efficiently mobilize the necessary
machinery to maintain local synaptic homeostasis. Our lab plans to collaborate with
groups who have expertise in imaging different rodent brain regions in vivo at high
resolutions using two-photon microscopy to test these challenging and exciting
hypotheses.
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4.2.6. Exploring the connections between neuronal activity and autophagy in
astrocytes
In chapter 2, we report the development of a robust system to co-culture neurons
and astrocytes to recapitulate in vivo cellular morphologies. Astrocytes form contacts
with neuronal synapses, and thus are a part of a functional unit known as the tripartite
synapse [162]. Via this functional connection with neurons, astrocytes have been shown
to be excitable by neuronal activity, and also exhibit calcium transients in response to
neuronal activity [162]. Our studies indicate that calcium transients in dendrites may be
responsible for the activity-dependent regulation of dendritic AV motility and function. We
can thus speculate that neuronal activity can also impact AV motility and function in
neighboring astrocytes, possibly in a calcium-dependent manner.
On the other hand, it will also be critical to assess whether autophagy in
astrocytes is important for the proper functioning of neuronal synapses. Using the coculture system developed in our study, we plan to block autophagy specifically in
astrocytes and study the impacts on synaptic activity, by calcium imaging and
electrophysiological measurements. Together, these studies will lead to a
comprehensive molecular understanding of the links between autophagy and synaptic
activity in the major cell types of the brain.
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